<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="86658536-ae22-47ed-93e8-8d0ae210eda0" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;article:article:pii\:S0092867420302701;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text;issue:issue:pii\:S0092867419X00094">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(20)30270-1">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/eec247c5-93c7-4d29-b8bb-a72768cf465d/fx1.jpg">
    


        <meta property="og:description" content="In mouse models of KRAS mutant pancreatic ductal adenocarcinoma, tumor cell senescence
following MEK and CDK4/6 inhibition promotes vascular remodeling through induction
of a pro-angiogenic senescence-associated secretory phenotype, leading to enhanced
drug delivery and T cell infiltration that sensitizes these tumors to chemotherapy
and immune checkpoint blockade.">
    











        <meta name="twitter:title" content="Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/eec247c5-93c7-4d29-b8bb-a72768cf465d/fx1.jpg">
    


        <meta name="twitter:description" content="In mouse models of KRAS mutant pancreatic ductal adenocarcinoma, tumor cell senescence
following MEK and CDK4/6 inhibition promotes vascular remodeling through induction
of a pro-angiogenic senescence-associated secretory phenotype, leading to enhanced
drug delivery and T cell infiltration that sensitizes these tumors to chemotherapy
and immune checkpoint blockade.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(20)30270-1">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer"> <meta name="citation_date" content="2020/04/16"> <meta name="citation_online_date" content="2020/03/31"> <meta name="citation_volume" content="181"> <meta name="citation_issue" content="2"> <meta name="citation_firstpage" content="424"> <meta name="citation_lastpage" content="441.e21"> <meta name="citation_pmid" content="32234521"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867420302701"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867420302701"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867420302701"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2020.03.008"> <meta name="citation_pmid" content="32234521"> <meta name="citation_author" content="Marcus Ruscetti"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="John P. Morris"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Riccardo Mezzadra"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="James Russell"><meta name="citation_author_institution" content="Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Josef Leibold"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Paul B. Romesser"><meta name="citation_author_institution" content="Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Janelle Simon"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Amanda Kulick"><meta name="citation_author_institution" content="Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Yu-jui Ho"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Myles Fennell"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Jinyang Li"><meta name="citation_author_institution" content="Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"><meta name="citation_author" content="Robert J. Norgard"><meta name="citation_author_institution" content="Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"><meta name="citation_author" content="John E. Wilkinson"><meta name="citation_author_institution" content="Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA"><meta name="citation_author" content="Direna Alonso-Curbelo"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Ramya Sridharan"><meta name="citation_author_institution" content="Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author_institution" content="Weill Cornell Medical College, Cornell University, New York, NY 10065, USA"><meta name="citation_author" content="Daniel A. Heller"><meta name="citation_author_institution" content="Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author_institution" content="Weill Cornell Medical College, Cornell University, New York, NY 10065, USA"><meta name="citation_author" content="Elisa de Stanchina"><meta name="citation_author_institution" content="Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author" content="Ben Z. Stanger"><meta name="citation_author_institution" content="Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"><meta name="citation_author" content="Charles J. Sherr"><meta name="citation_author_institution" content="Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA"><meta name="citation_author" content="Scott W. Lowe"><meta name="citation_author_email" content="lowes@mskcc.org"><meta name="citation_author_institution" content="Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"><meta name="citation_author_institution" content="Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA"><meta name="citation_keywords" content="pancreatic cancer; senescence; senescence-associated secretory phenotype; tumor microenvironment; vascular biology; endothelial cell activation; immunotherapy; T cells; targeted therapy; chemotherapy resistance"><meta name="citation_reference" content="citation_title=Signatures of mutational processes in human cancer; citation_author=L.B. Alexandrov; citation_author=S. Nik-Zainal; citation_author=D.C. Wedge; citation_author=S.A. Aparicio; citation_author=S. Behjati; citation_author=A.V. Biankin; citation_author=G.R. Bignell; citation_author=N. Bolli; citation_author=A. Borg; citation_author=A.L. Børresen-Dale; citation_author=Australian Pancreatic Cancer Genome Initiative; citation_author=ICGC Breast Cancer Consortium; citation_author=ICGC MMML-Seq Consortium; citation_author=ICGC PedBrain; citation_author=et al.; citation_journal_title=Nature; citation_volume=500; citation_firstpage=415; citation_lastpage=421; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis; citation_author=B. Ancrile; citation_author=K.H. Lim; citation_author=C.M. Counter; citation_journal_title=Genes Dev.; citation_volume=21; citation_firstpage=1714; citation_lastpage=1719; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=HTSeq--a Python framework to work with high-throughput sequencing data; citation_author=S. Anders; citation_author=P.T. Pyl; citation_author=W. Huber; citation_journal_title=Bioinformatics; citation_volume=31; citation_firstpage=166; citation_lastpage=169; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan; citation_author=D.J. Baker; citation_author=B.G. Childs; citation_author=M. Durik; citation_author=M.E. Wijers; citation_author=C.J. Sieben; citation_author=J. Zhong; citation_author=R.A. Saltness; citation_author=K.B. Jeganathan; citation_author=G.C. Verzosa; citation_author=A. Pezeshki; citation_author=et al.; citation_journal_title=Nature; citation_volume=530; citation_firstpage=184; citation_lastpage=189; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse; citation_author=N. Bardeesy; citation_author=A.J. Aguirre; citation_author=G.C. Chu; citation_author=K.H. Cheng; citation_author=L.V. Lopez; citation_author=A.F. Hezel; citation_author=B. Feng; citation_author=C. Brennan; citation_author=R. Weissleder; citation_author=U. Mahmood; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=103; citation_firstpage=5947; citation_lastpage=5952; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer; citation_author=J. Blando; citation_author=A. Sharma; citation_author=M.G. Higa; citation_author=H. Zhao; citation_author=L. Vence; citation_author=S.S. Yadav; citation_author=J. Kim; citation_author=A.M. Sepulveda; citation_author=M. Sharp; citation_author=A. Maitra; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=116; citation_firstpage=1692; citation_lastpage=1697; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Organoid models of human and mouse ductal pancreatic cancer; citation_author=S.F. Boj; citation_author=C.I. Hwang; citation_author=L.A. Baker; citation_author=I.I. Chio; citation_author=D.D. Engle; citation_author=V. Corbo; citation_author=M. Jager; citation_author=M. Ponz-Sarvise; citation_author=H. Tiriac; citation_author=M.S. Spector; citation_author=et al.; citation_journal_title=Cell; citation_volume=160; citation_firstpage=324; citation_lastpage=338; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Trimmomatic: a flexible trimmer for Illumina sequence data; citation_author=A.M. Bolger; citation_author=M. Lohse; citation_author=B. Usadel; citation_journal_title=Bioinformatics; citation_volume=30; citation_firstpage=2114; citation_lastpage=2120; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Safety and activity of anti-PD-L1 antibody in patients with advanced cancer; citation_author=J.R. Brahmer; citation_author=S.S. Tykodi; citation_author=L.Q. Chow; citation_author=W.J. Hwu; citation_author=S.L. Topalian; citation_author=P. Hwu; citation_author=C.G. Drake; citation_author=L.H. Camacho; citation_author=J. Kauh; citation_author=K. Odunsi; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=366; citation_firstpage=2455; citation_lastpage=2465; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells; citation_author=E.J. Brea; citation_author=C.Y. Oh; citation_author=E. Manchado; citation_author=S. Budhu; citation_author=R.S. Gejman; citation_author=G. Mo; citation_author=P. Mondello; citation_author=J.E. Han; citation_author=C.A. Jarvis; citation_author=D. Ulmert; citation_author=et al.; citation_journal_title=Cancer Immunol. Res.; citation_volume=4; citation_firstpage=936; citation_lastpage=947; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Endothelin B receptor mediates the endothelial barrier to T&nbsp;cell homing to tumors and disables immune therapy; citation_author=R.J. Buckanovich; citation_author=A. Facciabene; citation_author=S. Kim; citation_author=F. Benencia; citation_author=D. Sasaroli; citation_author=K. Balint; citation_author=D. Katsaros; citation_author=A. O’Brien-Jenkins; citation_author=P.A. Gimotty; citation_author=G. Coukos; citation_journal_title=Nat. Med.; citation_volume=14; citation_firstpage=28; citation_lastpage=36; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer; citation_author=M.E. Caldwell; citation_author=G.M. DeNicola; citation_author=C.P. Martins; citation_author=M.A. Jacobetz; citation_author=A. Maitra; citation_author=R.H. Hruban; citation_author=D.A. Tuveson; citation_journal_title=Oncogene; citation_volume=31; citation_firstpage=1599; citation_lastpage=1608; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Phase II study of gemcitabine in patients with advanced pancreatic cancer; citation_author=J. Carmichael; citation_author=U. Fink; citation_author=R.C. Russell; citation_author=M.F. Spittle; citation_author=A.L. Harris; citation_author=G. Spiessi; citation_author=J. Blatter; citation_journal_title=Br. J. Cancer; citation_volume=73; citation_firstpage=101; citation_lastpage=105; citation_publication_date=1996; "><meta name="citation_reference" content="citation_title=Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions; citation_author=C. Carrière; citation_author=A.J. Gore; citation_author=A.M. Norris; citation_author=J.R. Gunn; citation_author=A.L. Young; citation_author=D.S. Longnecker; citation_author=M. Korc; citation_journal_title=Gastroenterology; citation_volume=141; citation_firstpage=1091; citation_lastpage=1101; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels; citation_author=V.P. Chauhan; citation_author=J.D. Martin; citation_author=H. Liu; citation_author=D.A. Lacorre; citation_author=S.R. Jain; citation_author=S.V. Kozin; citation_author=T. Stylianopoulos; citation_author=A.S. Mousa; citation_author=X. Han; citation_author=P. Adstamongkonkul; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=4; citation_firstpage=2516; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence; citation_author=A. Chicas; citation_author=X. Wang; citation_author=C. Zhang; citation_author=M. McCurrach; citation_author=Z. Zhao; citation_author=O. Mert; citation_author=R.A. Dickins; citation_author=M. Narita; citation_author=M. Zhang; citation_author=S.W. Lowe; citation_journal_title=Cancer Cell; citation_volume=17; citation_firstpage=376; citation_lastpage=387; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity; citation_author=Y. Chien; citation_author=C. Scuoppo; citation_author=X. Wang; citation_author=X. Fang; citation_author=B. Balgley; citation_author=J.E. Bolden; citation_author=P. Premsrirut; citation_author=W. Luo; citation_author=A. Chicas; citation_author=C.S. Lee; citation_author=et al.; citation_journal_title=Genes Dev.; citation_volume=25; citation_firstpage=2125; citation_lastpage=2136; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples; citation_author=K. Cibulskis; citation_author=M.S. Lawrence; citation_author=S.L. Carter; citation_author=A. Sivachenko; citation_author=D. Jaffe; citation_author=C. Sougnez; citation_author=S. Gabriel; citation_author=M. Meyerson; citation_author=E.S. Lander; citation_author=G. Getz; citation_journal_title=Nat. Biotechnol.; citation_volume=31; citation_firstpage=213; citation_lastpage=219; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Dynamics of the immune reaction to pancreatic cancer from inception to invasion; citation_author=C.E. Clark; citation_author=S.R. Hingorani; citation_author=R. Mick; citation_author=C. Combs; citation_author=D.A. Tuveson; citation_author=R.H. Vonderheide; citation_journal_title=Cancer Res.; citation_volume=67; citation_firstpage=9518; citation_lastpage=9527; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice; citation_author=M.A. Collins; citation_author=F. Bednar; citation_author=Y. Zhang; citation_author=J.C. Brisset; citation_author=S. Galbán; citation_author=C.J. Galbán; citation_author=S. Rakshit; citation_author=K.S. Flannagan; citation_author=N.V. Adsay; citation_author=M. Pasca di Magliano; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=122; citation_firstpage=639; citation_lastpage=653; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Metastatic pancreatic cancer is dependent on oncogenic Kras in mice; citation_author=M.A. Collins; citation_author=J.C. Brisset; citation_author=Y. Zhang; citation_author=F. Bednar; citation_author=J. Pierre; citation_author=K.A. Heist; citation_author=C.J. Galbán; citation_author=S. Galbán; citation_author=M.P. di Magliano; citation_journal_title=PLoS ONE; citation_volume=7; citation_firstpage=e49707; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence; citation_author=J.P. Coppé; citation_author=K. Kauser; citation_author=J. Campisi; citation_author=C.M. Beauséjour; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=281; citation_firstpage=29568; citation_lastpage=29574; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor; citation_author=J.P. Coppé; citation_author=C.K. Patil; citation_author=F. Rodier; citation_author=Y. Sun; citation_author=D.P. Muñoz; citation_author=J. Goldstein; citation_author=P.S. Nelson; citation_author=P.Y. Desprez; citation_author=J. Campisi; citation_journal_title=PLoS Biol.; citation_volume=6; citation_firstpage=2853; citation_lastpage=2868; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=The senescence-associated secretory phenotype: the dark side of tumor suppression; citation_author=J.P. Coppé; citation_author=P.Y. Desprez; citation_author=A. Krtolica; citation_author=J. Campisi; citation_journal_title=Annu. Rev. Pathol.; citation_volume=5; citation_firstpage=99; citation_lastpage=118; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA; citation_author=M. Demaria; citation_author=N. Ohtani; citation_author=S.A. Youssef; citation_author=F. Rodier; citation_author=W. Toussaint; citation_author=J.R. Mitchell; citation_author=R.M. Laberge; citation_author=J. Vijg; citation_author=H. Van Steeg; citation_author=M.E. Dollé; citation_author=et al.; citation_journal_title=Dev. Cell; citation_volume=31; citation_firstpage=722; citation_lastpage=733; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse; citation_author=M. Demaria; citation_author=M.N. O’Leary; citation_author=J. Chang; citation_author=L. Shao; citation_author=S. Liu; citation_author=F. Alimirah; citation_author=K. Koenig; citation_author=C. Le; citation_author=N. Mitin; citation_author=A.M. Deal; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=7; citation_firstpage=165; citation_lastpage=176; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation; citation_author=J. Deng; citation_author=E.S. Wang; citation_author=R.W. Jenkins; citation_author=S. Li; citation_author=R. Dries; citation_author=K. Yates; citation_author=S. Chhabra; citation_author=W. Huang; citation_author=H. Liu; citation_author=A.R. Aref; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=8; citation_firstpage=216; citation_lastpage=233; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=STAR: ultrafast universal RNA-seq aligner; citation_author=A. Dobin; citation_author=C.A. Davis; citation_author=F. Schlesinger; citation_author=J. Drenkow; citation_author=C. Zaleski; citation_author=S. Jha; citation_author=P. Batut; citation_author=M. Chaisson; citation_author=T.R. Gingeras; citation_journal_title=Bioinformatics; citation_volume=29; citation_firstpage=15; citation_lastpage=21; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade; citation_author=P.J.R. Ebert; citation_author=J. Cheung; citation_author=Y. Yang; citation_author=E. McNamara; citation_author=R. Hong; citation_author=M. Moskalenko; citation_author=S.E. Gould; citation_author=H. Maecker; citation_author=B.A. Irving; citation_author=J.M. Kim; citation_author=et al.; citation_journal_title=Immunity; citation_volume=44; citation_firstpage=609; citation_lastpage=621; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Therapy-induced senescence in cancer; citation_author=J.A. Ewald; citation_author=J.A. Desotelle; citation_author=G. Wilding; citation_author=D.F. Jarrard; citation_journal_title=J.&nbsp;Natl. Cancer Inst.; citation_volume=102; citation_firstpage=1536; citation_lastpage=1546; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Unmasking senescence: context-dependent effects of SASP in cancer; citation_author=D.V. Faget; citation_author=Q. Ren; citation_author=S.A. Stewart; citation_journal_title=Nat. Rev. Cancer; citation_volume=19; citation_firstpage=439; citation_lastpage=453; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer; citation_author=C. Feig; citation_author=J.O. Jones; citation_author=M. Kraman; citation_author=R.J. Wells; citation_author=A. Deonarine; citation_author=D.S. Chan; citation_author=C.M. Connell; citation_author=E.W. Roberts; citation_author=Q. Zhao; citation_author=O.L. Caballero; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=110; citation_firstpage=20212; citation_lastpage=20217; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=CDK4/6 inhibition triggers anti-tumour immunity; citation_author=S. Goel; citation_author=M.J. DeCristo; citation_author=A.C. Watt; citation_author=H. BrinJones; citation_author=J. Sceneay; citation_author=B.B. Li; citation_author=N. Khan; citation_author=J.M. Ubellacker; citation_author=S. Xie; citation_author=O. Metzger-Filho; citation_author=et al.; citation_journal_title=Nature; citation_volume=548; citation_firstpage=471; citation_lastpage=475; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Vascular normalization in Rgs5-deficient tumours promotes immune destruction; citation_author=J. Hamzah; citation_author=M. Jugold; citation_author=F. Kiessling; citation_author=P. Rigby; citation_author=M. Manzur; citation_author=H.H. Marti; citation_author=T. Rabie; citation_author=S. Kaden; citation_author=H.J. Gröne; citation_author=G.J. Hämmerling; citation_author=et al.; citation_journal_title=Nature; citation_volume=453; citation_firstpage=410; citation_lastpage=414; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=The hallmarks of cancer; citation_author=D. Hanahan; citation_author=R.A. Weinberg; citation_journal_title=Cell; citation_volume=100; citation_firstpage=57; citation_lastpage=70; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Mouse models of pancreatic cancer; citation_author=M. Herreros-Villanueva; citation_author=E. Hijona; citation_author=A. Cosme; citation_author=L. Bujanda; citation_journal_title=World J. Gastroenterol.; citation_volume=18; citation_firstpage=1286; citation_lastpage=1294; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse; citation_author=S.R. Hingorani; citation_author=E.F. Petricoin; citation_author=A. Maitra; citation_author=V. Rajapakse; citation_author=C. King; citation_author=M.A. Jacobetz; citation_author=S. Ross; citation_author=T.P. Conrads; citation_author=T.D. Veenstra; citation_author=B.A. Hitt; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=4; citation_firstpage=437; citation_lastpage=450; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy; citation_author=Y. Huang; citation_author=J. Yuan; citation_author=E. Righi; citation_author=W.S. Kamoun; citation_author=M. Ancukiewicz; citation_author=J. Nezivar; citation_author=M. Santosuosso; citation_author=J.D. Martin; citation_author=M.R. Martin; citation_author=F. Vianello; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=109; citation_firstpage=17561; citation_lastpage=17566; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Improving immune-vascular crosstalk for cancer immunotherapy; citation_author=Y. Huang; citation_author=B.Y.S. Kim; citation_author=C.K. Chan; citation_author=S.M. Hahn; citation_author=I.L. Weissman; citation_author=W. Jiang; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=195; citation_lastpage=203; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Endothelial cell activation. A central pathophysiological process; citation_author=B.J. Hunt; citation_author=K.M. Jurd; citation_journal_title=BMJ; citation_volume=316; citation_firstpage=1328; citation_lastpage=1329; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Lessons from phase III clinical trials on anti-VEGF therapy for cancer; citation_author=R.K. Jain; citation_author=D.G. Duda; citation_author=J.W. Clark; citation_author=J.S. Loeffler; citation_journal_title=Nat. Clin. Pract. Oncol.; citation_volume=3; citation_firstpage=24; citation_lastpage=40; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy; citation_author=H. Jiang; citation_author=S. Hegde; citation_author=B.L. Knolhoff; citation_author=Y. Zhu; citation_author=J.M. Herndon; citation_author=M.A. Meyer; citation_author=T.M. Nywening; citation_author=W.G. Hawkins; citation_author=I.M. Shapiro; citation_author=D.T. Weaver; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=22; citation_firstpage=851; citation_lastpage=860; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Senescence surveillance of pre-malignant hepatocytes limits liver cancer development; citation_author=T.W. Kang; citation_author=T. Yevsa; citation_author=N. Woller; citation_author=L. Hoenicke; citation_author=T. Wuestefeld; citation_author=D. Dauch; citation_author=A. Hohmeyer; citation_author=M. Gereke; citation_author=R. Rudalska; citation_author=A. Potapova; citation_author=et al.; citation_journal_title=Nature; citation_volume=479; citation_firstpage=547; citation_lastpage=551; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer; citation_author=A. Kapoor; citation_author=W. Yao; citation_author=H. Ying; citation_author=S. Hua; citation_author=A. Liewen; citation_author=Q. Wang; citation_author=Y. Zhong; citation_author=C.J. Wu; citation_author=A. Sadanandam; citation_author=B. Hu; citation_author=et al.; citation_journal_title=Cell; citation_volume=158; citation_firstpage=185; citation_lastpage=197; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place; citation_author=P. Kotsantis; citation_author=E. Petermann; citation_author=S.J. Boulton; citation_journal_title=Cancer Discov.; citation_volume=8; citation_firstpage=537; citation_lastpage=555; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha; citation_author=M. Kraman; citation_author=P.J. Bambrough; citation_author=J.N. Arnold; citation_author=E.W. Roberts; citation_author=L. Magiera; citation_author=J.O. Jones; citation_author=A. Gopinathan; citation_author=D.A. Tuveson; citation_author=D.T. Fearon; citation_journal_title=Science; citation_volume=330; citation_firstpage=827; citation_lastpage=830; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Senescence of activated stellate cells limits liver fibrosis; citation_author=V. Krizhanovsky; citation_author=M. Yon; citation_author=R.A. Dickins; citation_author=S. Hearn; citation_author=J. Simon; citation_author=C. Miething; citation_author=H. Yee; citation_author=L. Zender; citation_author=S.W. Lowe; citation_journal_title=Cell; citation_volume=134; citation_firstpage=657; citation_lastpage=667; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Senescence-messaging secretome: SMS-ing cellular stress; citation_author=T. Kuilman; citation_author=D.S. Peeper; citation_journal_title=Nat. Rev. Cancer; citation_volume=9; citation_firstpage=81; citation_lastpage=94; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Enrichr: a comprehensive gene set enrichment analysis web server 2016 update; citation_author=M.V. Kuleshov; citation_author=M.R. Jones; citation_author=A.D. Rouillard; citation_author=N.F. Fernandez; citation_author=Q. Duan; citation_author=Z. Wang; citation_author=S. Koplev; citation_author=S.L. Jenkins; citation_author=K.M. Jagodnik; citation_author=A. Lachmann; citation_author=et al.; citation_journal_title=Nucleic Acids Res.; citation_volume=44; citation_number=W1; citation_firstpage=W90-7; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Stromal response to Hedgehog signaling restrains pancreatic cancer progression.; citation_author=J.J. Lee; citation_author=R.M. Perera; citation_author=H. Wang; citation_author=D.C. Wu; citation_author=X.S. Liu; citation_author=S. Han; citation_author=J. Fitamant; citation_author=P.D. Jones; citation_author=K.S. Ghanta; citation_author=S. Kawano; citation_author=et al.; citation_journal_title=Proc Natl Acad Sci U S A; citation_firstpage=E3091; citation_lastpage=E3100; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis; citation_author=M. Lesina; citation_author=S.M. Wörmann; citation_author=J. Morton; citation_author=K.N. Diakopoulos; citation_author=O. Korneeva; citation_author=M. Wimmer; citation_author=H. Einwächter; citation_author=J. Sperveslage; citation_author=I.E. Demir; citation_author=T. Kehl; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=126; citation_firstpage=2919; citation_lastpage=2932; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Fast and accurate short read alignment with Burrows-Wheeler transform; citation_author=H. Li; citation_author=R. Durbin; citation_journal_title=Bioinformatics; citation_volume=25; citation_firstpage=1754; citation_lastpage=1760; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=featureCounts: an efficient general purpose program for assigning sequence reads to genomic features; citation_author=Y. Liao; citation_author=G.K. Smyth; citation_author=W. Shi; citation_journal_title=Bioinformatics; citation_volume=30; citation_firstpage=923; citation_lastpage=930; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer; citation_author=M. Ligorio; citation_author=S. Sil; citation_author=J. Malagon-Lopez; citation_author=L.T. Nieman; citation_author=S. Misale; citation_author=M. Di Pilato; citation_author=R.Y. Ebright; citation_author=M.N. Karabacak; citation_author=A.S. Kulkarni; citation_author=A. Liu; citation_author=et al.; citation_journal_title=Cell; citation_volume=178; citation_firstpage=160; citation_lastpage=175 e127; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors; citation_author=P. Lorenzon; citation_author=E. Vecile; citation_author=E. Nardon; citation_author=E. Ferrero; citation_author=J.M. Harlan; citation_author=F. Tedesco; citation_author=A. Dobrina; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=142; citation_firstpage=1381; citation_lastpage=1391; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2; citation_author=M.I. Love; citation_author=W. Huber; citation_author=S. Anders; citation_journal_title=Genome Biol.; citation_volume=15; citation_firstpage=550; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Non-cell-autonomous tumor suppression by p53; citation_author=A. Lujambio; citation_author=L. Akkari; citation_author=J. Simon; citation_author=D. Grace; citation_author=D.F. Tschaharganeh; citation_author=J.E. Bolden; citation_author=Z. Zhao; citation_author=V. Thapar; citation_author=J.A. Joyce; citation_author=V. Krizhanovsky; citation_author=S.W. Lowe; citation_journal_title=Cell; citation_volume=153; citation_firstpage=449; citation_lastpage=460; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=A combinatorial strategy for treating KRAS-mutant lung cancer; citation_author=E. Manchado; citation_author=S. Weissmueller; citation_author=J.P. Morris; citation_author=C.C. Chen; citation_author=R. Wullenkord; citation_author=A. Lujambio; citation_author=E. de Stanchina; citation_author=J.T. Poirier; citation_author=J.F. Gainor; citation_author=R.B. Corcoran; citation_author=et al.; citation_journal_title=Nature; citation_volume=534; citation_firstpage=647; citation_lastpage=651; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Cutadapt removes adapter sequences from high-throughput sequencing reads; citation_author=M. Martin; citation_journal_title=EMBnet.journal; citation_volume=17; citation_firstpage=10; citation_lastpage=12; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data; citation_author=A. McKenna; citation_author=M. Hanna; citation_author=E. Banks; citation_author=A. Sivachenko; citation_author=K. Cibulskis; citation_author=A. Kernytsky; citation_author=K. Garimella; citation_author=D. Altshuler; citation_author=S. Gabriel; citation_author=M. Daly; citation_author=M.A. DePristo; citation_journal_title=Genome Res.; citation_volume=20; citation_firstpage=1297; citation_lastpage=1303; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma; citation_author=E. Meylan; citation_author=A.L. Dooley; citation_author=D.M. Feldser; citation_author=L. Shen; citation_author=E. Turk; citation_author=C. Ouyang; citation_author=T. Jacks; citation_journal_title=Nature; citation_volume=462; citation_firstpage=104; citation_lastpage=107; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in&nbsp;vitro and in a mouse xenograft model in&nbsp;vivo; citation_author=J. Mikuła-Pietrasik; citation_author=P. Sosińska; citation_author=E. Naumowicz; citation_author=K. Maksin; citation_author=H. Piotrowska; citation_author=A. Woźniak; citation_author=D. Szpurek; citation_author=K. Książek; citation_journal_title=Clin. Exp. Metastasis; citation_volume=33; citation_firstpage=15; citation_lastpage=27; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma; citation_author=J.P. Morris; citation_author=S.C. Wang; citation_author=M. Hebrok; citation_journal_title=Nat. Rev. Cancer; citation_volume=10; citation_firstpage=683; citation_lastpage=695; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=α-Ketoglutarate links p53 to cell fate during tumour suppression; citation_author=J.P. Morris; citation_author=J.J. Yashinskie; citation_author=R. Koche; citation_author=R. Chandwani; citation_author=S. Tian; citation_author=C.C. Chen; citation_author=T. Baslan; citation_author=Z.S. Marinkovic; citation_author=F.J. Sánchez-Rivera; citation_author=S.D. Leach; citation_author=et al.; citation_journal_title=Nature; citation_volume=573; citation_firstpage=595; citation_lastpage=599; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer; citation_author=J.P. Morton; citation_author=P. Timpson; citation_author=S.A. Karim; citation_author=R.A. Ridgway; citation_author=D. Athineos; citation_author=B. Doyle; citation_author=N.B. Jamieson; citation_author=K.A. Oien; citation_author=A.M. Lowy; citation_author=V.G. Brunton; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=107; citation_firstpage=246; citation_lastpage=251; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=ABRA: improved coding indel detection via assembly-based realignment; citation_author=L.E. Mose; citation_author=M.D. Wilkerson; citation_author=D.N. Hayes; citation_author=C.M. Perou; citation_author=J.S. Parker; citation_journal_title=Bioinformatics; citation_volume=30; citation_firstpage=2813; citation_lastpage=2815; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Tissue damage and senescence provide critical signals for cellular reprogramming in&nbsp;vivo; citation_author=L. Mosteiro; citation_author=C. Pantoja; citation_author=N. Alcazar; citation_author=R.M. Marión; citation_author=D. Chondronasiou; citation_author=M. Rovira; citation_author=P.J. Fernandez-Marcos; citation_author=M. Muñoz-Martin; citation_author=C. Blanco-Aparicio; citation_author=J. Pastor; citation_author=et al.; citation_journal_title=Science; citation_volume=354; citation_firstpage=aaf4445; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Mechanisms of transendothelial migration of leukocytes; citation_author=W.A. Muller; citation_journal_title=Circ. Res.; citation_volume=105; citation_firstpage=223; citation_lastpage=230; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T&nbsp;cell extravasation; citation_author=A. Nandi; citation_author=P. Estess; citation_author=M. Siegelman; citation_journal_title=Immunity; citation_volume=20; citation_firstpage=455; citation_lastpage=465; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence; citation_author=M. Narita; citation_author=S. Nũnez; citation_author=E. Heard; citation_author=M. Narita; citation_author=A.W. Lin; citation_author=S.A. Hearn; citation_author=D.L. Spector; citation_author=G.J. Hannon; citation_author=S.W. Lowe; citation_journal_title=Cell; citation_volume=113; citation_firstpage=703; citation_lastpage=716; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Of flies, mice, and men: evolutionarily conserved tissue damage responses and aging; citation_author=J. Neves; citation_author=M. Demaria; citation_author=J. Campisi; citation_author=H. Jasper; citation_journal_title=Dev. Cell; citation_volume=32; citation_firstpage=9; citation_lastpage=18; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer; citation_author=D. Öhlund; citation_author=A. Handly-Santana; citation_author=G. Biffi; citation_author=E. Elyada; citation_author=A.S. Almeida; citation_author=M. Ponz-Sarvise; citation_author=V. Corbo; citation_author=T.E. Oni; citation_author=S.A. Hearn; citation_author=E.J. Lee; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=214; citation_firstpage=579; citation_lastpage=596; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Molecular pathways: the basis for rational combination using MEK inhibitors in KRAS-mutant cancers; citation_author=S. Okumura; citation_author=P.A. Jänne; citation_journal_title=Clin. Cancer Res.; citation_volume=20; citation_firstpage=4193; citation_lastpage=4199; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer; citation_author=K.P. Olive; citation_author=M.A. Jacobetz; citation_author=C.J. Davidson; citation_author=A. Gopinathan; citation_author=D. McIntyre; citation_author=D. Honess; citation_author=B. Madhu; citation_author=M.A. Goldgraben; citation_author=M.E. Caldwell; citation_author=D. Allard; citation_author=et al.; citation_journal_title=Science; citation_volume=324; citation_firstpage=1457; citation_lastpage=1461; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy; citation_author=M. Oubaha; citation_author=K. Miloudi; citation_author=A. Dejda; citation_author=V. Guber; citation_author=G. Mawambo; citation_author=M.A. Germain; citation_author=G. Bourdel; citation_author=N. Popovic; citation_author=F.A. Rezende; citation_author=R.J. Kaufman; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=8; citation_firstpage=362ra144; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies; citation_author=R.Z. Panni; citation_author=J.M. Herndon; citation_author=C. Zuo; citation_author=S. Hegde; citation_author=G.D. Hogg; citation_author=B.L. Knolhoff; citation_author=M.A. Breden; citation_author=X. Li; citation_author=V.E. Krisnawan; citation_author=S.Q. Khan; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=11; citation_firstpage=eaau9240; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Gemcitabine: metabolism, mechanisms of action, and self-potentiation; citation_author=W. Plunkett; citation_author=P. Huang; citation_author=Y.Z. Xu; citation_author=V. Heinemann; citation_author=R. Grunewald; citation_author=V. Gandhi; citation_journal_title=Semin. Oncol.; citation_volume=22; citation_number=4, Suppl 11; citation_firstpage=3; citation_lastpage=10; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2; citation_author=J.T. Poirier; citation_author=E.E. Gardner; citation_author=N. Connis; citation_author=A.L. Moreira; citation_author=E. de Stanchina; citation_author=C.L. Hann; citation_author=C.M. Rudin; citation_journal_title=Oncogene; citation_volume=34; citation_firstpage=5869; citation_lastpage=5878; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma; citation_author=P.P. Provenzano; citation_author=C. Cuevas; citation_author=A.E. Chang; citation_author=V.K. Goel; citation_author=D.D. Von Hoff; citation_author=S.R. Hingorani; citation_journal_title=Cancer Cell; citation_volume=21; citation_firstpage=418; citation_lastpage=429; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma; citation_author=A.D. Rhim; citation_author=P.E. Oberstein; citation_author=D.H. Thomas; citation_author=E.T. Mirek; citation_author=C.F. Palermo; citation_author=S.A. Sastra; citation_author=E.N. Dekleva; citation_author=T. Saunders; citation_author=C.P. Becerra; citation_author=I.W. Tattersall; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=735; citation_lastpage=747; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Cancer immunotherapy using checkpoint blockade; citation_author=A. Ribas; citation_author=J.D. Wolchok; citation_journal_title=Science; citation_volume=359; citation_firstpage=1350; citation_lastpage=1355; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma; citation_author=A. Ribas; citation_author=D. Lawrence; citation_author=V. Atkinson; citation_author=S. Agarwal; citation_author=W.H. Miller; citation_author=M.S. Carlino; citation_author=R. Fisher; citation_author=G.V. Long; citation_author=F.S. Hodi; citation_author=J. Tsoi; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=936; citation_lastpage=940; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench; citation_author=D.E. Rosow; citation_author=A.S. Liss; citation_author=O. Strobel; citation_author=S. Fritz; citation_author=D. Bausch; citation_author=N.P. Valsangkar; citation_author=J. Alsina; citation_author=B. Kulemann; citation_author=J.K. Park; citation_author=J. Yamaguchi; citation_author=et al.; citation_journal_title=Surgery; citation_volume=152; citation_number=3, Suppl 1; citation_firstpage=S19; citation_lastpage=S32; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma; citation_author=R.E. Royal; citation_author=C. Levy; citation_author=K. Turner; citation_author=A. Mathur; citation_author=M. Hughes; citation_author=U.S. Kammula; citation_author=R.M. Sherry; citation_author=S.L. Topalian; citation_author=J.C. Yang; citation_author=I. Lowy; citation_author=S.A. Rosenberg; citation_journal_title=J.&nbsp;Immunother.; citation_volume=33; citation_firstpage=828; citation_lastpage=833; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination; citation_author=M. Ruscetti; citation_author=J. Leibold; citation_author=M.J. Bott; citation_author=M. Fennell; citation_author=A. Kulick; citation_author=N.R. Salgado; citation_author=C.C. Chen; citation_author=Y.J. Ho; citation_author=F.J. Sanchez-Rivera; citation_author=J. Feucht; citation_author=et al.; citation_journal_title=Science; citation_volume=362; citation_firstpage=1416; citation_lastpage=1422; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Host tissue determinants of tumour immunity; citation_author=H. Salmon; citation_author=R. Remark; citation_author=S. Gnjatic; citation_author=M. Merad; citation_journal_title=Nat. Rev. Cancer; citation_volume=19; citation_firstpage=215; citation_lastpage=227; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Tumor mutational load predicts survival after immunotherapy across multiple cancer types; citation_author=R.M. Samstein; citation_author=C.H. Lee; citation_author=A.N. Shoushtari; citation_author=M.D. Hellmann; citation_author=R. Shen; citation_author=Y.Y. Janjigian; citation_author=D.A. Barron; citation_author=A. Zehir; citation_author=E.J. Jordan; citation_author=A. Omuro; citation_author=et al.; citation_journal_title=Nat. Genet.; citation_volume=51; citation_firstpage=202; citation_lastpage=206; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade; citation_author=D.A. Schaer; citation_author=R.P. Beckmann; citation_author=J.A. Dempsey; citation_author=L. Huber; citation_author=A. Forest; citation_author=N. Amaladas; citation_author=Y. Li; citation_author=Y.C. Wang; citation_author=E.R. Rasmussen; citation_author=D. Chin; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=22; citation_firstpage=2978; citation_lastpage=2994; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Cellular senescence mediates fibrotic pulmonary disease; citation_author=M.J. Schafer; citation_author=T.A. White; citation_author=K. Iijima; citation_author=A.J. Haak; citation_author=G. Ligresti; citation_author=E.J. Atkinson; citation_author=A.L. Oberg; citation_author=J. Birch; citation_author=H. Salmonowicz; citation_author=Y. Zhu; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=8; citation_firstpage=14532; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Neoantigens in cancer immunotherapy; citation_author=T.N. Schumacher; citation_author=R.D. Schreiber; citation_journal_title=Science; citation_volume=348; citation_firstpage=69; citation_lastpage=74; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a; citation_author=M. Serrano; citation_author=A.W. Lin; citation_author=M.E. McCurrach; citation_author=D. Beach; citation_author=S.W. Lowe; citation_journal_title=Cell; citation_volume=88; citation_firstpage=593; citation_lastpage=602; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=The diverse functions of the PD1 inhibitory pathway; citation_author=A.H. Sharpe; citation_author=K.E. Pauken; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=153; citation_lastpage=167; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer; citation_author=R.K. Shrimali; citation_author=Z. Yu; citation_author=M.R. Theoret; citation_author=D. Chinnasamy; citation_author=N.P. Restifo; citation_author=S.A. Rosenberg; citation_journal_title=Cancer Res.; citation_volume=70; citation_firstpage=6171; citation_lastpage=6180; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Two-Step Senescence-Focused Cancer Therapies; citation_author=C.J. Sieben; citation_author=I. Sturmlechner; citation_author=B. van de Sluis; citation_author=J.M. van Deursen; citation_journal_title=Trends Cell Biol.; citation_volume=28; citation_firstpage=723; citation_lastpage=737; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Cancer statistics, 2019; citation_author=R.L. Siegel; citation_author=K.D. Miller; citation_author=A. Jemal; citation_journal_title=CA Cancer J. Clin.; citation_volume=69; citation_firstpage=7; citation_lastpage=34; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma; citation_author=C.W. Steele; citation_author=S.A. Karim; citation_author=J.D.G. Leach; citation_author=P. Bailey; citation_author=R. Upstill-Goddard; citation_author=L. Rishi; citation_author=M. Foth; citation_author=S. Bryson; citation_author=K. McDaid; citation_author=Z. Wilson; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=29; citation_firstpage=832; citation_lastpage=845; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3; citation_author=C. Sun; citation_author=S. Hobor; citation_author=A. Bertotti; citation_author=D. Zecchin; citation_author=S. Huang; citation_author=F. Galimi; citation_author=F. Cottino; citation_author=A. Prahallad; citation_author=W. Grernrum; citation_author=A. Tzani; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=7; citation_firstpage=86; citation_lastpage=93; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Regulation and Function of the PD-L1 Checkpoint; citation_author=C. Sun; citation_author=R. Mezzadra; citation_author=T.N. Schumacher; citation_journal_title=Immunity; citation_volume=48; citation_firstpage=434; citation_lastpage=452; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance; citation_author=N. Tasdemir; citation_author=A. Banito; citation_author=J.S. Roe; citation_author=D. Alonso-Curbelo; citation_author=M. Camiolo; citation_author=D.F. Tschaharganeh; citation_author=C.H. Huang; citation_author=O. Aksoy; citation_author=J.E. Bolden; citation_author=C.C. Chen; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=6; citation_firstpage=612; citation_lastpage=629; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Inflammatory networks and immune surveillance of pancreatic carcinoma; citation_author=R.H. Vonderheide; citation_author=L.J. Bayne; citation_journal_title=Curr. Opin. Immunol.; citation_volume=25; citation_firstpage=200; citation_lastpage=205; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation; citation_author=R.A. Woo; citation_author=R.Y. Poon; citation_journal_title=Genes Dev.; citation_volume=18; citation_firstpage=1317; citation_lastpage=1330; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Diminished leukocyte-endothelium interaction in tumor microvessels; citation_author=N.Z. Wu; citation_author=B. Klitzman; citation_author=R. Dodge; citation_author=M.W. Dewhirst; citation_journal_title=Cancer Res.; citation_volume=52; citation_firstpage=4265; citation_lastpage=4268; citation_publication_date=1992; "><meta name="citation_reference" content="citation_title=Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas; citation_author=W. Xue; citation_author=L. Zender; citation_author=C. Miething; citation_author=R.A. Dickins; citation_author=E. Hernando; citation_author=V. Krizhanovsky; citation_author=C. Cordon-Cardo; citation_author=S.W. Lowe; citation_journal_title=Nature; citation_volume=445; citation_firstpage=656; citation_lastpage=660; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Anti-Angiogenics: Current Situation and Future Perspectives; citation_author=K. Zirlik; citation_author=J. Duyster; citation_journal_title=Oncol. Res. Treat.; citation_volume=41; citation_firstpage=166; citation_lastpage=171; citation_publication_date=2018; "><meta name="citation_abstract" content="<h2>Summary</h2><p>KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic response that promotes hypovascularity, immunosuppression, and resistance to chemo- and immunotherapies. We show that a combination of MEK and CDK4/6 inhibitors that target KRAS-directed oncogenic signaling can suppress PDAC proliferation through induction of retinoblastoma (RB) protein-mediated senescence. In preclinical mouse models of PDAC, this senescence-inducing therapy produces a senescence-associated secretory phenotype (SASP) that includes pro-angiogenic factors that promote tumor vascularization, which in turn enhances drug delivery and efficacy of cytotoxic gemcitabine chemotherapy. In addition, SASP-mediated endothelial cell activation stimulates the accumulation of CD8<sup>+</sup> T&nbsp;cells into otherwise immunologically &quot;cold&quot; tumors, sensitizing tumors to PD-1 checkpoint blockade. Therefore, in PDAC models, therapy-induced senescence can establish emergent susceptibilities to otherwise ineffective chemo- and immunotherapies through SASP-dependent effects on the tumor vasculature and immune system.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=5843&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(20)30270-1&amp;be=4474&amp;fe=5692&amp;dc=5666&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749586094461,%22n%22:0,%22f%22:3807,%22dn%22:3807,%22dne%22:3807,%22c%22:3807,%22ce%22:3807,%22rq%22:3808,%22rp%22:4381,%22rpe%22:5378,%22dl%22:4386,%22di%22:5607,%22ds%22:5666,%22de%22:5684,%22dc%22:5691,%22l%22:5691,%22le%22:5722%7D,%22navigation%22:%7B%7D%7D&amp;fp=5016&amp;fcp=5016&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30270-1"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(20)30270-1"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-774458" aria-expanded="false" aria-controls="login-links-774458" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-774458" id="login-links--774458" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-774458" data-opens="#links-dialog-774458" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-774458" aria-modal="true"><button data-closes="#links-dialog-774458" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930270-1" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2020.03.008">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(20)30270-1" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(19)X0009-4"><span>Volume 181</span>, <span>Issue 2</span></a></span><span class="meta-panel__pages"><span>p424-441.e21</span></span><span class="meta-panel__onlineDate">April 16, 2020</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=181&amp;issue=2&amp;pii=S0092-8674%2819%29X0009-4" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Marcus</span> <span property="familyName">Ruscetti</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Marcus</span> <span property="familyName">Ruscetti</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ruscetti/Marcus" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">10</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">John P.</span> <span property="familyName">Morris</span>, <span>IV</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">John P.</span> <span property="familyName">Morris</span>, <span>IV</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Morris/John+P/IV" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">10</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Riccardo</span> <span property="familyName">Mezzadra</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Riccardo</span> <span property="familyName">Mezzadra</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Mezzadra/Riccardo" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">10</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">James</span> <span property="familyName">Russell</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James</span> <span property="familyName">Russell</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Russell/James" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Josef</span> <span property="familyName">Leibold</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Josef</span> <span property="familyName">Leibold</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Leibold/Josef" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Paul B.</span> <span property="familyName">Romesser</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Paul B.</span> <span property="familyName">Romesser</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Romesser/Paul+B" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Janelle</span> <span property="familyName">Simon</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Janelle</span> <span property="familyName">Simon</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Simon/Janelle" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Amanda</span> <span property="familyName">Kulick</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Amanda</span> <span property="familyName">Kulick</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Kulick/Amanda" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Yu-jui</span> <span property="familyName">Ho</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yu-jui</span> <span property="familyName">Ho</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ho/Yu-jui" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Myles</span> <span property="familyName">Fennell</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Myles</span> <span property="familyName">Fennell</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Fennell/Myles" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Jinyang</span> <span property="familyName">Li</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jinyang</span> <span property="familyName">Li</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Li/Jinyang" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Robert J.</span> <span property="familyName">Norgard</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert J.</span> <span property="familyName">Norgard</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Norgard/Robert+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">John E.</span> <span property="familyName">Wilkinson</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">John E.</span> <span property="familyName">Wilkinson</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wilkinson/John+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Direna</span> <span property="familyName">Alonso-Curbelo</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Direna</span> <span property="familyName">Alonso-Curbelo</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Alonso-Curbelo/Direna" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Ramya</span> <span property="familyName">Sridharan</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ramya</span> <span property="familyName">Sridharan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Weill Cornell Medical College, Cornell University, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Sridharan/Ramya" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Daniel A.</span> <span property="familyName">Heller</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Daniel A.</span> <span property="familyName">Heller</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Weill Cornell Medical College, Cornell University, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Heller/Daniel+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Elisa</span> <span property="familyName">de Stanchina</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Elisa</span> <span property="familyName">de Stanchina</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div></div><div class="core-author-link"><a href="/authored-by/de+Stanchina/Elisa" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Ben Z.</span> <span property="familyName">Stanger</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ben Z.</span> <span property="familyName">Stanger</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Stanger/Ben+Z" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Charles J.</span> <span property="familyName">Sherr</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Charles J.</span> <span property="familyName">Sherr</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Sherr/Charles+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Scott W.</span> <span property="familyName">Lowe</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Scott W.</span> <span property="familyName">Lowe</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:lowes@mskcc.org" property="email" title="Send email to Scott W. Lowe">lowes@mskcc.org</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">11</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Lowe/Scott+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a>,<a role="doc-noteref">11</a></sup> <a id="eadd0010" href="mailto:lowes@mskcc.org" property="email" title="Send email to Scott W. Lowe">lowes@mskcc.org</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Weill Cornell Medical College, Cornell University, New York, NY 10065, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">11</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received September 5, 2019</span>; <span>Revised December 20, 2019</span>; <span>Accepted February 21, 2020</span>; <span>Published online March 31, 2020</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2020.03.008" property="sameAs" target="_blank">10.1016/j.cell.2020.03.008 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867420302701" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2020 Published by Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2020.03.008" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(19)X0009-4"><img src="/cms/asset/8e0cf1f8-74dd-4ff1-8cf9-225c94c2740a/cov200h.gif" alt="Cover Image - Cell, Volume 181, Issue 2"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2820%2930270-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (2)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930270-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.03.008">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2820%2930270-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2020.03.008&amp;pii=S0092-8674%2820%2930270-1" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930270-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.03.008">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2020.03.008" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867420302701&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867420302701&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=181&amp;issue=2&amp;pii=S0092-8674%2819%29X0009-4" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(20)30232-4" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(20)30341-X" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★Methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental Information (2)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-relations"><div class="relation"><div class="relation--head">Correction: </div><div class="relation--body">Errata<div class="content--title"><a href="/cell/fulltext/S0092-8674(21)00887-4">Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer</a></div><div class="content--contributors">Marcus Ruscetti, John P. Morris IV, Riccardo Mezzadra ...</div><div class="content--publishDate"> September 2, 2021</div></div></div></div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Therapy-induced senescence in PDAC triggers SASP-dependent vascular remodeling</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">SASP-mediated vascularization facilitates chemotherapy uptake and efficacy</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">SASP-mediated endothelial activation drives T&nbsp;cell infiltration into PDAC lesions</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Senescence-inducing treatment potentiates PD-1 blockade in PDAC models</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic response that promotes hypovascularity, immunosuppression, and resistance to chemo- and immunotherapies. We show that a combination of MEK and CDK4/6 inhibitors that target KRAS-directed oncogenic signaling can suppress PDAC proliferation through induction of retinoblastoma (RB) protein-mediated senescence. In preclinical mouse models of PDAC, this senescence-inducing therapy produces a senescence-associated secretory phenotype (SASP) that includes pro-angiogenic factors that promote tumor vascularization, which in turn enhances drug delivery and efficacy of cytotoxic gemcitabine chemotherapy. In addition, SASP-mediated endothelial cell activation stimulates the accumulation of CD8<sup>+</sup> T&nbsp;cells into otherwise immunologically “cold” tumors, sensitizing tumors to PD-1 checkpoint blockade. Therefore, in PDAC models, therapy-induced senescence can establish emergent susceptibilities to otherwise ineffective chemo- and immunotherapies through SASP-dependent effects on the tumor vasculature and immune system.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/6c5c6942-fc30-4956-afcd-93795d09194e/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2020.03.008/asset/eec247c5-93c7-4d29-b8bb-a72768cf465d/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6c5c6942-fc30-4956-afcd-93795d09194e/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;pancreatic+cancer&quot;" alt="Search on this keyword" rel="nofollow">pancreatic cancer</a></li><li><a href="/action/doSearch?AllField=&quot;senescence&quot;" alt="Search on this keyword" rel="nofollow">senescence</a></li><li><a href="/action/doSearch?AllField=&quot;senescence-associated+secretory+phenotype&quot;" alt="Search on this keyword" rel="nofollow">senescence-associated secretory phenotype</a></li><li><a href="/action/doSearch?AllField=&quot;tumor+microenvironment&quot;" alt="Search on this keyword" rel="nofollow">tumor microenvironment</a></li><li><a href="/action/doSearch?AllField=&quot;vascular+biology&quot;" alt="Search on this keyword" rel="nofollow">vascular biology</a></li><li><a href="/action/doSearch?AllField=&quot;endothelial+cell+activation&quot;" alt="Search on this keyword" rel="nofollow">endothelial cell activation</a></li><li><a href="/action/doSearch?AllField=&quot;immunotherapy&quot;" alt="Search on this keyword" rel="nofollow">immunotherapy</a></li><li><a href="/action/doSearch?AllField=&quot;T+cells&quot;" alt="Search on this keyword" rel="nofollow">T cells</a></li><li><a href="/action/doSearch?AllField=&quot;targeted+therapy&quot;" alt="Search on this keyword" rel="nofollow">targeted therapy</a></li><li><a href="/action/doSearch?AllField=&quot;chemotherapy+resistance&quot;" alt="Search on this keyword" rel="nofollow">chemotherapy resistance</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">Pancreatic ductal adenocarcinoma (PDAC) conveys a dismal prognosis (<span class="dropBlock reference-citations"><a id="body-ref-sref94" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94" aria-controls="sref94">Siegel et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref94"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">95.</div><div>Siegel, R.L. ∙ Miller, K.D. ∙ Jemal, A.</div><div><strong>Cancer statistics, 2019</strong></div><div><em>CA Cancer J. Clin.</em> 2019; <strong>69</strong>:7-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3322/caac.21551" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85059687888" target="_blank" aria-label="Open Scopus in new tab">Scopus (5520)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30620402/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3322%2Fcaac.21551&amp;pmid=30620402" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and is refractory to chemo- and immunotherapies, including immune checkpoint blockade that has revolutionized the treatment landscape of other tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref83-1" href="#" role="doc-biblioref" data-xml-rid="bib80 bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-1" aria-controls="sref83-1">Ribas and Wolchok, 2018; Royal et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref83-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Ribas, A. ∙ Wolchok, J.D.</div><div><strong>Cancer immunotherapy using checkpoint blockade</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:1350-1355</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar4060" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85045378539" target="_blank" aria-label="Open Scopus in new tab">Scopus (1070)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29567705/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar4060&amp;pmid=29567705" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Royal, R.E. ∙ Levy, C. ∙ Turner, K. ...</div><div><strong>Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma</strong></div><div><em>J.&nbsp;Immunother.</em> 2010; <strong>33</strong>:828-833</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/CJI.0b013e3181eec14c" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77958050577" target="_blank" aria-label="Open Scopus in new tab">Scopus (506)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20842054/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCJI.0b013e3181eec14c&amp;pmid=20842054" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This treatment-refractory behavior likely results from the unique characteristics of PDAC, which arises through perturbations in a combination of undruggable cancer drivers, including mutations in the <i>KRAS</i> oncogene and disruption of the <i>TP53</i>, <i>SMAD4</i>, and <i>CDKN2A</i> tumor suppressors (<span class="dropBlock reference-citations"><a id="body-ref-sref62" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62" aria-controls="sref62">Morris et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref62"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Morris, 4th, J.P. ∙ Wang, S.C. ∙ Hebrok, M.</div><div><strong>KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:683-695</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2899" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77957150824" target="_blank" aria-label="Open Scopus in new tab">Scopus (376)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20814421/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2899&amp;pmid=20814421" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, the disease evolves within a heterogeneous tumor microenvironment (TME) characterized by a fibro-inflammatory stroma that contributes to disease progression (<span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib53 bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Ligorio et&nbsp;al., 2019; Öhlund et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Ligorio, M. ∙ Sil, S. ∙ Malagon-Lopez, J. ...</div><div><strong>Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:160-175 e127</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2019.05.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2019.05.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85067683716" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31155233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.05.012&amp;pmid=31155233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Öhlund, D. ∙ Handly-Santana, A. ∙ Biffi, G. ...</div><div><strong>Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2017; <strong>214</strong>:579-596</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20162024" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85018017663" target="_blank" aria-label="Open Scopus in new tab">Scopus (381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28232471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20162024&amp;pmid=28232471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), limits drug accessibility (<span class="dropBlock reference-citations"><a id="body-ref-sref78-1" href="#" role="doc-biblioref" data-xml-rid="bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-1" aria-controls="sref78-1">Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and enforces an immune suppressive niche that suppresses anti-tumor immunity (<span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Kraman et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Kraman, M. ∙ Bambrough, P.J. ∙ Arnold, J.N. ...</div><div><strong>Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha</strong></div><div><em>Science.</em> 2010; <strong>330</strong>:827-830</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1195300" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-78149298209" target="_blank" aria-label="Open Scopus in new tab">Scopus (559)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21051638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1195300&amp;pmid=21051638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, several strategies have targeted aspects of the PDAC TME to improve drug uptake (<span class="dropBlock reference-citations"><a id="body-ref-sref78-2" href="#" role="doc-biblioref" data-xml-rid="bib15 bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-2" aria-controls="sref78-2">Chauhan et&nbsp;al., 2013; Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chauhan, V.P. ∙ Martin, J.D. ∙ Liu, H. ...</div><div><strong>Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels</strong></div><div><em>Nat. Commun.</em> 2013; <strong>4</strong>:2516</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms3516" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84885129359" target="_blank" aria-label="Open Scopus in new tab">Scopus (381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24084631/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms3516&amp;pmid=24084631" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and sensitivity to immunotherapies (<span class="dropBlock reference-citations"><a id="body-ref-sref42-1" href="#" role="doc-biblioref" data-xml-rid="bib32 bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-1" aria-controls="sref42-1">Feig et&nbsp;al., 2013; Jiang et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref42-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (623)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0035" role="paragraph"><i>KRAS</i> mutations occur in over 90% of human PDAC, and mouse models implicate oncogenic KRAS in initiating and maintaining tumorigenesis as well as the stromal changes that accompany disease progression (<span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib20 bib21 bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Collins et&nbsp;al., 2012a, 2012b; Kapoor et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Collins, M.A. ∙ Bednar, F. ∙ Zhang, Y. ...</div><div><strong>Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2012; <strong>122</strong>:639-653</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI59227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84863012865" target="_blank" aria-label="Open Scopus in new tab">Scopus (360)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22232209/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI59227&amp;pmid=22232209" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Collins, M.A. ∙ Brisset, J.C. ∙ Zhang, Y. ...</div><div><strong>Metastatic pancreatic cancer is dependent on oncogenic Kras in mice</strong></div><div><em>PLoS ONE.</em> 2012; <strong>7</strong>:e49707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0049707" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84870709449" target="_blank" aria-label="Open Scopus in new tab">Scopus (95)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23226501/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0049707&amp;pmid=23226501" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Kapoor, A. ∙ Yao, W. ∙ Ying, H. ...</div><div><strong>Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer</strong></div><div><em>Cell.</em> 2014; <strong>158</strong>:185-197</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.06.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.06.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84903984143" target="_blank" aria-label="Open Scopus in new tab">Scopus (324)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24954535/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.06.003&amp;pmid=24954535" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). While pharmacological efforts to directly target KRAS or its downstream effectors have proven largely ineffective to date, combinatorial strategies for inhibiting RAS pathway components and interfering with compensatory or negative feedback signaling have shown promise in preclinical studies (<span class="dropBlock reference-citations"><a id="body-ref-sref96" href="#" role="doc-biblioref" data-xml-rid="bib57 bib72 bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96" aria-controls="sref96">Manchado et&nbsp;al., 2016; Okumura and Jänne, 2014; Sun et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref96"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Manchado, E. ∙ Weissmueller, S. ∙ Morris, 4th, J.P. ...</div><div><strong>A combinatorial strategy for treating KRAS-mutant lung cancer</strong></div><div><em>Nature.</em> 2016; <strong>534</strong>:647-651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18600" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338794/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18600&amp;pmid=27338794" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Okumura, S. ∙ Jänne, P.A.</div><div><strong>Molecular pathways: the basis for rational combination using MEK inhibitors in KRAS-mutant cancers</strong></div><div><em>Clin. Cancer Res.</em> 2014; <strong>20</strong>:4193-4199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-13-2365" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84905985518" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24907112/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-13-2365&amp;pmid=24907112" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Sun, C. ∙ Hobor, S. ∙ Bertotti, A. ...</div><div><strong>Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3</strong></div><div><em>Cell Rep.</em> 2014; <strong>7</strong>:86-93</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2014.02.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2014.02.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84898023140" target="_blank" aria-label="Open Scopus in new tab">Scopus (171)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24685132/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.02.045&amp;pmid=24685132" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Recently, we demonstrated that one of these targeted therapy combinations—the MEK inhibitor trametinib and CDK4/6 inhibitor palbociclib—could lead to durable cell-cycle exit of KRAS mutant lung and pancreas cancer cells through induction of retinoblastoma (RB) protein-mediated cellular senescence (<span class="dropBlock reference-citations"><a id="body-ref-sref84-1" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-1" aria-controls="sref84-1">Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0040" role="paragraph">Cellular senescence is a physiological stress-response that results in the proliferative arrest and immune-mediated clearance of damaged and pre-malignant cells, seemingly as a part of a wound healing process that facilitates tissue regeneration after injury (<span class="dropBlock reference-citations"><a id="body-ref-sref66-1" href="#" role="doc-biblioref" data-xml-rid="bib25 bib43 bib47 bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-1" aria-controls="sref66-1">Demaria et&nbsp;al., 2014; Kang et&nbsp;al., 2011; Krizhanovsky et&nbsp;al., 2008; Mosteiro et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref66-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Demaria, M. ∙ Ohtani, N. ∙ Youssef, S.A. ...</div><div><strong>An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA</strong></div><div><em>Dev. Cell.</em> 2014; <strong>31</strong>:722-733</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84919480323" target="_blank" aria-label="Open Scopus in new tab">Scopus (528)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25499914/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2014.11.012&amp;pmid=25499914" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Kang, T.W. ∙ Yevsa, T. ∙ Woller, N. ...</div><div><strong>Senescence surveillance of pre-malignant hepatocytes limits liver cancer development</strong></div><div><em>Nature.</em> 2011; <strong>479</strong>:547-551</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10599" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-81855169964" target="_blank" aria-label="Open Scopus in new tab">Scopus (661)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22080947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10599&amp;pmid=22080947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Krizhanovsky, V. ∙ Yon, M. ∙ Dickins, R.A. ...</div><div><strong>Senescence of activated stellate cells limits liver fibrosis</strong></div><div><em>Cell.</em> 2008; <strong>134</strong>:657-667</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-49749145668" target="_blank" aria-label="Open Scopus in new tab">Scopus (955)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18724938/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2008.06.049&amp;pmid=18724938" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Mosteiro, L. ∙ Pantoja, C. ∙ Alcazar, N. ...</div><div><strong>Tissue damage and senescence provide critical signals for cellular reprogramming in&nbsp;vivo</strong></div><div><em>Science.</em> 2016; <strong>354</strong>:aaf4445</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf4445" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27884981/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf4445&amp;pmid=27884981" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Senescence can be triggered by oncogenic signaling, including by mutant KRAS in pre-malignant lesions such as pancreatic intraepithelial neoplasias (PanINs) (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Caldwell et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Caldwell, M.E. ∙ DeNicola, G.M. ∙ Martins, C.P. ...</div><div><strong>Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer</strong></div><div><em>Oncogene.</em> 2012; <strong>31</strong>:1599-1608</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/onc.2011.350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84860389717" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21860420/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fonc.2011.350&amp;pmid=21860420" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), thus serving as a natural barrier to malignancy. The CDKN2A/RB and p53 tumor suppressor programs collaborate to regulate this process, and their disruption can disable senescence and facilitate cancer initiation and progression, including in PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib5 bib14 bib64 bib90" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Bardeesy et&nbsp;al., 2006; Carrière et&nbsp;al., 2011; Morton et&nbsp;al., 2010; Serrano et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bardeesy, N. ∙ Aguirre, A.J. ∙ Chu, G.C. ...</div><div><strong>Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2006; <strong>103</strong>:5947-5952</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0601273103" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33645824724" target="_blank" aria-label="Open Scopus in new tab">Scopus (387)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16585505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0601273103&amp;pmid=16585505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Carrière, C. ∙ Gore, A.J. ∙ Norris, A.M. ...</div><div><strong>Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions</strong></div><div><em>Gastroenterology.</em> 2011; <strong>141</strong>:1091-1101</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1053%2Fj.gastro.2011.05.041&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1053%2Fj.gastro.2011.05.041&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80052127297" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21699781/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2011.05.041&amp;pmid=21699781" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Morton, J.P. ∙ Timpson, P. ∙ Karim, S.A. ...</div><div><strong>Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:246-251</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0908428107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-76249108357" target="_blank" aria-label="Open Scopus in new tab">Scopus (344)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20018721/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0908428107&amp;pmid=20018721" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Serrano, M. ∙ Lin, A.W. ∙ McCurrach, M.E. ...</div><div><strong>Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</strong></div><div><em>Cell.</em> 1997; <strong>88</strong>:593-602</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981902-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981902-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0030944985" target="_blank" aria-label="Open Scopus in new tab">Scopus (3547)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9054499/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2800%2981902-9&amp;pmid=9054499" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0045" role="paragraph">Two key molecular modules involved in senescence are an RB-dependent program that produces a repressive chromatin state to transcriptionally silence many pro-proliferative genes (<span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib16 bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Chicas et&nbsp;al., 2010; Narita et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Chicas, A. ∙ Wang, X. ∙ Zhang, C. ...</div><div><strong>Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:376-387</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77950486542" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20385362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.01.023&amp;pmid=20385362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Narita, M. ∙ Nũnez, S. ∙ Heard, E. ...</div><div><strong>Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence</strong></div><div><em>Cell.</em> 2003; <strong>113</strong>:703-716</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2803%2900401-X&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2803%2900401-X&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0037667702" target="_blank" aria-label="Open Scopus in new tab">Scopus (1447)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12809602/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2803%2900401-X&amp;pmid=12809602" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and a nuclear factor κB (NF-κB)-regulated gene activation program that induces expression of secreted factors that can influence the microenvironment (<span class="dropBlock reference-citations"><a id="body-ref-sref98-1" href="#" role="doc-biblioref" data-xml-rid="bib17 bib50 bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98-1" aria-controls="sref98-1">Chien et&nbsp;al., 2011; Lesina et&nbsp;al., 2016; Tasdemir et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref98-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chien, Y. ∙ Scuoppo, C. ∙ Wang, X. ...</div><div><strong>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</strong></div><div><em>Genes Dev.</em> 2011; <strong>25</strong>:2125-2136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.17276711" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80054789761" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21979375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.17276711&amp;pmid=21979375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Lesina, M. ∙ Wörmann, S.M. ∙ Morton, J. ...</div><div><strong>RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2016; <strong>126</strong>:2919-2932</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI86477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987806939" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27454298/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI86477&amp;pmid=27454298" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Tasdemir, N. ∙ Banito, A. ∙ Roe, J.S. ...</div><div><strong>BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:612-629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-0217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27099234/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-0217&amp;pmid=27099234" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This latter component is often referred to as the senescence-associated secretory phenotype (SASP) and is characterized by the secretion of chemokines, cytokines, matrix metalloproteinases (MMPs), and other paracrine signaling factors (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib23 bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Coppé et&nbsp;al., 2008; Kuilman and Peeper, 2009</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Coppé, J.P. ∙ Patil, C.K. ∙ Rodier, F. ...</div><div><strong>Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor</strong></div><div><em>PLoS Biol.</em> 2008; <strong>6</strong>:2853-2868</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pbio.0060301" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-58149163445" target="_blank" aria-label="Open Scopus in new tab">Scopus (1689)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19053174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pbio.0060301&amp;pmid=19053174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Kuilman, T. ∙ Peeper, D.S.</div><div><strong>Senescence-messaging secretome: SMS-ing cellular stress</strong></div><div><em>Nat. Rev. Cancer.</em> 2009; <strong>9</strong>:81-94</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2560" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-58849154235" target="_blank" aria-label="Open Scopus in new tab">Scopus (510)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19132009/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2560&amp;pmid=19132009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given the pleiotropic nature of many of these secreted factors, the consequences of SASP are context-dependent, and can influence multiple cell types within the tumor milieu (<span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib24 bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Coppé et&nbsp;al., 2010; Faget et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Coppé, J.P. ∙ Desprez, P.Y. ∙ Krtolica, A. ...</div><div><strong>The senescence-associated secretory phenotype: the dark side of tumor suppression</strong></div><div><em>Annu. Rev. Pathol.</em> 2010; <strong>5</strong>:99-118</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-pathol-121808-102144" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77949881221" target="_blank" aria-label="Open Scopus in new tab">Scopus (1551)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20078217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-pathol-121808-102144&amp;pmid=20078217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Faget, D.V. ∙ Ren, Q. ∙ Stewart, S.A.</div><div><strong>Unmasking senescence: context-dependent effects of SASP in cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:439-453</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0156-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85068065547" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31235879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0156-2&amp;pmid=31235879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Hence, while SASP factors can be pro- or anti-tumorigenic, their production by pre-malignant cells can stimulate immune surveillance, leading to the clearance of senescent cells and contributing to tumor suppression (<span class="dropBlock reference-citations"><a id="body-ref-sref98-2" href="#" role="doc-biblioref" data-xml-rid="bib43 bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98-2" aria-controls="sref98-2">Kang et&nbsp;al., 2011; Tasdemir et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref98-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Kang, T.W. ∙ Yevsa, T. ∙ Woller, N. ...</div><div><strong>Senescence surveillance of pre-malignant hepatocytes limits liver cancer development</strong></div><div><em>Nature.</em> 2011; <strong>479</strong>:547-551</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10599" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-81855169964" target="_blank" aria-label="Open Scopus in new tab">Scopus (661)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22080947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10599&amp;pmid=22080947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Tasdemir, N. ∙ Banito, A. ∙ Roe, J.S. ...</div><div><strong>BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:612-629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-0217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27099234/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-0217&amp;pmid=27099234" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0050" role="paragraph">Although cancer cells evade senescence early during the course of tumor evolution, restoration of this program in advanced cancers can have profound anti-tumor effects. Indeed, genetic restoration of p53 in a RAS-driven liver carcinoma model induces senescence to promote tumor clearance by triggering innate immune surveillance (<span class="dropBlock reference-citations"><a id="body-ref-sref102" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102" aria-controls="sref102">Xue et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref102"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Xue, W. ∙ Zender, L. ∙ Miething, C. ...</div><div><strong>Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas</strong></div><div><em>Nature.</em> 2007; <strong>445</strong>:656-660</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature05529" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33846937033" target="_blank" aria-label="Open Scopus in new tab">Scopus (1502)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17251933/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature05529&amp;pmid=17251933" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Pharmacological strategies that induce tumor cell senescence can also facilitate anti-tumor immunity and tumor regressions despite the absence of cytotoxicity to cancer cells themselves. For example, in a KRAS mutant lung cancer model, the induction of senescence by trametinib and palbociclib treatment triggered SASP-dependent and natural killer (NK) cell-mediated tumor regressions, even in tumors lacking p53 (<span class="dropBlock reference-citations"><a id="body-ref-sref84-2" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-2" aria-controls="sref84-2">Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Intrigued by the ability of these RAS pathway-targeted therapies to produce therapeutically relevant effects on the surrounding TME, we set out to explore how senescence induction could remodel the hypovascular and immune suppressive PDAC TME and alter the treatment landscape of this disease.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Trametinib and Palbociclib Treatment Triggers Vascular Remodeling in PDAC</h3><div id="p0055" role="paragraph">Combined trametinib and palbociclib (T/P) treatment, but neither agent alone, potently induces senescence and SASP in human PDAC lines (<span class="dropBlock reference-citations"><a id="body-ref-sref84-3" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-3" aria-controls="sref84-3">Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To determine if therapy-induced senescence can alter the PDAC TME, we evaluated the response to T/P treatment in two mouse models of PDAC that recapitulate the histopathology and stromal responses observed clinically: the <i>Pdx1-Cre</i>;<i>LSL-KRAS</i><sup><i>G12D</i></sup>;<i>Trp53</i><sup><i>fl/wt</i></sup> (<i>KPC</i><sup><i>flox</i></sup>) genetically engineered mouse model (GEMM), where tumors form autochthonously in the pancreas (<span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Herreros-Villanueva et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Herreros-Villanueva, M. ∙ Hijona, E. ∙ Cosme, A. ...</div><div><strong>Mouse models of pancreatic cancer</strong></div><div><em>World J. Gastroenterol.</em> 2012; <strong>18</strong>:1286-1294</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3748/wjg.v18.i12.1286" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84859081186" target="_blank" aria-label="Open Scopus in new tab">Scopus (94)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22493542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3748%2Fwjg.v18.i12.1286&amp;pmid=22493542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); and orthotopic transplantation of PDAC organoids derived from tumors arising in <i>Pdx1-Cre</i>; <i>LSL-KRAS</i><sup><i>G12D</i></sup>;<i>Trp53</i><sup><i>R172H/wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) mice into the pancreata of syngeneic C57BL/6 recipients (<span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib7 bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Boj et&nbsp;al., 2015; Hingorani et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Boj, S.F. ∙ Hwang, C.I. ∙ Baker, L.A. ...</div><div><strong>Organoid models of human and mouse ductal pancreatic cancer</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:324-338</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.12.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.12.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84920983131" target="_blank" aria-label="Open Scopus in new tab">Scopus (662)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25557080/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.12.021&amp;pmid=25557080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Hingorani, S.R. ∙ Petricoin, E.F. ∙ Maitra, A. ...</div><div><strong>Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse</strong></div><div><em>Cancer Cell.</em> 2003; <strong>4</strong>:437-450</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1535-6108%2803%2900309-X&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1535-6108%2803%2900309-X&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-9144266295" target="_blank" aria-label="Open Scopus in new tab">Scopus (1501)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14706336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1535-6108%2803%2900309-X&amp;pmid=14706336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0060" role="paragraph">Two-week treatment with T/P (but neither agent alone) led to decreased proliferation, inhibition of ERK and RB phosphorylation, and induction of senescence-associated β-galactosidase (SA-β-gal) activity in the absence of apoptosis in both <i>KPC</i><sup><i>flox</i></sup> GEMM and <i>KPC</i><sup><i>mut</i></sup> organoid transplant models (<a id="crosref0195" href="#fig1">Figures 1</a>A, <a id="crosref0200" href="#figs1">S1</a>A, and S1B). This response was associated with a modest increase in the survival of PDAC-bearing animals (<a id="crosref0205" href="#figs1">Figures S1</a>C and S1D). In contrast to KRAS-driven lung cancer models (<span class="dropBlock reference-citations"><a id="body-ref-sref84-4" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-4" aria-controls="sref84-4">Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), however, T/P treatment did not increase NK cell numbers, activation, or cytotoxicity, and failed to elicit tumor regressions (<a id="crosref0210" href="#figs1">Figures S1</a>B and S1E–S1H). Therefore, while T/P treatment triggers senescence in PDAC, this does not engage NK cell surveillance or produce robust tumor regressions.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/0c1016e4-8971-48ba-a998-8a26797c70c2/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2020.03.008/asset/bc125d76-9d1d-43c1-98af-1775c2a7d20d/main.assets/gr1.jpg" height="698" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/0c1016e4-8971-48ba-a998-8a26797c70c2/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Trametinib and Palbociclib Treatment Triggers Vascular Remodeling in PDAC</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A and B) H&amp;E and immunohistochemical (IHC) staining of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks. Quantification of SA-β-gal positive area (A) and blood vessels per field (B) are shown (n&nbsp;= 2–3; p&nbsp;&lt; 0.02). Blue arrow, blood vessel; arrowhead, collapsed vessel; black arrow, visible lumen.</div><div id="fspara0020" role="paragraph">(C) Analysis of distance between vessels and tumor cells in (B) (n&nbsp;= 3).</div><div id="fspara0025" role="paragraph">(D) Quantification of vessels with visible lumens in (B) (n&nbsp;= 3).</div><div id="fspara0030" role="paragraph">(E–H) Immunofluorescence (IF) staining and quantification of αSMA (E), PDGFRβ (F), P-selectin (G), and VCAM-1 (H) colocalization with blood vessels in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated as in (A) (n&nbsp;= 2–3; p&nbsp;= 0.021, 0.044, 0.111, and 0.062, respectively).</div><div id="fspara0035" role="paragraph">Error bars, mean ± SEM. <sup>∗∗</sup>p&nbsp;&lt; 0.01. Scale bars, 50&nbsp;μm.</div><div id="fspara0040" role="paragraph">See also <a id="crosref0805" href="#figs1">Figure&nbsp;S1</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/6e51877a-02e5-404e-96d0-a7c057c84b36/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2020.03.008/asset/f6ea2f17-fe06-46c4-b219-e45b0f8e2fcd/main.assets/figs1.jpg" height="950" width="738" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6e51877a-02e5-404e-96d0-a7c057c84b36/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Trametinib and Palbociclib Treatment Does Not Induce NK Cell-Mediated Tumor Responses but Rather Leads to Vascular Remodeling in PDAC Models, Related to <a id="crosref0855" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0310" role="paragraph">(A) Immunohistochemical (IHC) staining and quantification of SA-β-gal positive area in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated with vehicle (V), trametinib (T) (1&nbsp;mg/kg), palbociclib (P) (100&nbsp;mg/kg), or both (T/P) for 2&nbsp;weeks (n&nbsp;= 3; T versus T/P and P versus T/P, p&nbsp;&lt; 0.0001).</div><div id="fspara0315" role="paragraph">(B) IHC staining and quantification of NKp46<sup>+</sup> NK cells in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated as in (A) (n&nbsp;= 2; p&nbsp;= 0.592).</div><div id="fspara0320" role="paragraph">(C and D) Kaplan-Meier survival curves of <i>KPC</i><sup><i>mut</i></sup> organoid transplant (C) and <i>KPC</i><sup><i>flox</i></sup> GEMM (D) mice treated as in (A) (n ≥ 5). Values for V and T/P-treated cohorts in (D) are the same displayed in <a id="crosref0860" href="#fig3">Figure&nbsp;3</a>F.</div><div id="fspara0325" role="paragraph">(E and F) Flow cytometry analysis of NK cell numbers and activation in <i>KPC</i><sup><i>mut</i></sup> transplant (E) or <i>KPC</i><sup><i>flox</i></sup> GEMM (F) tumors following treatment as in (A) (n ≥ 5).</div><div id="fspara0330" role="paragraph">(G and H) Waterfall plots of the response of <i>KPC</i><sup><i>mut</i></sup> transplant (G) or <i>KPC</i><sup><i>flox</i></sup> GEMM (H) tumors following treatment as in (A) (n ≥ 4). Values for V and T/P-treated cohorts in (H) are the same displayed in <a id="crosref0865" href="#fig3">Figure&nbsp;3</a>E.</div><div id="fspara0335" role="paragraph">(I–K) IHC staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated as in (A). Quantification of blood vessels per field (T versus T/P and P versus T/P, p&nbsp;&lt; 0.01) (I), vessel to tumor distance (J), and vessels with visible lumens (K) is shown (n&nbsp;= 3). Arrowhead, collapsed vessel; Arrow, visible lumen.</div><div id="fspara0340" role="paragraph">(L) IHC staining of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors following treatment as in (A) (n&nbsp;= 3; p&nbsp;= 0.88).</div><div id="fspara0345" role="paragraph">(M and N) IHC staining of <i>KPC</i><sup><i>flox</i></sup> GEMM (M) or <i>KPC</i><sup><i>mut</i></sup> organoid transplant (N) tumors following treatment as in (A).</div><div id="fspara0350" role="paragraph">(O and P) PDAC-bearing <i>KPC</i><sup><i>flox</i></sup> GEMM mice were treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) until survival endpoint, and the lungs and liver were subsequently analyzed for the presence (O) and number (P) of macrometastases (n ≥ 9).</div><div id="fspara0355" role="paragraph">(Q and R) Immunofluorescence (IF) staining and quantification of PDGFRβ (Q) and P-selectin and VCAM-1 (R) colocalization with blood vessels in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated as in (A) (n&nbsp;= 2-3; p&nbsp;= 0.0322, 0.0644, and 0.0396, respectively).</div><div id="fspara0360" role="paragraph">(S) Flow cytometry analysis of ICAM-1 expression on endothelial cells in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors following treatment as in (A) (n&nbsp;= 5).</div><div id="fspara0365" role="paragraph">One-way ANOVA (A, G, and I–K). Log-rank test (C and D). Error bars, mean ± SEM. <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0065" role="paragraph">Close inspection of T/P-treated tumor sections showed an accumulation of blood vessels adjacent to tumor cells (<a id="crosref0215" href="#fig1">Figure&nbsp;1</a>B), suggesting that T/P therapy may affect the TME in other ways. Combinatorial treatment led to an increase in CD31<sup>+</sup> blood vessel density and closer proximity of vessels and tumor cells in both organoid transplant and GEMM models (<a id="crosref0220" href="#fig1">Figures 1</a>B, 1C, <a id="crosref0225" href="#figs1">S1</a>I, and S1J). By contrast, no change in the number of lymphatic vessels was observed (<a id="crosref0230" href="#figs1">Figure&nbsp;S1</a>L). Although many blood vessels in vehicle-treated PDAC tumors appeared collapsed, most in T/P-treated tumors harbored open and readily discernible lumens (<a id="crosref0235" href="#fig1">Figures 1</a>B, 1D, <a id="crosref0240" href="#figs1">S1</a>I, and S1K). T/P treatment also reduced the stromal content of hyaluronic acid (HA), an effect linked to increased vessel opening in PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref78-3" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-3" aria-controls="sref78-3">Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), without affecting collagen deposition or accumulation of α-smooth muscle actin (αSMA)-positive myofibroblasts (<a id="crosref0250" href="#fig1">Figures 1</a>B, <a id="crosref0255" href="#figs1">S1</a>M, and S1N). Whereas the improved vascularization achieved through inhibition of signaling pathways involved in maintaining the desmoplastic stroma is associated with increased metastasis ( <span class="dropBlock reference-citations"><a id="body-ref-sref104" href="#" role="doc-biblioref" data-xml-rid="bib104" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref104" aria-controls="sref104">Lee et al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref104"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Lee, J.J. ∙ Perera, R.M. ∙ Wang, H. ...</div><div><strong>Stromal response to Hedgehog signaling restrains pancreatic cancer progression.</strong></div><div><em>Proc Natl Acad Sci U S A.</em> 2014; E3091-E3100</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1411679111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84904994417" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25024225/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1411679111&amp;pmid=25024225" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79-1" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79-1" aria-controls="sref79-1">Rhim et&nbsp;al.<i>,</i> 2014</a><div class="dropBlock__holder" data-db-target-of="sref79-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Rhim, A.D. ∙ Oberstein, P.E. ∙ Thomas, D.H. ...</div><div><strong>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:735-747</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84902435628" target="_blank" aria-label="Open Scopus in new tab">Scopus (857)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.021&amp;pmid=24856585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), PDAC-bearing mice treated with T/P showed fewer metastases compared to controls (<a id="crosref0265" href="#figs1">Figures S1</a>O and S1P). Hence, T/P treatment induces vascular remodeling without metastatic adaptation.</div><div id="p0070" role="paragraph">Compared to controls, the blood vessels present in T/P-treated tumors were associated with higher levels of αSMA and the pericyte marker PDGFRβ, characteristics of a mature vasculature (<a id="crosref0270" href="#fig1">Figures 1</a>E, 1F, and <a id="crosref0275" href="#figs1">S1</a>Q). Vascular endothelial cells also displayed upregulation of immunomodulatory cell surface molecules such as P-selectin, VCAM-1, and ICAM-1 (a phenomenon hereafter referred to as endothelial cell activation) that are expressed on permeable blood vessels that accompany tissue inflammation (<a id="crosref0280" href="#fig1">Figures 1</a>G, 1H, <a id="crosref0285" href="#figs1">S1</a>R, and S1S) (<span class="dropBlock reference-citations"><a id="body-ref-sref54-1" href="#" role="doc-biblioref" data-xml-rid="bib40 bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-1" aria-controls="sref54-1">Hunt and Jurd, 1998; Lorenzon et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref54-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Hunt, B.J. ∙ Jurd, K.M.</div><div><strong>Endothelial cell activation. A central pathophysiological process</strong></div><div><em>BMJ.</em> 1998; <strong>316</strong>:1328-1329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.316.7141.1328" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9563977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fbmj.316.7141.1328&amp;pmid=9563977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Lorenzon, P. ∙ Vecile, E. ∙ Nardon, E. ...</div><div><strong>Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1998; <strong>142</strong>:1381-1391</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.142.5.1381" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0032494169" target="_blank" aria-label="Open Scopus in new tab">Scopus (194)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9732297/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.142.5.1381&amp;pmid=9732297" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, T/P treatment, perhaps by promoting senescence, leads to multiple vascular remodeling phenotypes in PDAC models.</div></section><section id="sec-2-2"><h3>SASP Factors Contribute to Vascular Remodeling in PDAC</h3><div id="p0075" role="paragraph">In addition to immunomodulatory factors, senescent cells secrete SASP factors that can alter endothelial cell proliferation and behavior (<span class="dropBlock reference-citations"><a id="body-ref-sref74-1" href="#" role="doc-biblioref" data-xml-rid="bib2 bib22 bib61 bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-1" aria-controls="sref74-1">Ancrile et&nbsp;al., 2007; Coppé et&nbsp;al., 2006; Mikuła-Pietrasik et&nbsp;al., 2016; Oubaha et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref74-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Ancrile, B. ∙ Lim, K.H. ∙ Counter, C.M.</div><div><strong>Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis</strong></div><div><em>Genes Dev.</em> 2007; <strong>21</strong>:1714-1719</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1549407" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-34447506658" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17639077/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1549407&amp;pmid=17639077" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Coppé, J.P. ∙ Kauser, K. ∙ Campisi, J. ...</div><div><strong>Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2006; <strong>281</strong>:29568-29574</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M603307200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33749549246" target="_blank" aria-label="Open Scopus in new tab">Scopus (292)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16880208/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M603307200&amp;pmid=16880208" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Mikuła-Pietrasik, J. ∙ Sosińska, P. ∙ Naumowicz, E. ...</div><div><strong>Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in&nbsp;vitro and in a mouse xenograft model in&nbsp;vivo</strong></div><div><em>Clin. Exp. Metastasis.</em> 2016; <strong>33</strong>:15-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10585-015-9753-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84957438754" target="_blank" aria-label="Open Scopus in new tab">Scopus (11)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26433963/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10585-015-9753-y&amp;pmid=26433963" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Oubaha, M. ∙ Miloudi, K. ∙ Dejda, A. ...</div><div><strong>Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:362ra144</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aaf9440" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84993927167" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aaf9440&amp;pmid=27797960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, murine and human PDAC lines treated with T/P displayed increased secretion of pro-angiogenic factors (VEGF, PDGFA/B, FGF2) and MMPs (MMP2/3/7/9/10) compared to cells treated with single agents (<a id="crosref0290" href="#fig2">Figures 2</a>A and <a id="crosref0295" href="#figs2">S2</a>A). Increased expression of these SASP factors was also detected in tumor cells sorted from T/P-treated tumors derived from orthotopic transplant of <i>KPC</i><sup><i>mut</i></sup> cell lines engineered to express luciferase and GFP, and conditioned media from <i>KPC</i><sup><i>mut</i></sup> cells pretreated with T/P was able to support the proliferation of endothelial cells in culture (<a id="crosref0300" href="#fig2">Figures 2</a>B, <a id="crosref0305" href="#figs2">S2</a>B, and S2C). Similarly, when endothelial cells were grown on a 3D basement membrane, conditioned media from T/P-treated <i>KPC</i><sup><i>mut</i></sup> cells promoted the formation of tube-like structures that were reminiscent of vascular networks <i>in&nbsp;vivo</i> (<a id="crosref0310" href="#fig2">Figure&nbsp;2</a>C).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/06d3b520-2fdc-4369-9b86-4e86dec74055/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2020.03.008/asset/b336d3c0-3025-4666-9bca-626889fe2b59/main.assets/gr2.jpg" height="865" width="762" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/06d3b520-2fdc-4369-9b86-4e86dec74055/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">SASP Factors Contribute to Vascular Remodeling in PDAC</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0050" role="paragraph">(A) Heatmap of cytokine array results from <i>KPC</i><sup><i>mut</i></sup> cells following 8-day treatment with trametinib (25&nbsp;nM) and/or palbociclib (500&nbsp;nM). Data presented as mean of three biological replicates.</div><div id="fspara0055" role="paragraph">(B) Cell growth analysis of 3B11 cells cultured in serum-free (basal) or conditioned media (CM) from <i>KPC</i><sup><i>mut</i></sup> cells treated as in (A) (n&nbsp;= 3).</div><div id="fspara0060" role="paragraph">(C) Endothelial tube formation analysis of 3B11 cells cultured in CM from (B). Quantification of total tube length is shown (n&nbsp;= 2; V versus T/P, p&nbsp;= 0.01).</div><div id="fspara0065" role="paragraph">(D) Heatmap of cytokine array results from <i>KPC</i><sup><i>mut</i></sup> cells harboring control <i>Renilla</i> (<i>Ren</i>) or <i>p65</i> shRNAs and treated as in (A). Data presented as mean of three biological replicates.</div><div id="fspara0070" role="paragraph">(E) IHC staining and quantification of blood vessels per field in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs and treated for 2&nbsp;weeks with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) (n&nbsp;= 3; <i>Ren</i> T/P versus <i>p65</i> T/P, p&nbsp;= 0.003). Arrowhead, collapsed vessel; arrow, visible lumen.</div><div id="fspara0075" role="paragraph">(F) IHC and IF staining of tumor samples in (E). Quantification of HA staining and αSMA and VCAM-1 colocalization with blood vessels are shown (n&nbsp;= 2–3; <i>Ren</i> V versus <i>Ren</i> T/P, p ≤ 0.05; <i>Ren</i> T/P versus <i>p65</i> T/P, p ≤ 0.05).</div><div id="fspara0080" role="paragraph">(G) IHC staining and quantification of blood vessels per field in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) (n&nbsp;= 3; T/P versus T/P+DC101, p&nbsp;= 0.003).</div><div id="fspara0085" role="paragraph">(H) Flow cytometry analysis of VCAM-1 expression on endothelial cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or monoclonal antibodies (mAbs) targeting CCL5 (MAB478; 50&nbsp;μg), CXCL1 (MAB453; 25&nbsp;μg), TGF-β (1D11; 300&nbsp;μg), IL-1β (B122; 200&nbsp;μg), IL-6 (MP5-20F3; 200&nbsp;μg), or VEGFR-2 (DC101; 800&nbsp;μg) for 2&nbsp;weeks (n ≥ 4).</div><div id="fspara0090" role="paragraph">Two-way ANOVA (B). One-way ANOVA (F and H). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.01, Scale bars, 50&nbsp;μm.</div><div id="fspara0095" role="paragraph">See also <a id="crosref0810" href="#figs2">Figures S2</a> and <a id="crosref0815" href="#figs3">S3</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/e03d9525-93b8-4d16-be1a-ef8fbbce7425/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2020.03.008/asset/5cdece2b-6299-4872-bf78-ae386cc84e33/main.assets/figs2.jpg" height="941" width="812" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/e03d9525-93b8-4d16-be1a-ef8fbbce7425/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Therapy-Induced Senescence Triggers a Pro-angiogenic SASP Exclusively in PDAC Tumor Cells, Related to <a id="crosref0870" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0375" role="paragraph">(A) Cytokine array results from human KRAS mutant PDAC lines treated for 8&nbsp;days with trametinib (25&nbsp;nM) and/or palbociclib (500&nbsp;nM) (n&nbsp;= 2).</div><div id="fspara0380" role="paragraph">(B) Heatmap of RNA-seq analysis of SASP gene expression in tumors cells sorted from <i>KPC</i><sup><i>mut</i></sup> cell transplant mice treated for 2&nbsp;weeks with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (P) (100&nbsp;mg/kg) (n&nbsp;= 4).</div><div id="fspara0385" role="paragraph">(C) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from (B). NES, normalized enrichment score.</div><div id="fspara0390" role="paragraph">(D) Heatmap of cytokine array results from primary murine pancreatic fibroblasts following treatment as in (A). Data presented as mean of three biological replicates.</div><div id="fspara0395" role="paragraph">(E and F) Cell growth analysis of fibroblasts (E) or macrophages (F) harvested from C57BL/6 mice and cultured in basal or conditioned media from <i>KPC</i><sup><i>mut</i></sup> tumor cells treated for 8&nbsp;days as in (A) (n&nbsp;= 3).</div><div id="fspara0400" role="paragraph">(G and H) Flow cytometry analysis of F4/80<sup>+</sup> macrophage numbers and polarization in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) (n&nbsp;= 5).</div><div id="fspara0405" role="paragraph">(I) qRT-PCR analysis of M1 (<i>Tnfa, Il6, Il1b</i>), M2 (<i>Il10, Tgfb, Arg1</i>), and <i>Vegfa</i> gene expression in macrophages sorted from <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated as in (G) (n&nbsp;= 5). Cd11b was used as a macrophage loading control. A.U., arbitrary units.</div><div id="fspara0410" role="paragraph">(J and K) IHC staining and quantification of total blood vessels (p&nbsp;= 0.009) (J) and those with visible lumens (K) in tumors harvested from <i>KPC</i><sup><i>mut</i></sup> organoids transplanted into NOD-<i>scid</i> IL2Rγ<sup>null</sup> (NSG) mice treated as in (G) (n&nbsp;= 3).</div><div id="fspara0415" role="paragraph">(L) IF staining and quantification of P-selectin (p&nbsp;= 0.039) or VCAM-1 (p&nbsp;= 0.0126) colocalization with blood vessels in tumors from (J) (n&nbsp;= 4).</div><div id="fspara0420" role="paragraph">One-way ANOVA (A). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0080" role="paragraph">Other stromal subtypes in the PDAC TME, most prominently fibroblasts and macrophages, can also secrete factors that promote angiogenesis. However, T/P treatment did not stimulate the secretion of angiogenic factors from pancreatic fibroblasts, and conditioned media from T/P-treated senescent PDAC cells did not affect fibroblast or macrophage proliferation (<a id="crosref0315" href="#figs2">Figures S2</a>D–S2F). While there was an increase in the number of PDAC-associated F4/80<sup>+</sup> macrophages and their expression of MHC-II and CD86 following T/P treatment, we only observed minor changes in expression of VEGF or other macrophage polarization markers (<a id="crosref0320" href="#figs2">Figures S2</a>G–S2I). Furthermore, the vascular remodeling that accompanied senescence induction was not dependent on immune cells, as T/P treatment of tumors derived from <i>KPC</i><sup><i>mut</i></sup> organoids injected orthotopically into C567BL/6 or immunodeficient NOD-<i>scid</i> IL2Rγ<sup>null</sup> (NSG) mice led to similar increases in vascular density, open vessel lumens, and endothelial activation (<a id="crosref0325" href="#figs2">Figures S2</a>J–S2L). Therefore, senescent tumor cells are likely the primary source of angiogenic SASP factors following T/P treatment.</div><div id="p0085" role="paragraph">To directly test whether the SASP contributes to vascular remodeling <i>in&nbsp;vivo</i>, <i>KPC</i><sup><i>mut</i></sup> organoids were transduced with short hairpin RNAs (shRNAs) targeting the p65 subunit of NF-κB, a transcription factor required for SASP induction but dispensable for senescence-mediated growth arrest (<span class="dropBlock reference-citations"><a id="body-ref-sref84-5" href="#" role="doc-biblioref" data-xml-rid="bib17 bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-5" aria-controls="sref84-5">Chien et&nbsp;al., 2011; Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chien, Y. ∙ Scuoppo, C. ∙ Wang, X. ...</div><div><strong>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</strong></div><div><em>Genes Dev.</em> 2011; <strong>25</strong>:2125-2136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.17276711" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80054789761" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21979375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.17276711&amp;pmid=21979375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As predicted, suppression of NF-κB in PDAC cells treated with T/P reduced the secretion of both immune modulatory and pro-angiogenic SASP factors (<a id="crosref0330" href="#fig2">Figure&nbsp;2</a>D). <i>KPC</i><sup><i>mut</i></sup> organoids expressing the <i>p65</i> or control (<i>Ren</i>) shRNA were then transplanted orthotopically into C57BL/6 mice to assess the impact of SASP suppression on vascular remodeling. While potent NF-κB inhibition can block proliferation of KRAS mutant tumors in some contexts (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib50 bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Lesina et&nbsp;al., 2016; Meylan et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Lesina, M. ∙ Wörmann, S.M. ∙ Morton, J. ...</div><div><strong>RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2016; <strong>126</strong>:2919-2932</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI86477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987806939" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27454298/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI86477&amp;pmid=27454298" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Meylan, E. ∙ Dooley, A.L. ∙ Feldser, D.M. ...</div><div><strong>Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma</strong></div><div><em>Nature.</em> 2009; <strong>462</strong>:104-107</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature08462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-70449109147" target="_blank" aria-label="Open Scopus in new tab">Scopus (383)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19847165/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature08462&amp;pmid=19847165" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), partial NF-κB suppression using p65-targeting shRNAs did not affect tumor growth or senescence-associated cell-cycle arrest of <i>KPC</i><sup><i>mut</i></sup> organoid-derived tumors following T/P treatment (<a id="crosref0335" href="#figs3">Figures S3</a>A–S3C). Instead, p65 suppression blocked the increase in vascular density, maturation, perfusion, and immunomodulatory activation, as well as the decrease in HA levels that accompanies T/P treatment in tumors harboring <i>Ren</i> shRNAs (<a id="crosref0340" href="#fig2">Figures 2</a>E, 2F, and <a id="crosref0345" href="#figs3">S3</a>D–S3H).</div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/f9557230-afbb-4256-b274-2b4f43dbcc62/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2020.03.008/asset/63b1ddea-97ae-4ba1-95ef-f75925f7a5a6/main.assets/figs3.jpg" height="573" width="762" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/f9557230-afbb-4256-b274-2b4f43dbcc62/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Multiple SASP Factors Contribute to Divergent Vascular Remodeling Phenotypes following T/P Treatment, Related to <a id="crosref0875" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0430" role="paragraph">(A) qRT-PCR analysis of <i>p65</i> gene expression in <i>KPC</i><sup><i>mut</i></sup> cells harboring <i>Renilla</i> (<i>Ren</i>) or <i>p65</i> shRNAs and treated for 8&nbsp;days with vehicle or trametinib (25nM) and palbociclib (500nM). A.U., arbitrary units.</div><div id="fspara0435" role="paragraph">(B) IHC staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs and treated for 2&nbsp;weeks with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) (n&nbsp;= 2-3).</div><div id="fspara0440" role="paragraph">(C) Waterfall plot of the response of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs following treatment as in (B) (n ≥ 3).</div><div id="fspara0445" role="paragraph">(D and E) Quantification of vessel to tumor distance (D) and vessels with visible lumens per field (E) in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs and treated as in (B) (see <a id="crosref0880" href="#fig2">Figure&nbsp;2</a>E) (n&nbsp;= 2-3).</div><div id="fspara0450" role="paragraph">(F–H) Flow cytometry analysis of surface marker expression on endothelial cells in indicated <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated as in (B) (n&nbsp;= 3-5).</div><div id="fspara0455" role="paragraph">(I) IF staining and quantification of P-selectin (p&nbsp;= 0.17) or VCAM-1 (p&nbsp;= 0.01) colocalization with blood vessels in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) (n&nbsp;= 4).</div><div id="fspara0460" role="paragraph">One-way ANOVA (C–H). Error bars, mean ± SEM. <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0090" role="paragraph">VEGF was one SASP factor that contributed to vascular remodeling. Treatment of human and murine PDAC cells produced an NF-κB-dependent increase in VEGF secretion (<a id="crosref0350" href="#fig2">Figures 2</a>A, 2D, and <a id="crosref0355" href="#figs2">S2</a>A). Moreover, suppression of VEGFR-2, the cognate receptor for VEGF, using high doses of the VEGFR-2 blocking antibody DC101 effectively inhibited neo-vascularization following T/P treatment (<a id="crosref0360" href="#fig2">Figure&nbsp;2</a>G). By contrast, VEGFR-2 blockade did not inhibit the upregulation of endothelial activation markers P-selectin and VCAM-1 following T/P treatment, which instead were suppressed using antagonizing antibodies against other inflammatory SASP factors, including CCL5, CXCL1, and interleukin (IL)-6 (<a id="crosref0365" href="#fig2">Figures 2</a>H and <a id="crosref0370" href="#figs3">S3</a>I). Thus, different SASP factors collaborate to produce vascular remodeling and endothelial cell activation after T/P treatment.</div></section><section id="sec-2-3"><h3>Senescence-Inducing Therapies Sensitize PDAC to Cytotoxic Chemotherapy</h3><div id="p0095" role="paragraph">The hypovascularity and vascular compression associated with PDAC contributes to its chemo-refractory nature by impeding drug delivery to the tumor (<span class="dropBlock reference-citations"><a id="body-ref-sref78-4" href="#" role="doc-biblioref" data-xml-rid="bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-4" aria-controls="sref78-4">Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To determine if SASP-mediated vascular remodeling enhances tumor perfusion and permeability of soluble factors, including standard-of-care gemcitabine chemotherapy, tumor-bearing <i>KPC</i><sup><i>mu</i>t</sup> organoid transplant or <i>KPC</i><sup><i>flox</i></sup> GEMM mice were pretreated with vehicle or T/P for 2&nbsp;weeks, and then injected with (1) lectin, (2) a high molecular weight dextran, and/or (3) a <sup>14</sup>C-labeled gemcitabine radiotracer. Consistent with the increase in vessel size and maturation, vessels in T/P pretreated tumors had increased lectin perfusion (<a id="crosref0375" href="#fig3">Figure&nbsp;3</a>A). T/P pretreated tumors also had significantly more dextran accumulation as compared to controls, indicative of enhanced vessel permeability (<a id="crosref0380" href="#fig3">Figures 3</a>A and <a id="crosref0385" href="#figs4">S4</a>B). These dual effects of T/P treatment on vascular permeability and perfusion resulted in no change in hypoxia in the PDAC TME as assessed by pimonidazole staining (<a id="crosref0390" href="#figs4">Figure&nbsp;S4</a>A).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/887a5c76-69f5-48fb-af02-cded82efc560/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2020.03.008/asset/74ea3da0-c903-4286-81e3-fed3f15df195/main.assets/gr3.jpg" height="951" width="754" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/887a5c76-69f5-48fb-af02-cded82efc560/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Senescence-Inducing Therapies Sensitize PDAC to Cytotoxic Chemotherapy</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0105" role="paragraph">(A) <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice were pretreated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks and subsequently injected with <sup>14</sup>C-labeled gemcitabine (gem), dextran, and/or lectin prior to tissue harvest. Autoradiograph showing distribution of <sup>14</sup>C-gem in tumors. Below: overlay of autoradiographs with IHC/IF staining and quantification of lectin colocalization with blood vessels (n&nbsp;= 2–3; p&nbsp;= 0.054).</div><div id="fspara0110" role="paragraph">(B) <sup>14</sup>C-gem quantification in indicated tumors (n&nbsp;= 3–6).</div><div id="fspara0115" role="paragraph">(C) Waterfall plot of the response of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors after 2&nbsp;weeks treatment with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), gemcitabine (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) either continuously or on an alternating schedule (n ≥ 8).</div><div id="fspara0120" role="paragraph">(D) Kaplan-Meier survival curve of <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice treated as in (C) (n ≥ 7).</div><div id="fspara0125" role="paragraph">(E) Waterfall plot of the response of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors following treatment as in (C) (n ≥ 5).</div><div id="fspara0130" role="paragraph">(F) Kaplan-Meier survival curve of <i>KPC</i><sup><i>flox</i></sup> GEMM mice treated as in (C) (n ≥ 7).</div><div id="fspara0135" role="paragraph">(G) IHC staining of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated as in (C). Quantification of Ki67<sup>+</sup> and cleaved capase-3 (CC3<sup>+</sup>) cells per field is shown (n&nbsp;= 3; Gem versus T/P/G and T/P/G versus T/P/G/DC101, p&nbsp;&lt; 0.05).</div><div id="fspara0140" role="paragraph">One-way ANOVA (B, C, and E). Log-rank test (D and F). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale&nbsp;bars, 50&nbsp;μm.</div><div id="fspara0145" role="paragraph">See also <a id="crosref0820" href="#figs4">Figure&nbsp;S4</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/35f5a4ee-0de0-4fe9-bb7d-ca377baade99/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2020.03.008/asset/f2eb2959-6c57-4f37-80bc-05bbb69fc476/main.assets/figs4.jpg" height="950" width="742" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/35f5a4ee-0de0-4fe9-bb7d-ca377baade99/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Trametinib and Palbociclib Treatment Enhances Gemcitabine Cytotoxicity in Both Mouse and Human PDAC via Vascular Remodeling, Related to <a id="crosref0885" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0470" role="paragraph">(A) IF staining and quantification of activated pimonidazole in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks (n&nbsp;= 2; p&nbsp;= 0.41).</div><div id="fspara0475" role="paragraph">(B) <i>KPC</i><sup><i>flox</i></sup> GEMM mice were pretreated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks, and subsequently injected with <sup>14</sup>C-labeled gemcitabine (Gem) and dextran prior to tissue harvest. Heatmap representation of autoradiograph showing distribution and quantification of <sup>14</sup>C-Gem uptake into tumors (n&nbsp;= 3; p&nbsp;= 0.03). Below: dextran staining and quantification (n&nbsp;= 3-4; p&nbsp;= 0.0003).</div><div id="fspara0480" role="paragraph">(C) Quantification of <sup>14</sup>C-Gem levels in indicated tissues harvested from <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice following treatment as in (B) (n&nbsp;= 3).</div><div id="fspara0485" role="paragraph">(D) <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice were pretreated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) for 2&nbsp;weeks, and subsequently injected with <sup>14</sup>C-labeled gemcitabine and dextran prior to tissue harvest. Autoradiograph showing distribution and quantification of <sup>14</sup>C-Gem uptake into tumors (n&nbsp;= 2-3; p&nbsp;= 0.485). Below: dextran staining and quantification (n&nbsp;= 2-3; p&nbsp;= 0.844).</div><div id="fspara0490" role="paragraph">(E) IHC staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), gemcitabine (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) either continuously (C) or on an alternating (A) schedule. Quantification of Ki67<sup>+</sup> (Gem versus T/P/G (C), p&nbsp;= 0.0244; Gem versus T/P/G (A), p&nbsp;= 0.0029; T/P/G (C) versus T/P/G/DC101, p&nbsp;= 0.0727) and cleaved caspase-3 (CC3<sup>+</sup>) cells (Gem versus T/P/G (C), p&nbsp;= 0.0054; Gem versus T/P/G (A), p&nbsp;= 0.0072; T/P/G (C) versus T/P/G/DC101, p&nbsp;= 0.0056) per field is shown (n&nbsp;= 3).</div><div id="fspara0495" role="paragraph">(F) IF staining of a <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated for 2&nbsp;weeks with trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and gemcitabine (100&nbsp;mg/kg). Right: quantification of the percentage of CC3<sup>+</sup> cells in the epithelial (CK19<sup>+</sup>) versus stromal (CK19<sup>-</sup>) compartments (n&nbsp;= 4).</div><div id="fspara0500" role="paragraph">(G) Staining and quantification of SA-β-gal positive area in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or gemcitabine (100&nbsp;mg/kg) (n&nbsp;= 3; T/P versus T/P/G, p&nbsp;= 0.0183).</div><div id="fspara0505" role="paragraph">(H) IHC staining of PR-07 patient-derived xenograft (PDX) PDAC tumors treated as in (A). Quantification of αSMA (p&nbsp;= 0.3140), collagen (trichrome) (p&nbsp;= 0.2312), and hyaluronic acid (HA) (p&nbsp;= 0.0001) staining intensity, as well as SA-β-gal positive area (p&nbsp;= 0.0017), is shown (n&nbsp;= 3).</div><div id="fspara0510" role="paragraph">(I–K) IHC staining and quantification of blood vessels per field (p&nbsp;= 0.0004) (I), vessel to tumor distance (J), and vessels with visible lumens (K) in PR-07 PDX PDAC tumors treated as in (A) (n&nbsp;= 2-3). Arrowhead, collapsed vessel; Arrow, visible lumen.</div><div id="fspara0515" role="paragraph">(L and M) Tumor volumes of mice bearing PR-07 (L) or PR-05 (M) PDAC PDX tumors treated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or gemcitabine (100&nbsp;mg/kg) for indicated times (n&nbsp;= 7).</div><div id="fspara0520" role="paragraph">(N) IHC staining and quantification of CC3<sup>+</sup> cells in PR-07 PDAC PDX tumors treated as in (L) (n&nbsp;= 3; T/P versus T/P/G, p&nbsp;= 0.0046).</div><div id="fspara0525" role="paragraph">One-way ANOVA (E and G). Two-way ANOVA (L and M). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0100" role="paragraph">T/P pretreatment also increased gemcitabine penetration into the tumor, particularly in focal regions containing high densities of SA-β-gal<sup>+</sup> senescent cells and blood vessels (<a id="crosref0395" href="#fig3">Figures 3</a>A, 3B, and <a id="crosref0400" href="#figs4">S4</a>B). By contrast, such effects were not observed in the normal pancreas or other organs of the same tumor-bearing mice (<a id="crosref0405" href="#figs4">Figure&nbsp;S4</a>C). The increase in drug uptake and dextran accumulation in tumors following T/P treatment was suppressed upon tumor-specific <i>p65</i> knockdown or DC101 treatment, indicating these processes were dependent on SASP induction and signaling through the SASP factor VEGF (<a id="crosref0410" href="#fig3">Figures 3</a>B and <a id="crosref0415" href="#figs4">S4</a>D).</div><div id="p0105" role="paragraph">To assess whether the addition of gemcitabine to the T/P combination (T/P/G) produced better treatment outcomes than either regimen alone, cohorts of tumor-bearing <i>KPC</i><sup><i>mut</i></sup> organoid transplant or <i>KPC</i><sup><i>flox</i></sup> GEMM mice were monitored for tumor response and for overall survival following treatment with gemcitabine, T/P, or both. To examine the contribution of the remodeled vasculature to drug activity, some mice were also treated with DC101 to prevent SASP-mediated neo-vascularization. As is often observed clinically (<span class="dropBlock reference-citations"><a id="body-ref-sref13-1" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-1" aria-controls="sref13-1">Carmichael et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref13-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Carmichael, J. ∙ Fink, U. ∙ Russell, R.C. ...</div><div><strong>Phase II study of gemcitabine in patients with advanced pancreatic cancer</strong></div><div><em>Br. J. Cancer.</em> 1996; <strong>73</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/bjc.1996.18" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8554969/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fbjc.1996.18&amp;pmid=8554969" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), gemcitabine alone had modest effects on tumor growth and limited survival impact in our murine PDAC models (<a id="crosref0425" href="#fig3">Figures 3</a>C–3F). T/P treatment modestly delayed tumor growth and produced a marginal survival advantage, but the T/P/G regimen produced potent tumor regressions and significantly enhanced survival, effects that were largely ablated by DC101 (<a id="crosref0430" href="#fig3">Figures 3</a>C–3F). Similar efficacy was observed when PDAC-bearing mice were treated using an alternating weekly schedule of T/P and gemcitabine (<a id="crosref0435" href="#fig3">Figures 3</a>C). These results further support a role for T/P pretreatment in priming gemcitabine efficacy through its vascular remodeling effects, as has been observed in other settings (<span class="dropBlock reference-citations"><a id="body-ref-sref78-5" href="#" role="doc-biblioref" data-xml-rid="bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-5" aria-controls="sref78-5">Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0110" role="paragraph">Histological analyses of tumors revealed that T/P or gemcitabine treatment alone was not cytotoxic, but the T/P/G regimen produced considerable tumor cell apoptosis that could be blocked by DC101 (<a id="crosref0440" href="#fig3">Figures 3</a>G, <a id="crosref0940" href="#figs4">S4</a>E, and S4F). We suspect that this increase in tumor cell apoptosis results from a culling of cycling tumor cells that fail to senesce, as analysis of the residual tumor mass following short-term T/P/G treatment revealed an enrichment for non-proliferating and SA-β-gal-positive cells as compared to T/P or gemcitabine treatment alone (<a id="crosref0450" href="#fig3">Figures 3</a>G and <a id="crosref0455" href="#figs4">S4</a>E–S4G). Thus, SASP-provoked vascular remodeling can enhance PDAC responses to cytotoxic chemotherapy, at least in part, by facilitating drug uptake.</div><div id="p0115" role="paragraph">We also examined the treatment responses of two patient-derived xenograft (PDX) models propagated through subcutaneous transplantation of PDAC tissue into immunodeficient mice. While many subcutaneous xenograft models lack the dense stroma and hypovascularity found in autochthonous PDACs (<span class="dropBlock reference-citations"><a id="body-ref-sref73-5" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-5" aria-controls="sref73-5">Olive et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref73-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), two models obtained from patients that had progressed under gemcitabine chemotherapy regimens retained a robust and dense stroma and thus were chosen for further analysis (<a id="crosref0465" href="#figs4">Figure&nbsp;S4</a>H). As was noted in the murine models, T/P treatment triggered proliferative arrest and senescence in PDX tumors, together with an increase in vascular density and lumen diameter and HA degradation in the stroma (<a id="crosref0470" href="#figs4">Figures S4</a>H–S4K). Both PDX models had only a modest response to gemcitabine alone, whereas T/P/G therapy produced an increase in apoptosis associated with sustained tumor growth inhibition and partial tumor regressions in some mice (<a id="crosref0475" href="#figs4">Figures S4</a>L–S4N). Thus, vascular remodeling following therapy-induced senescence also sensitizes human PDAC to chemotherapy.</div></section><section id="sec-2-4"><h3>The SASP Promotes T Cell Infiltration via Endothelial Activation</h3><div id="p0120" role="paragraph">Besides its dysfunctional vasculature, human and mouse PDAC displays an abundance of immune suppressive myeloid and regulatory T&nbsp;cells (T<sub>regs</sub>) together with a scarcity of cytotoxic lymphocytes (<span class="dropBlock reference-citations"><a id="body-ref-sref99" href="#" role="doc-biblioref" data-xml-rid="bib6 bib19 bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99" aria-controls="sref99">Blando et&nbsp;al., 2019; Clark et&nbsp;al., 2007; Vonderheide and Bayne, 2013</a><div class="dropBlock__holder" data-db-target-of="sref99"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Blando, J. ∙ Sharma, A. ∙ Higa, M.G. ...</div><div><strong>Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2019; <strong>116</strong>:1692-1697</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1811067116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85060784961" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30635425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1811067116&amp;pmid=30635425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Clark, C.E. ∙ Hingorani, S.R. ∙ Mick, R. ...</div><div><strong>Dynamics of the immune reaction to pancreatic cancer from inception to invasion</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:9518-9527</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-07-0175" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-35148814410" target="_blank" aria-label="Open Scopus in new tab">Scopus (518)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17909062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-07-0175&amp;pmid=17909062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">100.</div><div>Vonderheide, R.H. ∙ Bayne, L.J.</div><div><strong>Inflammatory networks and immune surveillance of pancreatic carcinoma</strong></div><div><em>Curr. Opin. Immunol.</em> 2013; <strong>25</strong>:200-205</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2013.01.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84877052290" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23422836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2013.01.006&amp;pmid=23422836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As such, these tumors are considered immunologically “cold.” Hypovascularity and lack of an activated endothelium can also impair lymphocyte homing to normal and malignant tissues (<span class="dropBlock reference-citations"><a id="body-ref-sref101" href="#" role="doc-biblioref" data-xml-rid="bib39 bib67 bib101" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref101" aria-controls="sref101">Huang et&nbsp;al., 2018; Muller, 2009; Wu et&nbsp;al., 1992</a><div class="dropBlock__holder" data-db-target-of="sref101"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Huang, Y. ∙ Kim, B.Y.S. ∙ Chan, C.K. ...</div><div><strong>Improving immune-vascular crosstalk for cancer immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:195-203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.145" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85042584062" target="_blank" aria-label="Open Scopus in new tab">Scopus (72)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29332937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.145&amp;pmid=29332937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Muller, W.A.</div><div><strong>Mechanisms of transendothelial migration of leukocytes</strong></div><div><em>Circ. Res.</em> 2009; <strong>105</strong>:223-230</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/CIRCRESAHA.109.200717" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-69249238022" target="_blank" aria-label="Open Scopus in new tab">Scopus (194)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19644057/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FCIRCRESAHA.109.200717&amp;pmid=19644057" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Wu, N.Z. ∙ Klitzman, B. ∙ Dodge, R. ...</div><div><strong>Diminished leukocyte-endothelium interaction in tumor microvessels</strong></div><div><em>Cancer Res.</em> 1992; <strong>52</strong>:4265-4268</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1638539/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=1638539" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We therefore used a combination of genetic and pharmacological approaches to assess the consequences of perturbing SASP, neo-vascularization, or endothelial cell activation on immune cell infiltrates following T/P therapy.</div><div id="p0125" role="paragraph">Consistent with the above results (see <a id="crosref0480" href="#figs1">Figures S1</a>E and S1F), drug treatment did not increase NK cell numbers or activity in any of the three murine PDAC models tested, and antibody-mediated NK cell depletion did not affect the survival of T/P-treated mice harboring orthotopically transplanted <i>KPC</i><sup><i>mut</i></sup> cell-derived tumors (<a id="crosref0485" href="#figs5">Figures S5</a>A and S5B). Instead, we noted a substantial increase in the influx of T&nbsp;cells, and in particular, CD8<sup>+</sup> T&nbsp;cells, into the tumor mass of transplanted and autochthonous PDAC following 2-week T/P treatment (<a id="crosref0490" href="#fig4">Figures 4</a>A, 4B, and <a id="crosref0495" href="#figs5">S5</a>C). Immunophenotyping confirmed that this increase was mainly due to CD8<sup>+</sup> T&nbsp;cell accumulation that occurred in the absence of changes in Ly6G<sup>+</sup> neutrophil, Gr-1<sup>hi</sup>CD11b<sup>+</sup> myeloid-derived suppressor cell (MDSC), FOXP3<sup>+</sup> T<sub>reg</sub>, or FAP<sup>+</sup> fibroblast populations that have been associated with CD8<sup>+</sup> T&nbsp;cell suppression in PDAC (<a id="crosref0500" href="#fig4">Figures 4</a>C, 4D, and <a id="crosref0505" href="#figs5">S5</a>D–S5F) (<span class="dropBlock reference-citations"><a id="body-ref-sref95" href="#" role="doc-biblioref" data-xml-rid="bib19 bib32 bib42 bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95" aria-controls="sref95">Clark et&nbsp;al., 2007; Feig et&nbsp;al., 2013; Jiang et&nbsp;al., 2016; Steele et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref95"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Clark, C.E. ∙ Hingorani, S.R. ∙ Mick, R. ...</div><div><strong>Dynamics of the immune reaction to pancreatic cancer from inception to invasion</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:9518-9527</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-07-0175" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-35148814410" target="_blank" aria-label="Open Scopus in new tab">Scopus (518)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17909062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-07-0175&amp;pmid=17909062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (623)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Steele, C.W. ∙ Karim, S.A. ∙ Leach, J.D.G. ...</div><div><strong>CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2016; <strong>29</strong>:832-845</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccell.2016.04.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccell.2016.04.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976515614" target="_blank" aria-label="Open Scopus in new tab">Scopus (247)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27265504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.04.014&amp;pmid=27265504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This T/P treatment-induced increase in CD8<sup>+</sup> T&nbsp;cells required SASP-mediated vascular remodeling, as the effect was largely abolished in tumors harboring a <i>p65</i> shRNA or treated with DC101 (<a id="crosref0510" href="#fig4">Figures 4</a>E–4H).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/6a978171-43e4-4e7b-a6ab-2a5acf373a93/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2020.03.008/asset/a0dfc3bc-8d0b-41cc-bcc4-54f1feb70233/main.assets/gr4.jpg" height="951" width="741" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6a978171-43e4-4e7b-a6ab-2a5acf373a93/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">The SASP Promotes T Cell Infiltration via Endothelial Activation</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0155" role="paragraph">(A and B) IHC staining and quantification of intratumoral total (A) and CD8<sup>+</sup> (B) T&nbsp;cells per field in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks (n&nbsp;= 3; p&nbsp;&lt; 0.01).</div><div id="fspara0160" role="paragraph">(C and D) Flow cytometry analysis of CD4<sup>+</sup> (C) and CD8<sup>+</sup> (D) T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle, trametinib (1&nbsp;mg/kg), and/or palbociclib (100&nbsp;mg/kg) (n&nbsp;= 5).</div><div id="fspara0165" role="paragraph">(E) Flow cytometry analysis of CD8<sup>+</sup> T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors harboring control <i>Ren</i> or <i>p65</i> shRNAs and treated as in (A) (n&nbsp;= 4–7).</div><div id="fspara0170" role="paragraph">(F) Flow cytometry analysis of CD8<sup>+</sup> T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) for 2&nbsp;weeks (n&nbsp;= 3–5).</div><div id="fspara0175" role="paragraph">(G) IHC staining and quantification of intratumoral T&nbsp;cells per field in <i>KPC</i><sup><i>mut</i></sup> organoid tumors harboring <i>Ren</i> or <i>p65</i> shRNAs and treated as in (A) (n&nbsp;= 2–3; <i>Ren</i> T/P versus <i>p65</i> T/P, p&nbsp;= 0.0001).</div><div id="fspara0180" role="paragraph">(H) IHC staining and quantification of intratumoral T&nbsp;cells per field in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated as in (F) (n&nbsp;= 2–3; T/P versus T/P/DC101, p&nbsp;= 0.007).</div><div id="fspara0185" role="paragraph">(I) Flow cytometry analysis of CD8<sup>+</sup> T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or neutralizing mAbs targeting PSGL-1 (4RA10; 50&nbsp;μg), ICAM-1 (YN1/1.7.4; 200&nbsp;μg), or VCAM-1 (M/K-2.7; 200&nbsp;μg) (n&nbsp;= 4–5).</div><div id="fspara0190" role="paragraph">(J) IHC staining and quantification of intratumoral T&nbsp;cells per field in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VCAM-1 neutralizing antibody (M/K-2.7; 200&nbsp;μg) for 2&nbsp;weeks (n ≥ 3; T/P versus T/P/VCAM-1, p&nbsp;= 0.008). Values for V and T/P-treated cohorts are the same displayed in (A).</div><div id="fspara0195" role="paragraph">One-way ANOVA (C–F and I). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale bars, 50&nbsp;μm.</div><div id="fspara0200" role="paragraph">See also <a id="crosref0825" href="#figs5">Figure&nbsp;S5</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/5a12f040-eb55-44f0-80f9-3633e07311d8/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2020.03.008/asset/21dbc32c-28a9-4c5c-b193-f26f548142da/main.assets/figs5.jpg" height="361" width="762" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/5a12f040-eb55-44f0-80f9-3633e07311d8/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Therapy-Induced Senescence Directly Promotes CD8<sup>+</sup> T Cell Accumulation in PDAC, Related to <a id="crosref0890" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0535" role="paragraph">(A) Flow cytometry analysis of NK cell numbers (left) and activity (right) in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) (n&nbsp;= 4-5).</div><div id="fspara0540" role="paragraph">(B) Kaplan-Meier survival curve of <i>KPC</i><sup><i>mut</i></sup> cell transplant mice treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) in the presence or absence of a NK1.1 depleting antibody (PK136; 250 ug) (n ≥ 7).</div><div id="fspara0545" role="paragraph">(C) IHC staining and quantification of CD8<sup>+</sup> T&nbsp;cells per field in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated as in (A) (n&nbsp;= 2-3; p&nbsp;= 0.037).</div><div id="fspara0550" role="paragraph">(D and E) Flow cytometry analysis of neutrophils (D) and MDSCs (E) in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated as in (A) (n&nbsp;= 4-5).</div><div id="fspara0555" role="paragraph">(F) IHC staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated as in (A). Representative images of 3 biological replicates.</div><div id="fspara0560" role="paragraph">(G) Flow cytometry analysis of VLA-4 expression on CD8<sup>+</sup> T&nbsp;cells in indicated <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated as in (A) (n&nbsp;= 3-5).</div><div id="fspara0565" role="paragraph">One-way ANOVA (G). Log-rank test (B). Error bars, mean ± SEM. <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01. n.s., not significant. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0130" role="paragraph">To assess whether endothelial cell activation contributes to&nbsp;CD8<sup>+</sup> T&nbsp;cell accumulation that accompanies senescence in T/P-treated PDAC, we used neutralizing antibodies against the P-selectin ligand PSGL-1, VCAM-1, and ICAM-1, and evaluated the PDAC immune landscape. Blockade of VCAM-1, but not PSGL-1 or ICAM-1, significantly reduced the numbers of total and CD8<sup>+</sup> tumor-infiltrating T&nbsp;cells in T/P treated-mice (<a id="crosref0515" href="#fig4">Figures 4</a>I and 4J). VCAM-1 induction on endothelial cells facilitates blood vessel adhesion and tissue extravasation of T&nbsp;cells expressing its ligand, VLA-4 (<span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib54 bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Lorenzon et&nbsp;al., 1998; Nandi et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Lorenzon, P. ∙ Vecile, E. ∙ Nardon, E. ...</div><div><strong>Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1998; <strong>142</strong>:1381-1391</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.142.5.1381" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0032494169" target="_blank" aria-label="Open Scopus in new tab">Scopus (194)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9732297/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.142.5.1381&amp;pmid=9732297" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Nandi, A. ∙ Estess, P. ∙ Siegelman, M.</div><div><strong>Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T&nbsp;cell extravasation</strong></div><div><em>Immunity.</em> 2004; <strong>20</strong>:455-465</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1074-7613%2804%2900077-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1074-7613%2804%2900077-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-1842633889" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15084274/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2804%2900077-9&amp;pmid=15084274" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Accordingly, VLA-4 expression was elevated on CD8<sup>+</sup> T&nbsp;cells isolated from transplanted PDAC in a SASP-dependent manner following T/P treatment (<a id="crosref0520" href="#figs5">Figure&nbsp;S5</a>G). Thus, SASP-induced vascular remodeling, in part through the VCAM-1/VLA-4 cell adhesion axis, enables the penetration of CD8<sup>+</sup> T&nbsp;cells into the PDAC TME.</div></section><section id="sec-2-5"><h3>Therapy-Induced Senescence Leads to T Cell Activation and Exhaustion</h3><div id="p0135" role="paragraph">PDAC-associated CD8<sup>+</sup> T&nbsp;cells expressed higher levels of the activation markers CD69 and CD44 following T/P, but not single agent or vehicle treatment (<a id="crosref0525" href="#fig5">Figures 5</a>A and 5B). This effect was dependent on SASP-mediated vascular remodeling (<a id="crosref0530" href="#figs6">Figures S6</a>A–S6D), hinting that senescence induction in tumor cells may stimulate the activity of tumor-reactive T&nbsp;cells. Of note, both MEK and CDK4/6 inhibitors can increase antigen presentation and T&nbsp;cell targeting of tumor cells in other cancer models (<span class="dropBlock reference-citations"><a id="body-ref-sref87-1" href="#" role="doc-biblioref" data-xml-rid="bib10 bib27 bib29 bib33 bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-1" aria-controls="sref87-1">Brea et&nbsp;al., 2016; Deng et&nbsp;al., 2018; Ebert et&nbsp;al., 2016; Goel et&nbsp;al., 2017; Schaer et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref87-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Brea, E.J. ∙ Oh, C.Y. ∙ Manchado, E. ...</div><div><strong>Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells</strong></div><div><em>Cancer Immunol. Res.</em> 2016; <strong>4</strong>:936-947</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2326-6066.CIR-16-0177" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85016108628" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27680026/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2326-6066.CIR-16-0177&amp;pmid=27680026" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Deng, J. ∙ Wang, E.S. ∙ Jenkins, R.W. ...</div><div><strong>CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:216-233</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0915" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85041378182" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29101163/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0915&amp;pmid=29101163" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Ebert, P.J.R. ∙ Cheung, J. ∙ Yang, Y. ...</div><div><strong>MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:609-621</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84960450202" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26944201/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.01.024&amp;pmid=26944201" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Goel, S. ∙ DeCristo, M.J. ∙ Watt, A.C. ...</div><div><strong>CDK4/6 inhibition triggers anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>548</strong>:471-475</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23465" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85028340229" target="_blank" aria-label="Open Scopus in new tab">Scopus (296)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813415/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23465&amp;pmid=28813415" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Schaer, D.A. ∙ Beckmann, R.P. ∙ Dempsey, J.A. ...</div><div><strong>The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade</strong></div><div><em>Cell Rep.</em> 2018; <strong>22</strong>:2978-2994</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85043587035" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29539425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.02.053&amp;pmid=29539425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and, accordingly, transcripts encoding components of the antigen processing/presentation machinery were elevated in human PDAC lines following T or P treatment alone (<a id="crosref0935" href="#figs6">Figure S6</a>E). Nonetheless, the T/P combination produced a much greater increase in the expression of these genes as well as surface level expression of MHC-I in orthotopic <i>KPC</i><sup><i>mut</i></sup> tumors (<a id="crosref0535" href="#fig5">Figures 5</a>C and <a id="crosref0540" href="#figs6">S6</a>E). This effect appeared functionally meaningful, as OT-1 T&nbsp;cells co-cultured with antigen matched ovalbumin (OVA)-expressing <i>KPC</i><sup><i>mut</i></sup> PDAC cells showed enhanced T&nbsp;cell activation and expression of the effector cytokines tumor necrosis factor alpha (TNF-α) and interferon (IFN)-γ after T/P-pretreatment of tumor cells in an MHC-I-dependent manner (<a id="crosref0545" href="#figs6">Figures S6</a>F and S6G).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/89261136-185e-46cb-be63-893ba8579cf4/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2020.03.008/asset/b9f8c110-e985-4688-b253-f3b0e5930fd7/main.assets/gr5.jpg" height="636" width="762" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/89261136-185e-46cb-be63-893ba8579cf4/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Therapy-Induced Senescence Leads to T Cell Activation and Exhaustion</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0210" role="paragraph">(A–D) Flow cytometry analysis of <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle, trametinib (1&nbsp;mg/kg) and/or palbociclib (100&nbsp;mg/kg) (n&nbsp;=&nbsp;3–5). (A) Percentage of CD69<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells. (B) Percentage of CD44<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells. (C) Representative histograms (left) and quantification of mean fluorescent intensity (MFI) of MHC-I (H-2k<sup>b</sup>) expression on tumor cells. (D) Percentage of CD107a<sup>+</sup> T&nbsp;cells.</div><div id="fspara0215" role="paragraph">(E) Kaplan-Meier survival curve of <i>KPC</i><sup><i>mut</i></sup> cell transplant mice treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) in the presence or absence of a CD8 (2.43; 200&nbsp;μg) or CD4 (GK1.5; 200&nbsp;μg) depleting antibody (n ≥ 6).</div><div id="fspara0220" role="paragraph">(F and G) Flow cytometry analysis of <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following treatment as in (A). (F) Representative flow cytometry plots and MFI for PD-1 (p&nbsp;=&nbsp;0.016), 2B4 (p&nbsp;&lt; 0.0001), LAG3 (p&nbsp;&lt; 0.0001), and CTLA-4 (p&nbsp;= 0.0002) expression on CD8<sup>+</sup> T&nbsp;cells (n&nbsp;= 3–5). (G) Percentage of PD-L1<sup>+</sup> tumor, immune, and endothelial cells (n&nbsp;= 5).</div><div id="fspara0225" role="paragraph">One-way ANOVA (A–D). Log-rank test (E). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant.</div><div id="fspara0230" role="paragraph">See also <a id="crosref0830" href="#figs6">Figure&nbsp;S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/fa1cd72c-b600-4d21-b764-b57fee0a8610/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2020.03.008/asset/498a237c-641a-43ea-ac39-541dc85da308/main.assets/figs6.jpg" height="806" width="762" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/fa1cd72c-b600-4d21-b764-b57fee0a8610/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Therapy-Induced Senescence Stimulates CD8<sup>+</sup> T Cell Activation, Related to <a id="crosref0895" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0575" role="paragraph">(A and B) Flow cytometry analysis of CD8<sup>+</sup> T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> PDAC cell transplant tumors harboring control <i>Ren</i> or <i>p65</i>-targeting shRNAs and treated with vehicle or trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) for 2&nbsp;weeks (n&nbsp;= 4-5 mice).</div><div id="fspara0580" role="paragraph">(C and D) Flow cytometry analysis of CD8<sup>+</sup> T&nbsp;cells in <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a VEGFR-2 blocking antibody (DC101; 800&nbsp;μg) for 2&nbsp;weeks (n&nbsp;= 3-5).</div><div id="fspara0585" role="paragraph">(E) Heatmap of expression of genes related to antigen processing and presentation in human KRAS mutant PDAC lines following 8&nbsp;day treatment with trametinib (25&nbsp;nM) and/or palbociclb (500&nbsp;nM) as assessed from analysis of RNA-seq data generated in <span class="dropBlock reference-citations"><a id="body-ref-sref84-6" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-6" aria-controls="sref84-6">Ruscetti et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref84-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>. Two biological replicates per cell line are shown.</div><div id="fspara0590" role="paragraph">(F and G) Reprentative histograms and quantification of T&nbsp;cell activation (F) and effector function (G) markers following flow cytometry analysis of OTI CD8<sup>+</sup> T&nbsp;cells co-cultured with control or chicken ovalbumin (OVA)-expressing <i>KPC</i><sup><i>mut</i></sup> tumor cells pretreated with vehicle or trametinib (25&nbsp;nM) and palbociclb (500&nbsp;nM) for 8&nbsp;days. PMA/ionomycin (P/I) stimulation served as a positive control for T&nbsp;cell activation, and MHC-I activity was functionally blocked with an H-2k<sup>b</sup> blocking antibody (Y-3; 40&nbsp;μg/ml) (n&nbsp;= 3).</div><div id="fspara0595" role="paragraph">One-way ANOVA (A–D, F, and G). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01. n.s., not significant.</div></div></div></div></figcaption></figure></div><div id="p0140" role="paragraph">Despite producing conditions that favor activation of cytotoxic T&nbsp;cell effector functions, T/P treatment did not stimulate robust anti-tumor T&nbsp;cell immunity in PDAC. Hence, T&nbsp;cells isolated from <i>KPC</i><sup><i>mut</i></sup> tumors following T/P treatment did not express the cytotoxicity marker CD107a, and neither CD8 nor CD4 depletion altered the modest survival advantage produced by T/P therapy (<a id="crosref0550" href="#fig5">Figures 5</a>D and 5E). In agreement, CD8<sup>+</sup> T&nbsp;cells isolated from the T/P treatment cohort displayed higher expression levels of the exhaustion markers PD-1, 2B4, CTLA-4, and LAG3 (<a id="crosref0555" href="#fig5">Figure&nbsp;5</a>F). While PD-1 expression can indicate prior T&nbsp;cell activation and priming, it can also induce T&nbsp;cell exhaustion and dysfunction through binding to its ligand PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref97" href="#" role="doc-biblioref" data-xml-rid="bib91 bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97" aria-controls="sref97">Sharpe and Pauken, 2018; Sun et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref97"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Sharpe, A.H. ∙ Pauken, K.E.</div><div><strong>The diverse functions of the PD1 inhibitory pathway</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:153-167</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.108" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85041484537" target="_blank" aria-label="Open Scopus in new tab">Scopus (266)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28990585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.108&amp;pmid=28990585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">98.</div><div>Sun, C. ∙ Mezzadra, R. ∙ Schumacher, T.N.</div><div><strong>Regulation and Function of the PD-L1 Checkpoint</strong></div><div><em>Immunity.</em> 2018; <strong>48</strong>:434-452</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2018.03.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2018.03.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85043754064" target="_blank" aria-label="Open Scopus in new tab">Scopus (945)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29562194/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.03.014&amp;pmid=29562194" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, immune, endothelial, and tumor cells each showed a significant increase in surface expression of PD-L1 after T/P treatment (<a id="crosref0560" href="#fig5">Figure&nbsp;5</a>G). Therefore, despite initial influx of activated T&nbsp;cells into PDAC undergoing therapy-induced senescence, CD8<sup>+</sup> T&nbsp;cells rapidly become phenotypically exhausted and do not contribute to an anti-tumor response.</div></section><section id="sec-2-6"><h3>T Cell Exhaustion Is Reversed by PD-1 Blockade that Triggers Anti-tumor Immunity</h3><div id="p0145" role="paragraph">Induction of the PD-1/PD-L1 inhibitory axis in T&nbsp;cell inflamed tumors following T/P treatment provides a clear rationale for combining senescence-inducing agents with PD-1 blockade. First, we examined activation and exhaustion marker expression on CD8<sup>+</sup> T&nbsp;cells isolated from <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors treated with T/P in combination with PD-1 blockade (T/P/PD-1). Remarkably, CD8<sup>+</sup> T&nbsp;cells from T/P/PD-1-treated tumors displayed reduced expression of exhaustion markers and increased co-expression of activation markers CD69 and CD44 compared to T/P treatment alone (<a id="crosref0565" href="#fig6">Figures 6</a>A–6C). These T&nbsp;cells also displayed higher TNF-α, INF-γ, and granzyme B expression compared to those harvested from tumors following T/P or PD-1 treatment alone, further indicative of reversion of lymphocyte dysfunction (<a id="crosref0570" href="#fig6">Figures 6</a>D and 6E).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/99f48614-18d7-48b0-94c7-95bab5edfaa2/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2020.03.008/asset/0d56817e-9b04-4dca-9c83-d200589e95ff/main.assets/gr6.jpg" height="753" width="678" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/99f48614-18d7-48b0-94c7-95bab5edfaa2/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">T Cell Exhaustion Is Reversed by PD-1 Blockade that Triggers Anti-tumor Immunity</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0240" role="paragraph">(A–D) Flow cytometry analysis of <i>KPC</i><sup><i>mut</i></sup> cell transplant tumors following 2-week treatment with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or a PD-1 blocking antibody (RMP1-14; 200&nbsp;μg). (A) Exhaustion marker expression on CD8<sup>+</sup> T&nbsp;cells (n&nbsp;= 4–5). Representative flow cytometry plots (B) and quantification (C) of CD69 and CD44 expression on CD8<sup>+</sup> T&nbsp;cells (n&nbsp;= 5). (D) Percentage of CD8<sup>+</sup> T&nbsp;cells expressing TNF-α and/or IFN-γ (n&nbsp;= 5–6).</div><div id="fspara0245" role="paragraph">(E) IHC staining and quantification of granyzme B<sup>+</sup> cells in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors following treatment as in (A) (n&nbsp;= 2–3; T/P versus T/P/PD-1, p&nbsp;=&nbsp;0.030; PD-1 versus T/P/PD-1, p&nbsp;= 0.041).</div><div id="fspara0250" role="paragraph">(F) IHC staining and quantification of CC3<sup>+</sup> cells in <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or mAbs targeting PD-1 (RMP1-14; 200&nbsp;μg), VEGFR-2 (DC101; 800&nbsp;μg), CD8 (2.43; 200&nbsp;μg), or VCAM-1 (M/K-2.7; 200&nbsp;μg) (n&nbsp;= 2-3; T/P versus T/P/PD-1, p&nbsp;= 0.016; T/P/PD-1 versus T/P/PD-1/DC101, p&nbsp;= 0.001; T/P/PD-1 versus T/P/PD-1/CD8, p&nbsp;= 0.0001; T/P/PD-1 versus T/P/PD-1/VCAM-1, p&nbsp;= 0.005). Values for V and T/P-treated cohorts are the same displayed in <a id="crosref0835" href="#fig3">Figure&nbsp;3</a>G.</div><div id="fspara0255" role="paragraph">(G) Staining and quantification of SA-β-gal<sup>+</sup> area in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated with trametinib (1&nbsp;mg/kg) and palbociclib (100&nbsp;mg/kg) in the presence or absence of a PD-1 blocking antibody (RMP1-14; 200&nbsp;μg) for 2&nbsp;weeks (n&nbsp;= 3; p&nbsp;= 0.011).</div><div id="fspara0260" role="paragraph">(H) <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs were treated for 2&nbsp;weeks as in (G). Quantification of CC3<sup>+</sup> cells is shown (n&nbsp;= 3; p&nbsp;= 0.03).</div><div id="fspara0265" role="paragraph">One-way ANOVA (C and D). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗</sup>p&nbsp;&lt; 0.05. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0150" role="paragraph">Tumors isolated from mice treated with T/P and PD-1 blockade displayed increased apoptosis compared to anti-PD-1 therapy alone (<a id="crosref0575" href="#fig6">Figure&nbsp;6</a>F). Activated T&nbsp;cells appeared to preferentially target senescent tumor cells, as T/P/PD-1-treated tumors showed a reduction in SA-β-gal positive cells compared to T/P treatment (<a id="crosref0580" href="#fig6">Figure&nbsp;6</a>G). Both senescence-associated vascular remodeling and CD8<sup>+</sup> T&nbsp;cell mobilization were required for these effects, because apoptosis produced by T/P/PD-1 treatment was abrogated by tumor specific suppression of <i>p65</i>, VEGFR-2 signaling disruption, VCAM-1 neutralization, and CD8 depletion (<a id="crosref0585" href="#fig6">Figures 6</a>F and 6H). Thus, PD-1 checkpoint blockade reawakens exhausted CD8<sup>+</sup> T&nbsp;cells to trigger anti-tumor immunity following senescence induction.</div></section><section id="sec-2-7"><h3>Senescence-Associated Vascular Remodeling Potentiates Immune Checkpoint Blockade</h3><div id="p0155" role="paragraph">The above results prompted us to assess the efficacy of T/P/PD-1 therapy in our preclinical murine PDAC models. Studies suggest that immune checkpoint blockade efficacy is partly dependent on mutations recognized as “non-self” by T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref89" href="#" role="doc-biblioref" data-xml-rid="bib86 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89" aria-controls="sref89">Samstein et&nbsp;al., 2019; Schumacher and Schreiber, 2015</a><div class="dropBlock__holder" data-db-target-of="sref89"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Samstein, R.M. ∙ Lee, C.H. ∙ Shoushtari, A.N. ...</div><div><strong>Tumor mutational load predicts survival after immunotherapy across multiple cancer types</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:202-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0312-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85059965982" target="_blank" aria-label="Open Scopus in new tab">Scopus (423)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0312-8&amp;pmid=30643254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Schumacher, T.N. ∙ Schreiber, R.D.</div><div><strong>Neoantigens in cancer immunotherapy</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:69-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa4971" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84928770388" target="_blank" aria-label="Open Scopus in new tab">Scopus (1840)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25838375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa4971&amp;pmid=25838375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); accordingly, we observed a mutation burden consistent with that of human PDAC in our mouse models (<a id="crosref0590" href="#figs7">Figure&nbsp;S7</a>A). Thus, PDAC-bearing <i>KPC</i><sup><i>mut</i></sup> organoid transplant or <i>KPC</i><sup><i>flox</i></sup> GEMM mice were treated with T/P and/or anti-PD-1 therapy and monitored for changes in biological responses, tumor growth, and overall survival.</div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/d1cbc36e-743d-4b32-8d02-876c989efc6e/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2020.03.008/asset/c1be2b73-90b0-4e29-8f0f-3edc174d46e6/main.assets/figs7.jpg" height="950" width="763" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/d1cbc36e-743d-4b32-8d02-876c989efc6e/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Synergy between T/P Treatment and PD-1 Checkpoint Blockade Is Dependent on SASP-Mediated Vascular Remodeling, Related to <a id="crosref0905" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0605" role="paragraph">(A) Quantification of number of somatic mutations (per megabase) in <i>KPC</i><sup><i>flox</i></sup> GEMM (yellow dots; n&nbsp;= 4) and <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors (red dots; n&nbsp;= 3) as compared to human PDAC tumors (gray dots) from <span class="dropBlock reference-citations"><a id="body-ref-sref1-1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-1" aria-controls="sref1-1">Alexandrov et&nbsp;al. (2013)</a><div class="dropBlock__holder" data-db-target-of="sref1-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alexandrov, L.B. ∙ Nik-Zainal, S. ∙ Wedge, D.C. ..., Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, ICGC PedBrain</div><div><strong>Signatures of mutational processes in human cancer</strong></div><div><em>Nature.</em> 2013; <strong>500</strong>:415-421</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84882837534" target="_blank" aria-label="Open Scopus in new tab">Scopus (4094)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23945592/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12477&amp;pmid=23945592" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>.</div><div id="fspara0610" role="paragraph">(B) IHC staining and quantification of SA-β-gal<sup>+</sup> (p&nbsp;= 0.0028), Ki67<sup>+</sup> (p&nbsp;= 0.031), CD3<sup>+</sup> (p&nbsp;= 0.0026), and CD31<sup>+</sup> (p&nbsp;&lt; 0.0001) cells per field in <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated with palbociclib (100&nbsp;mg/kg) in combination with standard (1&nbsp;mg/kg) and low dose (T-low) (0.3&nbsp;mg/kg) trametinib (n&nbsp;= 2-3). Values for SA-β-gal, CD31, and Ki67 in the T/P-treated cohort are the same displayed in <a id="crosref0915" href="#figs1">Figures S1</a>A, S1I, and <a id="crosref0920" href="#figs4">S4</a>E.</div><div id="fspara0615" role="paragraph">(C) Kaplan-Meier survival curve of <i>KPC</i><sup><i>mut</i></sup> PDAC organoid transplant mice treated with vehicle, trametinib (1 or 0.3 (T-low) mg/kg), palbociclib (100&nbsp;mg/kg), and/or a PD-1 blocking antibody (RMP1-14; 200&nbsp;μg) (n ≥ 7). Values for V, T/P, PD-1, and T/P/PD-1-treated cohorts are the same displayed in <a id="crosref0925" href="#fig7">Figure&nbsp;7</a>F.</div><div id="fspara0620" role="paragraph">(D) Waterfall plot of the response of <i>KPC</i><sup><i>mut</i></sup> PDAC organoid transplant tumors after 2&nbsp;weeks of treatment as in (C) (n ≥ 7). Values for V, T/P, PD-1, and T/P/PD-1-treated cohorts are the same displayed in <a id="crosref0930" href="#fig7">Figure&nbsp;7</a>D.</div><div id="fspara0625" role="paragraph">(E and F) <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors harboring <i>Ren</i> or <i>p65</i> shRNAs were treated for 2&nbsp;weeks with trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and a PD-1 blocking antibody (RMP1-14; 200&nbsp;μg). (E) H&amp;E staining and quantification of percent of tumor covered in necrosis (n&nbsp;= 2-3; p&nbsp;= 0.03). (F) Waterfall plot of the response of individual tumors to treatment (n ≥ 6).</div><div id="fspara0630" role="paragraph">(G–I) IHC and IF staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors following acute 2&nbsp;week treatment (response) or &gt; 80&nbsp;days of treatment (relapse) with trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and a PD-1 blocking antibody (RMP1-14; 200&nbsp;μg). (G) Quantification of CD31<sup>+</sup> (p&nbsp;= 0.0085) and CD3<sup>+</sup> (p&nbsp;= 0.0048) cells per field (n&nbsp;= 2-3). (H) Quantification of blood vessels with visible lumens (n&nbsp;= 2-3). (I) Quantification of VCAM-1 (p&nbsp;= 0.0195) colocalization with blood vessels (n&nbsp;= 4).</div><div id="fspara0640" role="paragraph">One-way ANOVA (D). Log-rank test (C). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale bars, 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0160" role="paragraph">The anti-tumor effects of combining immune checkpoint blockade with the senescence-inducing T/P regimen went well beyond what was observed following standard-of-care gemcitabine (see <a id="crosref0595" href="#fig3">Figure&nbsp;3</a>), or either T/P or anti-PD1 treatment alone. Two-week treatment with T/P/PD-1 produced areas of tumor destruction visible by gross histology and tumor regressions in 4/9 <i>KPC</i><sup><i>flox</i></sup> GEMM and 10/10 <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice (<a id="crosref0600" href="#fig7">Figures 7</a>A–7D). By contrast, all tumors treated with anti-PD1 alone continued to progress after 2-week treatment (<a id="crosref0605" href="#fig7">Figures 7</a>C and 7D). These anti-tumor effects translated into increased survival, producing an over 5-fold increase in the median survival of <i>KPC</i><sup><i>flox</i></sup> GEMM mice treated with T/P/PD-1 as compared to PD-1 alone and a number of long-term survivors in both models (<a id="crosref0610" href="#fig7">Figures 7</a>E and 7F). The anti-tumor effects of PD-1 checkpoint blockade were predicated on potent MEK inhibition, as administration of the T/P/PD-1 regimen at a suboptimal trametinib dose (0.3&nbsp;mg/kg) that was insufficient to inhibit ERK phosphorylation or induce senescence and its vascular or T&nbsp;cell remodeling effects was not efficacious (<a id="crosref0615" href="#figs7">Figures S7</a>B–S7D). These data imply that senescence induction upon combined T/P treatment is necessary to potentiate PD-1 blockade in PDAC models.</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.03.008/asset/4c4db4a0-924b-4a5f-925e-5213893373a9/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2020.03.008/asset/81d8b5bc-f40f-42bc-a96c-d3a80315a538/main.assets/gr7.jpg" height="956" width="786" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/4c4db4a0-924b-4a5f-925e-5213893373a9/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Senescence-Associated Vascular Remodeling Potentiates Immune Checkpoint Blockade in PDAC</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0275" role="paragraph">(A) H&amp;E staining of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors treated for 2&nbsp;weeks with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or mAbs targeting PD-1 (RMP1-14; 200&nbsp;μg), VEGFR-2 (DC101; 800&nbsp;μg), or CD8 (2.43; 200&nbsp;μg). Percent of tumor covered in necrosis is shown (n&nbsp;= 3; T/P versus T/P/PD-1, p&nbsp;= 0.08; PD-1 versus T/P/PD-1, p&nbsp;= 0.027).</div><div id="fspara0280" role="paragraph">(B) H&amp;E staining of <i>KPC</i><sup><i>mut</i></sup> organoid transplant tumors treated for 2&nbsp;weeks as in (A). Percent of tumor covered in necrosis is shown (n&nbsp;= 3; T/P versus T/P/PD-1, p&nbsp;= 0.004; PD-1 versus T/P/PD-1, p&nbsp;= 0.019; T/P/PD-1 versus T/P/PD-1/DC101, p&nbsp;= 0.016; T/P/PD-1 versus T/P/PD-1/CD8, p&nbsp;= 0.09).</div><div id="fspara0285" role="paragraph">(C and D) Waterfall plot of the response of <i>KPC</i><sup><i>flox</i></sup> GEMM (C) and <i>KPC</i><sup><i>mut</i></sup> organoid transplant (D) tumors after 2&nbsp;weeks of treatment with vehicle, trametinib (1&nbsp;mg/kg), palbociclib (100&nbsp;mg/kg), and/or mAbs targeting PD-1 (RMP1-14; 200&nbsp;μg), VEGFR-2 (DC101; 800&nbsp;μg), CD8 (2.43; 200&nbsp;μg), CD4 (GK1.5; 200&nbsp;μg), or VCAM-1 (M/K-2.7; 200&nbsp;μg) (n ≥ 6). Values for V and T/P-treated cohorts are the same displayed in <a id="crosref0840" href="#fig3">Figures 3</a>C and 3E.</div><div id="fspara0290" role="paragraph">(E and F) Kaplan-Meier survival curves of <i>KPC</i><sup><i>flox</i></sup> GEMM (E) and <i>KPC</i><sup><i>mut</i></sup> organoid transplant (F) mice treated as in (D) (n ≥ 7). Values for V and T/P-treated cohorts are the same displayed in <a id="crosref0845" href="#fig3">Figures 3</a>D and 3F.</div><div id="fspara0295" role="paragraph">One-way ANOVA (C and D). Log-rank test (E and F). Error bars, mean ± SEM. <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗</sup>p&nbsp;&lt; 0.05. n.s., not significant. Scale&nbsp;bars, 50&nbsp;μm.</div><div id="fspara0300" role="paragraph">See also <a id="crosref0850" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0165" role="paragraph">We also evaluated treatment responses in PDAC-bearing mice in which SASP was disabled by <i>p65</i> shRNA, vascular remodeling was perturbed by VEGFR-2 or VCAM-1 antibodies, or either CD4<sup>+</sup> or CD8<sup>+</sup> T&nbsp;cells were depleted. <i>p65</i>, VEGFR-2, or VCAM-1 inhibition largely blocked the ability of T/P/PD-1 treatment to elicit tumor destruction and produce robust tumor regressions (<a id="crosref0620" href="#fig7">Figures 7</a>A–7F, <a id="crosref0625" href="#figs7">S7</a>E, and S7F). Synergy between T/P treatment and PD-1 blockade was dependent on CD8<sup>+</sup>, but not CD4<sup>+</sup> T&nbsp;cells (<a id="crosref0630" href="#fig7">Figures 7</a>A–7F). Histological analysis of <i>KPC</i><sup><i>flox</i></sup> GEMM tumors that relapsed after long-term T/P/PD-1 therapy consistently showed hypovascularization, as well as poor endothelial activation and T&nbsp;cell penetration, similar to those of vehicle-treated mice (<a id="crosref0635" href="#figs7">Figures S7</a>G–S7I). These data imply that senescence-inducing therapies can increase T&nbsp;cell infiltration and reactivity in previously immunologically “cold” tumors, thus sensitizing PDAC to immune checkpoint blockade.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0170" role="paragraph">The desmoplastic stroma of PDAC fosters a hypovascularized and immune suppressive TME that impedes the penetration of small molecule drugs and stifles anti-tumor immunity, leading to <i>de novo</i> resistance to chemotherapy and immune checkpoint blockade (<span class="dropBlock reference-citations"><a id="body-ref-sref83-2" href="#" role="doc-biblioref" data-xml-rid="bib9 bib13 bib73 bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-2" aria-controls="sref83-2">Brahmer et&nbsp;al., 2012; Carmichael et&nbsp;al., 1996; Olive et&nbsp;al., 2009; Royal et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref83-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Brahmer, J.R. ∙ Tykodi, S.S. ∙ Chow, L.Q. ...</div><div><strong>Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2455-2465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1200694" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84862903106" target="_blank" aria-label="Open Scopus in new tab">Scopus (4530)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22658128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1200694&amp;pmid=22658128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Carmichael, J. ∙ Fink, U. ∙ Russell, R.C. ...</div><div><strong>Phase II study of gemcitabine in patients with advanced pancreatic cancer</strong></div><div><em>Br. J. Cancer.</em> 1996; <strong>73</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/bjc.1996.18" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8554969/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fbjc.1996.18&amp;pmid=8554969" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Royal, R.E. ∙ Levy, C. ∙ Turner, K. ...</div><div><strong>Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma</strong></div><div><em>J.&nbsp;Immunother.</em> 2010; <strong>33</strong>:828-833</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/CJI.0b013e3181eec14c" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77958050577" target="_blank" aria-label="Open Scopus in new tab">Scopus (506)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20842054/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCJI.0b013e3181eec14c&amp;pmid=20842054" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Here, we show how molecularly targeted therapies that drive PDAC cells into senescence can engage a tumor suppressive program that remodels the TME and creates therapeutic vulnerabilities, at least in part, through SASP-facilitated vascular remodeling. On one hand, this response increases blood vessel density and permeability, leading to enhanced uptake and activity of the chemotherapeutic drug gemcitabine; on the other, it facilitates the tumor infiltration of CD8<sup>+</sup> T&nbsp;cells that, although exhausted, can be reawakened by checkpoint blockade. As a consequence, the addition of gemcitabine or anti-PD-1 therapy to the T/P regimen produces tumor cell death and sustained tumor regressions in otherwise highly refractory PDAC models.</div><div id="p0175" role="paragraph">The impact of therapy-induced senescence on PDAC vasculature function was unexpected. While the SASP can alter endothelial cell behavior in culture and in xenograft models, the biological impact of pro-angiogenic SASP factors on the TME has been hypothesized to be pro-oncogenic (<span class="dropBlock reference-citations"><a id="body-ref-sref74-2" href="#" role="doc-biblioref" data-xml-rid="bib2 bib22 bib61 bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-2" aria-controls="sref74-2">Ancrile et&nbsp;al., 2007; Coppé et&nbsp;al., 2006; Mikuła-Pietrasik et&nbsp;al., 2016; Oubaha et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref74-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Ancrile, B. ∙ Lim, K.H. ∙ Counter, C.M.</div><div><strong>Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis</strong></div><div><em>Genes Dev.</em> 2007; <strong>21</strong>:1714-1719</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1549407" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-34447506658" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17639077/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1549407&amp;pmid=17639077" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Coppé, J.P. ∙ Kauser, K. ∙ Campisi, J. ...</div><div><strong>Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2006; <strong>281</strong>:29568-29574</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M603307200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33749549246" target="_blank" aria-label="Open Scopus in new tab">Scopus (292)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16880208/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M603307200&amp;pmid=16880208" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Mikuła-Pietrasik, J. ∙ Sosińska, P. ∙ Naumowicz, E. ...</div><div><strong>Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in&nbsp;vitro and in a mouse xenograft model in&nbsp;vivo</strong></div><div><em>Clin. Exp. Metastasis.</em> 2016; <strong>33</strong>:15-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10585-015-9753-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84957438754" target="_blank" aria-label="Open Scopus in new tab">Scopus (11)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26433963/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10585-015-9753-y&amp;pmid=26433963" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Oubaha, M. ∙ Miloudi, K. ∙ Dejda, A. ...</div><div><strong>Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:362ra144</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aaf9440" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84993927167" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aaf9440&amp;pmid=27797960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, in PDAC, these SASP factors produce the opposite outcome, leading to improved access of small molecules and immune cells into the tumor that ultimately enables its destruction. Mechanistically, SASP-facilitated vascular remodeling involves collaboration between pro-angiogenic (e.g., VEGF) and pro-inflammatory (e.g., CCL5, CXCL-1, and IL-6) SASP components, leading to increased blood vessel density and endothelial cell activation, respectively. While stromal sources of angiogenic or inflammatory cytokines may potentiate its effects, our results demonstrate that SASP secretion from tumor cells is essential for the observed phenotypes.</div><div id="p0180" role="paragraph">Neo-angiogenesis is typically considered a prerequisite for cancer progression and, as such, therapies that inhibit this process have been a focus of drug development efforts (<span class="dropBlock reference-citations"><a id="body-ref-sref103" href="#" role="doc-biblioref" data-xml-rid="bib35 bib41 bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103" aria-controls="sref103">Hanahan and Weinberg, 2000; Jain et&nbsp;al., 2006; Zirlik and Duyster, 2018</a><div class="dropBlock__holder" data-db-target-of="sref103"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>The hallmarks of cancer</strong></div><div><em>Cell.</em> 2000; <strong>100</strong>:57-70</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981683-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981683-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0034614637" target="_blank" aria-label="Open Scopus in new tab">Scopus (19600)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10647931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2800%2981683-9&amp;pmid=10647931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Jain, R.K. ∙ Duda, D.G. ∙ Clark, J.W. ...</div><div><strong>Lessons from phase III clinical trials on anti-VEGF therapy for cancer</strong></div><div><em>Nat. Clin. Pract. Oncol.</em> 2006; <strong>3</strong>:24-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncponc0403" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-30944446883" target="_blank" aria-label="Open Scopus in new tab">Scopus (855)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16407877/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncponc0403&amp;pmid=16407877" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">104.</div><div>Zirlik, K. ∙ Duyster, J.</div><div><strong>Anti-Angiogenics: Current Situation and Future Perspectives</strong></div><div><em>Oncol. Res. Treat.</em> 2018; <strong>41</strong>:166-171</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1159/000488087" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85044394391" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29562226/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1159%2F000488087&amp;pmid=29562226" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By contrast, owing to the hypovascularity of PDAC, studies suggest that therapies that improve, rather than inhibit, vascular function might establish therapeutic windows for treating this disease (<span class="dropBlock reference-citations"><a id="body-ref-sref78-6" href="#" role="doc-biblioref" data-xml-rid="bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-6" aria-controls="sref78-6">Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). One such approach involves disrupting stromal hedgehog signaling, which leads to increased vascular perfusion and drug accessibility by inhibiting myofibroblast activity (<span class="dropBlock reference-citations"><a id="body-ref-sref73-8" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-8" aria-controls="sref73-8">Olive et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref73-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, over time, depletion of key tumor suppressive stromal elements with this method culminates in tumor cell dedifferentiation and a more aggressive and metastatic disease (<span class="dropBlock reference-citations"><a id="body-ref-sref82" href="#" role="doc-biblioref" data-xml-rid="bib79 bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82" aria-controls="sref82">Rhim et&nbsp;al., 2014; Rosow et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref82"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Rhim, A.D. ∙ Oberstein, P.E. ∙ Thomas, D.H. ...</div><div><strong>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:735-747</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84902435628" target="_blank" aria-label="Open Scopus in new tab">Scopus (857)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.021&amp;pmid=24856585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Rosow, D.E. ∙ Liss, A.S. ∙ Strobel, O. ...</div><div><strong>Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench</strong></div><div><em>Surgery.</em> 2012; <strong>152</strong>:S19-S32</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.surg.2012.05.030&amp;cf=fulltext&amp;site=ymsy-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.surg.2012.05.030&amp;cf=pdf&amp;site=ymsy-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84865266369" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770959/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.surg.2012.05.030&amp;pmid=22770959" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By contrast, the manner in which therapy-induced senescence increases tumor perfusion is distinct, producing a more functional vasculature without compromising tumor suppressive stromal components or promoting metastasis. Additionally, T/P-induced reduction in stromal HA content may relieve interstitial fluid pressures and contribute to enhanced vascular perfusion in our models (<span class="dropBlock reference-citations"><a id="body-ref-sref78-7" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-7" aria-controls="sref78-7">Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0185" role="paragraph">Despite its limited activity, gemcitabine is part of the standard-of-care therapy for pancreatic cancer patients. While combinatorial approaches using gemcitabine are in pre-clinical and clinical use, the notion of combining cytostatic therapies with gemcitabine would not typically be pursued owing to the apparent requirement for DNA synthesis for gemcitabine-mediated toxicity (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Plunkett et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Plunkett, W. ∙ Huang, P. ∙ Xu, Y.Z. ...</div><div><strong>Gemcitabine: metabolism, mechanisms of action, and self-potentiation</strong></div><div><em>Semin. Oncol.</em> 1995; <strong>22</strong>:3-10</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7481842/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=7481842" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, our data demonstrate that T/P therapy facilitates both gemcitabine uptake and its ability to promote tumor cell apoptosis, similar to what occurs following treatment with other agents that increase vascular perfusion in PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref78-8" href="#" role="doc-biblioref" data-xml-rid="bib73 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-8" aria-controls="sref78-8">Olive et&nbsp;al., 2009; Provenzano et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref78-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We suspect that the efficacy of this three-drug combination is not a result of tumor-cell specific synergies, but instead arises from the improved ability of gemcitabine to target tumor cells that fail to senesce upon T/P treatment. Still, it remains possible that genomic instability resulting from senescence induction (<span class="dropBlock reference-citations"><a id="body-ref-sref100" href="#" role="doc-biblioref" data-xml-rid="bib45 bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100" aria-controls="sref100">Kotsantis et&nbsp;al., 2018; Woo and Poon, 2004</a><div class="dropBlock__holder" data-db-target-of="sref100"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Kotsantis, P. ∙ Petermann, E. ∙ Boulton, S.J.</div><div><strong>Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:537-555</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-1461" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85047864974" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29653955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-1461&amp;pmid=29653955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">101.</div><div>Woo, R.A. ∙ Poon, R.Y.</div><div><strong>Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation</strong></div><div><em>Genes Dev.</em> 2004; <strong>18</strong>:1317-1330</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1165204" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-2642527955" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15175263/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1165204&amp;pmid=15175263" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), perhaps exacerbated by a defective p53-dependent G1 checkpoint, might also enhance gemcitabine cytotoxicity.</div><div id="p0190" role="paragraph">In addition to promoting uptake of soluble factors, SASP-facilitated vascular remodeling enables T&nbsp;cell penetration into PDAC and improves the efficacy of checkpoint blockade. Here, one critical outcome of SASP induction is increased endothelial cell expression of VCAM-1, a cell surface protein that stimulates lymphocyte adhesion and extravasation into tissues. Indeed, VCAM-1 is required for T&nbsp;cell infiltration and potentiation of PD-1 blockade following T/P therapy in our PDAC models. Collectively, these observations provide a compelling link between therapy-induced SASP, vascular remodeling, and immune cell infiltration, and add to a growing body of evidence that vascular normalization can enhance the efficacy of other T&nbsp;cell-directed immunotherapies (<span class="dropBlock reference-citations"><a id="body-ref-sref92" href="#" role="doc-biblioref" data-xml-rid="bib11 bib34 bib38 bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92" aria-controls="sref92">Buckanovich et&nbsp;al., 2008; Hamzah et&nbsp;al., 2008; Huang et&nbsp;al., 2012; Shrimali et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref92"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Buckanovich, R.J. ∙ Facciabene, A. ∙ Kim, S. ...</div><div><strong>Endothelin B receptor mediates the endothelial barrier to T&nbsp;cell homing to tumors and disables immune therapy</strong></div><div><em>Nat. Med.</em> 2008; <strong>14</strong>:28-36</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm1699" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-38049000452" target="_blank" aria-label="Open Scopus in new tab">Scopus (322)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18157142/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm1699&amp;pmid=18157142" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Hamzah, J. ∙ Jugold, M. ∙ Kiessling, F. ...</div><div><strong>Vascular normalization in Rgs5-deficient tumours promotes immune destruction</strong></div><div><em>Nature.</em> 2008; <strong>453</strong>:410-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature06868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-43749112760" target="_blank" aria-label="Open Scopus in new tab">Scopus (360)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18418378/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature06868&amp;pmid=18418378" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Huang, Y. ∙ Yuan, J. ∙ Righi, E. ...</div><div><strong>Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:17561-17566</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1215397109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84867902940" target="_blank" aria-label="Open Scopus in new tab">Scopus (412)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23045683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1215397109&amp;pmid=23045683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Shrimali, R.K. ∙ Yu, Z. ∙ Theoret, M.R. ...</div><div><strong>Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer</strong></div><div><em>Cancer Res.</em> 2010; <strong>70</strong>:6171-6180</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-0153" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77955406159" target="_blank" aria-label="Open Scopus in new tab">Scopus (353)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20631075/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-0153&amp;pmid=20631075" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0195" role="paragraph">Previous work has established that targeted therapies, including CDK4/6 inhibitors, can cooperate with PD-1/PD-L1 blockade in other cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref87-2" href="#" role="doc-biblioref" data-xml-rid="bib27 bib29 bib33 bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-2" aria-controls="sref87-2">Deng et&nbsp;al., 2018; Ebert et&nbsp;al., 2016; Goel et&nbsp;al., 2017; Schaer et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref87-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Deng, J. ∙ Wang, E.S. ∙ Jenkins, R.W. ...</div><div><strong>CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:216-233</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0915" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85041378182" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29101163/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0915&amp;pmid=29101163" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Ebert, P.J.R. ∙ Cheung, J. ∙ Yang, Y. ...</div><div><strong>MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:609-621</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84960450202" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26944201/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.01.024&amp;pmid=26944201" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Goel, S. ∙ DeCristo, M.J. ∙ Watt, A.C. ...</div><div><strong>CDK4/6 inhibition triggers anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>548</strong>:471-475</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23465" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85028340229" target="_blank" aria-label="Open Scopus in new tab">Scopus (296)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813415/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23465&amp;pmid=28813415" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Schaer, D.A. ∙ Beckmann, R.P. ∙ Dempsey, J.A. ...</div><div><strong>The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade</strong></div><div><em>Cell Rep.</em> 2018; <strong>22</strong>:2978-2994</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85043587035" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29539425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.02.053&amp;pmid=29539425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, in contrast to our work, these studies employed immunologically “hot” and T&nbsp;cell “rich” cancer models that are typically responsive to checkpoint blockade. Moreover, focus of previous work has been on how these agents might increase T&nbsp;cell recognition or cytotoxicity rather than how T&nbsp;cells gain access to the tumor. Our study uses immunologically “cold” models of PDAC, a disease unresponsive to checkpoint blockade, to establish a mechanism for the latter effect, showing how T/P-induced senescence leads to endothelial activation and VCAM-1 upregulation that promotes T&nbsp;cell extravasation into tumors and sets the stage for efficient immunotherapy responses. Tumor cell autonomous effects may also play a role in stimulating T&nbsp;cell reactivity, and it is noteworthy that MHC-I upregulation following T/P treatment of PDAC cells is much greater than that produced by either agent alone.</div><div id="p0200" role="paragraph">The effects of the SASP on the TME can be context-dependent. Thus, while the most prominent effects of T/P therapy in PDAC are SASP-dependent vascular remodeling and T&nbsp;cell surveillance, the outcome of T/P-induced senescence in lung cancer models involves a SASP-facilitated NK cell surveillance program (<span class="dropBlock reference-citations"><a id="body-ref-sref84-7" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-7" aria-controls="sref84-7">Ruscetti et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This tissue specificity cannot be explained by differences in tumor genotype (both studies used models driven by mutant KRAS and p53 alterations) or in VEGF secretion (that was induced in pancreas and lung cancer models). Instead, we hypothesize that these contextual differences arise from the tissue architecture of tumors arising in each organ: the lungs are generally NK cell-rich and lung tumors are highly vascularized; by contrast, the pancreas harbors few NK cells and PDAC tumors are avascular (<span class="dropBlock reference-citations"><a id="body-ref-sref85" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85" aria-controls="sref85">Salmon et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref85"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Salmon, H. ∙ Remark, R. ∙ Gnjatic, S. ...</div><div><strong>Host tissue determinants of tumour immunity</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:215-227</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0125-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85063013311" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30867580/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0125-9&amp;pmid=30867580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As such, each TME may be more or less susceptible to different SASP components. Regardless, in both models, pharmacological induction of senescence can evoke latent anti-tumor immunity.</div><div id="p0205" role="paragraph">We suspect the profound tissue remodeling observed following therapy-induced senescence reflects the reengagement of an innate tumor suppressive mechanism that participates in tissue regeneration. Numerous studies suggest that senescence coordinates tissue remodeling activities associated with wound repair and resolution that are critical for organ homeostasis (<span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib25 bib47 bib56 bib66 bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Demaria et&nbsp;al., 2014; Krizhanovsky et&nbsp;al., 2008; Lujambio et&nbsp;al., 2013; Mosteiro et&nbsp;al., 2016; Neves et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Demaria, M. ∙ Ohtani, N. ∙ Youssef, S.A. ...</div><div><strong>An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA</strong></div><div><em>Dev. Cell.</em> 2014; <strong>31</strong>:722-733</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84919480323" target="_blank" aria-label="Open Scopus in new tab">Scopus (528)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25499914/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2014.11.012&amp;pmid=25499914" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Krizhanovsky, V. ∙ Yon, M. ∙ Dickins, R.A. ...</div><div><strong>Senescence of activated stellate cells limits liver fibrosis</strong></div><div><em>Cell.</em> 2008; <strong>134</strong>:657-667</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-49749145668" target="_blank" aria-label="Open Scopus in new tab">Scopus (955)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18724938/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2008.06.049&amp;pmid=18724938" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Lujambio, A. ∙ Akkari, L. ∙ Simon, J. ...</div><div><strong>Non-cell-autonomous tumor suppression by p53</strong></div><div><em>Cell.</em> 2013; <strong>153</strong>:449-460</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2013.03.020&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2013.03.020&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84876291823" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23562644/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2013.03.020&amp;pmid=23562644" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Mosteiro, L. ∙ Pantoja, C. ∙ Alcazar, N. ...</div><div><strong>Tissue damage and senescence provide critical signals for cellular reprogramming in&nbsp;vivo</strong></div><div><em>Science.</em> 2016; <strong>354</strong>:aaf4445</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf4445" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27884981/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf4445&amp;pmid=27884981" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Neves, J. ∙ Demaria, M. ∙ Campisi, J. ...</div><div><strong>Of flies, mice, and men: evolutionarily conserved tissue damage responses and aging</strong></div><div><em>Dev. Cell.</em> 2015; <strong>32</strong>:9-18</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.028&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.028&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84922350817" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25584795/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2014.11.028&amp;pmid=25584795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In the presence of chronic tissue damage, hyperactivation of this wound-healing response without senescent cell clearance can be deleterious and even pro-oncogenic (<span class="dropBlock reference-citations"><a id="body-ref-sref88" href="#" role="doc-biblioref" data-xml-rid="bib4 bib26 bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88" aria-controls="sref88">Baker et&nbsp;al., 2016; Demaria et&nbsp;al., 2017; Schafer et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref88"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Baker, D.J. ∙ Childs, B.G. ∙ Durik, M. ...</div><div><strong>Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan</strong></div><div><em>Nature.</em> 2016; <strong>530</strong>:184-189</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature16932" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84958093401" target="_blank" aria-label="Open Scopus in new tab">Scopus (895)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26840489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature16932&amp;pmid=26840489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Demaria, M. ∙ O’Leary, M.N. ∙ Chang, J. ...</div><div><strong>Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:165-176</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-0241" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85011802318" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27979832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-0241&amp;pmid=27979832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Schafer, M.J. ∙ White, T.A. ∙ Iijima, K. ...</div><div><strong>Cellular senescence mediates fibrotic pulmonary disease</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:14532</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms14532" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85013807598" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28230051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms14532&amp;pmid=28230051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, when acutely activated in tumor cells, the senescence program recapitulates many aspects of this native wound resolution response, halting further tumor cell proliferation while simultaneously modulating multiple components of the tissue environment to promote homeostasis. As such, senescence induction may prove more effective at remodeling the TME than targeting individual tissue components. It will be interesting to compare and contrast the immune-enhancing effects of senescence-inducing therapies to agents that target specific immune suppressive factors in PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib32 bib42 bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Feig et&nbsp;al., 2013; Jiang et&nbsp;al., 2016; Panni et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (623)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Panni, R.Z. ∙ Herndon, J.M. ∙ Zuo, C. ...</div><div><strong>Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies</strong></div><div><em>Sci. Transl. Med.</em> 2019; <strong>11</strong>:eaau9240</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aau9240" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85069269407" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31270275/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aau9240&amp;pmid=31270275" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0210" role="paragraph">Our data provide a clear rationale for combining senescence-inducing therapies with both chemotherapy and immunotherapy to cull heterogeneous tumor cell populations in PDAC and perhaps other cancers as well. Although well-tolerated in our mouse models, the potential toxicities of the three drug combinations (trametinib and palbociclib together with either gemcitabine or anti-PD-1) will need to be closely monitored when extending these preclinical findings to human clinical trials. In principle, the stability of the senescence phenotype following T/P treatment may enable treatment regimens where these agents can be given sequentially on alternating schedules instead of simultaneously and continuously. It is noteworthy that treatment of BRAF mutant melanoma patients with a combination of MEK and BRAF inhibitors together with PD-1 blockade is highly efficacious and can be tolerated using an appropriate regimen (<span class="dropBlock reference-citations"><a id="body-ref-sref81" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81" aria-controls="sref81">Ribas et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref81"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Ribas, A. ∙ Lawrence, D. ∙ Atkinson, V. ...</div><div><strong>Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:936-940</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0476-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85067192938" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31171879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0476-5&amp;pmid=31171879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). While the MEK and CDK4/6 inhibitor combination studied herein is a potent inducer of senescence in KRAS mutant cancers, other targeted and cytotoxic agents can also promote tumor cell senescence across a spectrum of cancer lineages and genotypic contexts (<span class="dropBlock reference-citations"><a id="body-ref-sref93" href="#" role="doc-biblioref" data-xml-rid="bib30 bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93" aria-controls="sref93">Ewald et&nbsp;al., 2010; Sieben et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref93"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Ewald, J.A. ∙ Desotelle, J.A. ∙ Wilding, G. ...</div><div><strong>Therapy-induced senescence in cancer</strong></div><div><em>J.&nbsp;Natl. Cancer Inst.</em> 2010; <strong>102</strong>:1536-1546</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jnci/djq364" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77958590185" target="_blank" aria-label="Open Scopus in new tab">Scopus (351)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20858887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fjnci%2Fdjq364&amp;pmid=20858887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Sieben, C.J. ∙ Sturmlechner, I. ∙ van de Sluis, B. ...</div><div><strong>Two-Step Senescence-Focused Cancer Therapies</strong></div><div><em>Trends Cell Biol.</em> 2018; <strong>28</strong>:723-737</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.tcb.2018.04.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.tcb.2018.04.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85047207382" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29776716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tcb.2018.04.006&amp;pmid=29776716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Consequently, our study provides one paradigm for combining such agents with immunomodulatory therapies to improve therapeutic outcomes.</div></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key Resources Table</h3><div id="p0215" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr class="rowsep"><td>See <a id="crosref0670" href="#mmc1">Table S1</a> for Antibody information</td><td>N/A</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Biological Samples</b></td></tr><tr><td>Pancreatic cancer PDX: MSK-PR07</td><td>MSKCC/ This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Pancreatic cancer PDX: MSK-PR05</td><td>MSKCC/ This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, Peptides, and Recombinant Proteins</b></td></tr><tr><td>Trametinib (<i>in&nbsp;vitro</i>)</td><td>Selleck chemicals</td><td>Cat#S2673</td></tr><tr><td>Palbociclib (<i>in&nbsp;vitro</i>)</td><td>Selleck chemicals</td><td>Cat#S1116</td></tr><tr><td>Trametinib (<i>in&nbsp;vivo</i>)</td><td>LC Laboratories</td><td>Cat#T-8123</td></tr><tr><td>Palbociclib (<i>in&nbsp;vivo</i>)</td><td>LC Laboratories</td><td>Cat#P-7744</td></tr><tr><td>Gemcitabine</td><td>MSKCC Pharmacy</td><td>Cas#:122111-03-9</td></tr><tr><td><sup>14</sup>C-Gemcitabine</td><td>Moravek Biochemicals</td><td>Cat#MC 2246</td></tr><tr><td>Recombinant mouse IL-2</td><td>Biolegend</td><td>Cat#575402</td></tr><tr><td>Recombinant human IL-7</td><td>Peprotech</td><td>Cat#200-07</td></tr><tr><td>Recombinant human IL-15</td><td>Peprotech</td><td>Cat#200-15</td></tr><tr><td>Matrigel</td><td>Corning</td><td>Cat#354230</td></tr><tr><td>Solvable</td><td>Perkin Elmer</td><td>Cat#6NE9100</td></tr><tr><td>Ultima Gold</td><td>Perkin Elmer</td><td>Cat#6013321</td></tr><tr><td>Collagenase type V</td><td>Sigma</td><td>Cat#C9263</td></tr><tr><td>Culturex reduced growth factor basement membrane extract</td><td>R&amp;D systems</td><td>Cat#3533-005-02</td></tr><tr><td>B27 supplement</td><td>Invitrogen</td><td>Cat#12634-028</td></tr><tr><td>hEGF</td><td>Peprotech</td><td>Cat#PMG8034</td></tr><tr><td>mNoggin</td><td>Peprotech</td><td>Cat#250-38</td></tr><tr><td>hFGF10</td><td>Peprotech</td><td>Cat#100-26</td></tr><tr><td>hLeu-Gastrin I</td><td>Sigma</td><td>Cat#G9145</td></tr><tr><td>N-acetylcysteine</td><td>Sigma</td><td>Cat#A9165</td></tr><tr><td>Nicotinamide</td><td>Sigma</td><td>Cat#N0636</td></tr><tr><td>Dynabeads Mouse T-Activator CD3/CD28</td><td>Thermo Fisher Scientific</td><td>Cat#11452D</td></tr><tr><td>PMA</td><td>Sigma</td><td>Cat#P8139</td></tr><tr><td>Ionomycin</td><td>Stem cell technologies</td><td>Cat#73724</td></tr><tr><td>GolgiStop</td><td>BD bioscience</td><td>Cat#554724</td></tr><tr><td>Trizol</td><td>Invitrogen</td><td>Cat#15596026</td></tr><tr><td>Biotinylated tomato lectin</td><td>Vector Laboratories</td><td>Cat#B1175</td></tr><tr><td>FITC-dextran (MW 2,000,000)</td><td>Sigma-Aldrich</td><td>Cat#52471</td></tr><tr class="rowsep"><td>Pimonidazole</td><td>Hypoxyprobe</td><td>Cat#HP1-1000Kit</td></tr><tr class="rowsep"><td colspan="3"><b>Critical Commercial Assays</b></td></tr><tr><td>Human Cytokine/Chemokine Array 42-Plex Discovery Assay</td><td>Eve Technologies</td><td>Cat#HD42</td></tr><tr><td>Mouse Cytokine/Chemokine Array 31-Plex</td><td>Eve Technologies</td><td>Cat#MD31</td></tr><tr><td>CellTiter-Glo Viability Assay</td><td>Promega</td><td>Cat#G924A</td></tr><tr><td>eBioscience Foxp3 / Transcription Factor Staining Buffer Set</td><td>eBioscience</td><td>Cat#00-5523-00</td></tr><tr><td>TaqMan reverse transcription reagent</td><td>Thermo Fisher</td><td>Cat#N8080234</td></tr><tr class="rowsep"><td>SYBR Green PCR master Mix</td><td>Thermo Fisher</td><td>Cat#4309155</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited Data</b></td></tr><tr><td>RNA sequencing data</td><td>This paper</td><td>GEO: <a id="interref105" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141684" target="_blank">GSE141684</a></td></tr><tr><td>RNA sequencing data</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref84-8" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-8" aria-controls="sref84-8">Ruscetti et&nbsp;al.<i>,</i> 2018</a><div class="dropBlock__holder" data-db-target-of="sref84-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GEO: <a id="interref110" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110397" target="_blank">GSE110397</a></td></tr><tr class="rowsep"><td>Mouse whole exome sequencing</td><td>This paper</td><td>NCBI BioProject: PRJNA607826</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Cell Lines</b></td></tr><tr><td>PANC-1 (human)</td><td>ATCC</td><td>Cat#CRL-1469; RRID: CVCL_0480</td></tr><tr><td>PU-8988T (human)</td><td>DSMZ</td><td>Cat#ACC-162; RRID:CVCL_1847</td></tr><tr><td>MiaPaca-2 (human)</td><td>ATCC</td><td>Cat#CRL-1420; RRID:CVCL_0428</td></tr><tr><td>3B11 (murine)</td><td>ATCC</td><td>Cat#CRL-2160; RRID:CVCL_5487</td></tr><tr><td><i>Pdx1-Cre; LSL-Kras</i><sup><i>G12D/+</i></sup><i>; LSL-p53</i><sup><i>R172H/</i></sup><sup><i>wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) PDAC cells/organoids (murine)</td><td>This paper</td><td>N/A</td></tr><tr><td>Primary pancreatic fibroblasts from C57BL/6 mice</td><td>Cell Biologics, Inc.</td><td>Cat#C57-6201</td></tr><tr class="rowsep"><td>Primary BMDM (Bone marrow-derived macrophages) from C57BL/6 mice</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Organisms/Strains</b></td></tr><tr><td>Mouse: C57BL/6</td><td>Jackson laboratory</td><td>Cat#JAX:000664; RRID:IMSR_JAX:000664</td></tr><tr><td>Mouse: NOD-scid IL2Rγ<sup>null</sup>: NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ</td><td>Jackson laboratory</td><td>Cat#JAX:005557; RRID:IMSR_JAX:005557</td></tr><tr><td>Mouse: C57BL/6-Tg(TcraTcrb)1100Mjb/J</td><td>Jackson laboratory</td><td>Cat#JAX:003831; RRID:IMSR_JAX:003831</td></tr><tr><td>Mouse: LSL-K-ras G12D: B6.129S4-Krastm4Tyj/J</td><td><a id="intref0010" href="https://www.astm.org/Standards/Jackson" target="_blank">Jackson</a> laboratory</td><td>Cat#JAX:008179; RRID:IMSR_JAX:008179</td></tr><tr><td>Mouse: Pdx1-Cre: B6.FVB-Tg(Pdx1-cre)6Tuv/J</td><td>Jackson laboratory</td><td>Cat#JAX:014647: RRID:IMSR_JAX:014647</td></tr><tr><td>Mouse: LSL-p53<sup>R172H</sup>: p53LSL.R172H 129svj</td><td>Jackson laboratory</td><td>Cat#JAX:008652; RRID:IMSR_JAX:008652</td></tr><tr class="rowsep"><td>Mouse: p53flox: B6.129P2-Trp53tm1Brn/J</td><td>Jackson laboratory</td><td>Cat#JAX:008462; RRID:IMSR_JAX:008462</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>shRNA sequence: Renilla: TAGATAAGCATTATAATTCCT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref16-2" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-2" aria-controls="sref16-2">Chicas et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref16-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Chicas, A. ∙ Wang, X. ∙ Zhang, C. ...</div><div><strong>Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:376-387</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77950486542" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20385362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.01.023&amp;pmid=20385362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>shRNA sequence: p65: TATAGCTTCAGGGTACTCCATC</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref17-3" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-3" aria-controls="sref17-3">Chien et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref17-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chien, Y. ∙ Scuoppo, C. ∙ Wang, X. ...</div><div><strong>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</strong></div><div><em>Genes Dev.</em> 2011; <strong>25</strong>:2125-2136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.17276711" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80054789761" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21979375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.17276711&amp;pmid=21979375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>qPCR primer: p65 left: CTCAACTTCTGTCCCCAAGC</td><td>This paper</td><td>N/A</td></tr><tr><td>qPCR primer: p65 right: GAGGTACCATGGCTGAGGAA</td><td>This paper</td><td>N/A</td></tr><tr><td>qPCR primer: 36B4 left: GCTCCAAGCAGATGCAGCA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref63-1" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-1" aria-controls="sref63-1">Morris et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref63-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Morris, 4th, J.P. ∙ Yashinskie, J.J. ∙ Koche, R. ...</div><div><strong>α-Ketoglutarate links p53 to cell fate during tumour suppression</strong></div><div><em>Nature.</em> 2019; <strong>573</strong>:595-599</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1577-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85072686860" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31534224/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1577-5&amp;pmid=31534224" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>qPCR primer: 36B4 right: CCGGATGTGAGGCAGCAG</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref63-2" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-2" aria-controls="sref63-2">Morris et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref63-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Morris, 4th, J.P. ∙ Yashinskie, J.J. ∙ Koche, R. ...</div><div><strong>α-Ketoglutarate links p53 to cell fate during tumour suppression</strong></div><div><em>Nature.</em> 2019; <strong>573</strong>:595-599</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1577-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85072686860" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31534224/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1577-5&amp;pmid=31534224" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>See <a id="crosref0700" href="#mmc2">Table S2</a> for additional qPCR primers</td><td>N/A</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>Plasmid: MSCV-Luciferase-IRES-GFP</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Plasmid: LMP-shRNA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref16-3" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-3" aria-controls="sref16-3">Chicas et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref16-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Chicas, A. ∙ Wang, X. ∙ Zhang, C. ...</div><div><strong>Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:376-387</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77950486542" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20385362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.01.023&amp;pmid=20385362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and Algorithms</b></td></tr><tr><td>Vevo LAB software</td><td>VisualSonic</td><td>VevoLab</td></tr><tr><td>Living Image software</td><td>Caliper Life Science</td><td>Cat#128113; RRID:SCR_014247</td></tr><tr><td>STAR</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref28-1" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-1" aria-controls="sref28-1">Dobin et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref28-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ...</div><div><strong>STAR: ultrafast universal RNA-seq aligner</strong></div><div><em>Bioinformatics.</em> 2013; <strong>29</strong>:15-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/bts635" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84871809302" target="_blank" aria-label="Open Scopus in new tab">Scopus (8544)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23104886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbts635&amp;pmid=23104886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_015899;</td></tr><tr><td>featureCounts</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Liao et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Liao, Y. ∙ Smyth, G.K. ∙ Shi, W.</div><div><strong>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:923-930</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btt656" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84897397058" target="_blank" aria-label="Open Scopus in new tab">Scopus (3491)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24227677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtt656&amp;pmid=24227677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_012919; <a id="intref0020" href="http://bioinf.wehi.edu.au/featureCounts/" target="_blank">http://bioinf.wehi.edu.au/featureCounts/</a></td></tr><tr><td>R</td><td>N/A</td><td><a id="intref0025" href="https://www.r-project.org" target="_blank">https://www.r-project.org</a></td></tr><tr><td>cutadapt</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Martin, 2011</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Martin, M.</div><div><strong>Cutadapt removes adapter sequences from high-throughput sequencing reads</strong></div><div><em>EMBnet.journal.</em> 2011; <strong>17</strong>:10-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.14806/ej.17.1.200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.14806%2Fej.17.1.200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_011841; <a id="intref0030" href="http://gensoft.pasteur.fr/docs/cutadapt/1.6/guide.html" target="_blank">http://gensoft.pasteur.fr/docs/cutadapt/1.6/guide.html</a></td></tr><tr><td>BWA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Li and Durbin, 2009</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (17629)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_010910; <a id="intref0035" href="http://bio-bwa.sourceforge.net" target="_blank">http://bio-bwa.sourceforge.net</a></td></tr><tr><td>PICARD</td><td>N/A</td><td>RRID:SCR_006525; <a id="intref0040" href="http://broadinstitute.github.io/picard/index.html" target="_blank">http://broadinstitute.github.io/picard/index.html</a></td></tr><tr><td>GATK</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref59" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59" aria-controls="sref59">McKenna et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref59"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>McKenna, A. ∙ Hanna, M. ∙ Banks, E. ...</div><div><strong>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</strong></div><div><em>Genome Res.</em> 2010; <strong>20</strong>:1297-1303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.107524.110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77956295988" target="_blank" aria-label="Open Scopus in new tab">Scopus (9757)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.107524.110&amp;pmid=20644199" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_001876; <a id="intref0045" href="https://gatk.broadinstitute.org/" target="_blank">https://gatk.broadinstitute.org/</a></td></tr><tr><td>ABRA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Mose et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Mose, L.E. ∙ Wilkerson, M.D. ∙ Hayes, D.N. ...</div><div><strong>ABRA: improved coding indel detection via assembly-based realignment</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:2813-2815</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84911383104" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24907369/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu376&amp;pmid=24907369" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_003277; <a id="intref0050" href="https://github.com/mozack/abra" target="_blank">https://github.com/mozack/abra</a></td></tr><tr><td>muTect</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Cibulskis et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cibulskis, K. ∙ Lawrence, M.S. ∙ Carter, S.L. ...</div><div><strong>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</strong></div><div><em>Nat. Biotechnol.</em> 2013; <strong>31</strong>:213-219</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.2514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84874025843" target="_blank" aria-label="Open Scopus in new tab">Scopus (1950)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23396013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.2514&amp;pmid=23396013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_000559; <a id="intref0055" href="https://software.broadinstitute.org/cancer/cga/mutect" target="_blank">https://software.broadinstitute.org/cancer/cga/mutect</a></td></tr><tr><td>DESeq2</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Love et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Love, M.I. ∙ Huber, W. ∙ Anders, S.</div><div><strong>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</strong></div><div><em>Genome Biol.</em> 2014; <strong>15</strong>:550</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13059-014-0550-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84924629414" target="_blank" aria-label="Open Scopus in new tab">Scopus (12911)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25516281/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13059-014-0550-8&amp;pmid=25516281" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_015687; <a id="intref0060" href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html" target="_blank">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</a></td></tr><tr><td>Trimmomatic</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref8-1" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-1" aria-controls="sref8-1">Bolger et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref8-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bolger, A.M. ∙ Lohse, M. ∙ Usadel, B.</div><div><strong>Trimmomatic: a flexible trimmer for Illumina sequence data</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:2114-2120</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu170" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84905049901" target="_blank" aria-label="Open Scopus in new tab">Scopus (13125)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24695404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu170&amp;pmid=24695404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_011848; <a id="intref0065" href="http://www.usadellab.org/cms/?page=trimmomatic" target="_blank">http://www.usadellab.org/cms/?page=trimmomatic</a></td></tr><tr><td>HTSeq</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref3-1" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-1" aria-controls="sref3-1">Anders et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref3-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Anders, S. ∙ Pyl, P.T. ∙ Huber, W.</div><div><strong>HTSeq--a Python framework to work with high-throughput sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:166-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu638" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84928987900" target="_blank" aria-label="Open Scopus in new tab">Scopus (6221)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25260700/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu638&amp;pmid=25260700" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_005514; <a id="intref0070" href="https://htseq.readthedocs.io/en/release_0.11.1/" target="_blank">https://htseq.readthedocs.io/en/release_0.11.1/</a></td></tr><tr class="rowsep"><td>Enrichr</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref49-1" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-1" aria-controls="sref49-1">Kuleshov et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref49-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Kuleshov, M.V. ∙ Jones, M.R. ∙ Rouillard, A.D. ...</div><div><strong>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:W90-7</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkw377" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987663170" target="_blank" aria-label="Open Scopus in new tab">Scopus (1516)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27141961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkw377&amp;pmid=27141961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID:SCR_001575; <a id="intref0075" href="http://amp.pharm.mssm.edu/Enrichr" target="_blank">http://amp.pharm.mssm.edu/Enrichr</a></td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>Vevo 2100 System ultrasound</td><td>VisualSonic</td><td>RRID:SCR_015816</td></tr><tr><td>Xenogen IVIS Spectrum imager</td><td>PerkinElmer</td><td>Cat#124262</td></tr><tr><td>Typhoon FLA 7000 laser scanner</td><td>GE healthcare</td><td>Cat#28-9558-09</td></tr><tr><td>Gentle MACS Octo dissociator with heaters</td><td>Miltenyi Biotech</td><td>Cat#130-096-427</td></tr><tr><td>Guava Easycyte</td><td>Millipore</td><td>Cat#0500-4008</td></tr><tr><td>ViiA 7 Real-Time PCR System</td><td>Invitrogen</td><td>Cat#4453536</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2820%2930270-1" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Lead Contact and Materials Availability</h3><div id="p0220" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Scott W. Lowe (<a id="intref0080" href="mailto:lowes@mskcc.org">lowes@mskcc.org</a>).</div><div id="p0225" role="paragraph">All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.</div></section><section id="sec-4-3"><h3>Experimental Model and Subject Details</h3><section id="sec-4-3-1"><h4>Cell and organoid culture and derivation</h4><div id="p0230" role="paragraph">PANC-1 (human, male), PU-8988T (human, female), MiaPaca-2 (human, male), and 3B11 (murine, male) cells were purchased from the American Type Culture Collection (ATCC) or DSMZ. Murine <i>KPC</i><sup><i>mut</i></sup> PDAC cell lines and organoids (male) were generated from PDAC arising in aged <i>Pdx1-Cre;Kras</i><sup><i>LSL-G12D/+</i></sup><i>;Trp53</i><sup><i>R172H/wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) mice. Cells were grown in “complete DMEM” containing 10% FBS and 100 IU/ml penicillin/streptomycin (P/S). Cells and organoids were maintained in a humidified incubator at 37°C with 5% CO<sub>2</sub>. Only cell lines were used for <i>in&nbsp;vitro</i> studies. All cells and organoids used were negative for mycoplasma. All human cell lines were authenticated by their source repository.</div><div id="p0235" role="paragraph">To generate <i>KPC</i><sup><i>mut</i></sup> PDAC cell lines, tumors arising in <i>Pdx1-Cre; LSL-Kras</i><sup><i>G12D/+</i></sup><i>; LSL-p53</i><sup><i>R172H/</i></sup><sup><i>wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) mice were minced with scissors and the dissociated in 1&nbsp;mg/ml Collagenase type V (C9263; Sigma) and 2U/ml Dispase II (04942078001; Roche) diluted in Hanks Buffered Saline Solution (HBSS) (14025-076; Life technologies) at 37°C with mild agitation for up to 1 hour. The cell suspension was then plated on 10&nbsp;cm<sup>2</sup> culture dishes coated with 100&nbsp;μg/ml collagen (PureCol) (5005; Advanced Biomatrix) and grown in complete DMEM. Primary cultures were passaged at least 3 times to remove fibroblast contamination. <i>KPC</i><sup><i>mut</i></sup> PDAC cells were then transduced with a Luciferase (Luc)-GFP co-expression vector to visualize them <i>in&nbsp;vivo</i>. Luc-GFP constructs were cloned into MSCV-based vectors and retroviruses were packaged by co-transfection of Gag-Pol expressing 293 T&nbsp;cells with expression constructs and envelope vectors (VSV-G) using the calcium phosphate method. Following transduction, cells were purified by FACS sorting the GFP<sup>+</sup> population on a FACSAria (BD Biosciences).</div><div id="p0240" role="paragraph"><i>KPC</i><sup><i>mut</i></sup> PDAC organoids were generated by mincing and dissociating tumors arising in <i>Pdx1-Cre; LSL-Kras</i><sup><i>G12D/+</i></sup><i>; LSL-p53</i><sup><i>R172H/</i></sup><sup><i>wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) mice with collagenase and dispase as described above. Unfiltered, dissociated tissue was then seeded in growth factor-reduced (GFR) Matrigel (BD) and cultured in advanced DMEM/F12 supplemented with the following: 1% P/S, 2mM glutamine, 1X B27 supplement (12634-028; Invitrogen), 50ng/ml hEGF (PMG8043; Peprotech), 100ng/ml mNoggin (250-38; Peprotech), 100ng/ml hFGF10 (100-26; Peprotech), 10&nbsp;nM hLeu-Gastrin I (G9145, Sigma), 1.25mM N-acetylcysteine (A9165; Sigma), 10mM Nicotinamide (N0636; Sigma), and R-spondin1 conditioned media (10% final). Organoids were passaged every 3-4&nbsp;days.</div><div id="p0245" role="paragraph">Primary murine pancreatic fibroblasts from C57BL/6 mice were purchased from Cell Biologics, Inc. and grown in complete fibroblast media (M2267). To generate primary bone marrow-derived macrophages (BMDMs), bone marrow was flushed from the hind limbs of 9&nbsp;week old female C57BL/6 mice under sterile conditions, passed through a 40&nbsp;μm strainer and cultured in 30&nbsp;mL Teflon Bags (PL-30; PermaLife) in DMEM supplemented with 10% FBS and 10&nbsp;ng/ml of recombinant mouse CSF1 (R&amp;D systems). Bone marrow cells were cultured for 7&nbsp;days, refreshing CSF1-containing media every other day, after which they were referred to as BMDMs.</div></section><section id="sec-4-3-2"><h4>Animal Studies</h4><div id="p0250" role="paragraph">All mouse experiments were approved by the Memorial Sloan Kettering Cancer Center (MSKCC) Internal Animal Care and Use Committee under MSKCC IACUC protocol 11-06-018. Mice were maintained under specific pathogen-free conditions, and food and water were provided <i>ad libitum</i>.</div><section id="sec-4-3-2-1"><h5>KPC<sup>flox</sup> PDAC GEMM</h5><div id="p0255" role="paragraph"><i>Trp53</i><sup><i>fl/fl</i></sup><i>, LSL-Kras</i><sup><i>G12D/+</i></sup><i>,</i> and <i>Pdx1-Cre</i> strains on a C57BL/6 background were interbred to obtain <i>Pdx1-Cre; LSL-Kras</i><sup><i>G12D/+</i></sup><i>; Trp53</i><sup><i>fl/wt</i></sup> (<i>KPC</i><sup><i>flox</i></sup>) mice. Both male and female <i>KPC</i><sup><i>flox</i></sup> mice ranging from 2.5 to 12&nbsp;months of age were used for treatment studies upon confirmation of tumor development. Mice were monitored for tumor development by ultrasound, and enrolled and randomized into treatment groups once tumors reached 100-300&nbsp;mm<sup>3</sup>. Ultrasound imaging was repeated every 2&nbsp;weeks during treatment to assess changes in pancreas tumor burden. For immunohistochemical and flow cytometry analysis, mice were treated for 2&nbsp;weeks with indicated drugs. Upon sacrifice pancreas tumor tissue was allocated for 10% formalin fixation, OCT frozen blocks, and snap frozen tissue, and the rest used to generate single cell suspensions for flow cytometry analysis.</div></section><section id="sec-4-3-2-2"><h5>KPC<sup>mut</sup> PDAC organoid transplant model</h5><div id="p0260" role="paragraph">For orthotopic engraftment of <i>KPC</i><sup><i>mut</i></sup> PDAC organoids derived from <i>Pdx1-Cre; LSL-KRAS</i><sup><i>G12D/+</i></sup><i>; Trp53</i><sup><i>R172H/wt</i></sup> (<i>KPC</i><sup><i>mut</i></sup>) tumors, 8-10&nbsp;week old C57BL/6 or NOD-<i>scid</i> IL2Rγ<sup>null</sup> (NSG) female mice (Jackson Laboratory) were first anesthetized using isoflurane and an incision was made in the left abdominal side. Organoids (approximately 1-3x10<sup>5</sup> cells/mouse) were prepared from cultures. Organoid cultures were dissociated with TrypLE (ThermoFisher; 12604-021) and finally resuspended in 25&nbsp;μL of growth factor reduced Matrigel (354230; Corning) diluted 1:1 with cold adDMEM F/12 media supplemented with 2mM glutamine. The organoid suspension was injected into the tail region of the pancreas using a Hamilton Syringe. Successful injection was verified by the appearance of a fluid bubble without signs of intraperitoneal leakage. The abdominal wall was sutured with absorbable Vicryl sutures (Ethicon), and the skin was closed with wound clips (CellPoint Scientific Inc.). Mice were monitored for tumor development by ultrasound (anywhere from 1.5-6&nbsp;months post-transplantation), and enrolled and randomized into treatment groups once tumors reached 100-300&nbsp;mm<sup>3</sup>. Ultrasound imaging was repeated every 2&nbsp;weeks during treatment to assess changes in pancreas tumor burden. For immunohistochemical and flow cytometry analysis, mice were treated for 2&nbsp;weeks with indicated drugs. Upon sacrifice pancreas tumor tissue was allocated for 10% formalin fixation, OCT frozen blocks, and snap frozen tissue, and the rest used to generate single cell suspensions for flow cytometry analysis.</div></section><section id="sec-4-3-2-3"><h5>KPC<sup>mut</sup> PDAC cell line transplant model</h5><div id="p0265" role="paragraph">To rapidly generate orthotopic PDAC tumors in immunocompetent mice for immunophenotyping experiments, 5x10<sup>4</sup> <i>KPC</i><sup><i>mut</i></sup> PDAC cells expressing luciferase and GFP (LUC-GFP) were orthotopically transplanted into the pancreas of 8-10&nbsp;week old C57BL/6 female mice as described above. Mice were monitored for tumor development (5-8&nbsp;days post-transplantation) by bioluminescence imaging (BLI) on a Xenogen IVIS Spectrum imager (PerkinElmer) before being randomized into various study cohorts. For immunohistochemical and flow cytometry analysis, mice were treated for 2&nbsp;weeks with indicated drugs. Upon sacrifice pancreas tumor tissue was allocated for 10% formalin fixation, OCT frozen blocks, snap frozen tissue, and the rest for flow cytometric analysis.</div></section><section id="sec-4-3-2-4"><h5>Patient-Derived Xenograft (PDX) models</h5><div id="p0270" role="paragraph">5-7&nbsp;week old female NOD-<i>scid</i> IL2Rγ<sup>null</sup> (NSG) mice were used for animal experiments with patient-derived xenografts (PDXs). PDAC PDXs used for preclinical studies were selected based upon presence of a robust stromal compartment and resistance to gemcitabine chemotherapy. MSK-PR07 is a PDAC PDX harboring mutations in <i>KRAS</i> (<i>G12D</i>) and <i>p53</i> (L344Q) and derived from a patient treated with three rounds of chemotherapy: 1) gemcitabine and cisplatin, 2) FOLFIRINOX, and 3) gemcitabine and abraxane. MSK-PR05 is a PDAC PDX derived from a patient previously treated with gemcitabine, abraxane, and the HA degrading agent PEGPH20. Tumors were cut into pieces and inserted into a pocket in the subcutaneous space as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Poirier et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Poirier, J.T. ∙ Gardner, E.E. ∙ Connis, N. ...</div><div><strong>DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2</strong></div><div><em>Oncogene.</em> 2015; <strong>34</strong>:5869-5878</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/onc.2015.38" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84948570001" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25746006/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fonc.2015.38&amp;pmid=25746006" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Following inoculation, mice were monitored daily, weighed twice weekly, and caliper measurements begun when tumors became visible. Tumor volume was calculated using the following formula: tumor volume&nbsp;= (D x d<sup>2</sup>)/2, in which D and d refer to the long and short tumor diameter, respectively. When tumors reached a size of 100-200&nbsp;mm<sup>3</sup>, mice were randomized based on starting tumor volume (caliper measurements) and enrolled into treatment groups. Tumor size and mouse weights were recorded twice weekly. Experimental endpoints were achieved when tumors reached 2000&nbsp;mm<sup>3</sup> or became ulcerated.</div></section></section></section><section id="sec-4-4"><h3>Method Details</h3><section id="sec-4-4-1"><h4>Compounds</h4><div id="p0275" role="paragraph">Trametinib (S2673) and palbociclib (S1116) were purchased from Selleck chemicals for <i>in&nbsp;vitro</i> studies. Drugs for <i>in&nbsp;vitro</i> studies were dissolved in DMSO (vehicle) to yield 10&nbsp;mM stock solutions and stored at −80°C. For <i>in&nbsp;vitro</i> studies, growth media with or without drugs was changed every 2-3&nbsp;days. For <i>in&nbsp;vivo</i> studies, trametinib (T-8123) and palbociclib (P-7744) were purchased from LC Laboratories. Trametinib was dissolved in a 5% hydroxypropyl methylcellulose and 2% Tween-80 solution (Sigma), and palbociclib in sodium lactate buffer (pH 4). Gemcitabine was purchased from the MSKCC pharmacy and diluted accordingly in saline.</div></section><section id="sec-4-4-2"><h4>Short-hairpin RNA (shRNA) knockdown</h4><div id="p0280" role="paragraph">MiR30-based shRNAs targeting <i>p65</i> and <i>Renilla</i> (as a control) were cloned into the XhoI EcoRI locus of the MSCV-based LMP vector (<span class="dropBlock reference-citations"><a id="body-ref-sref17-4" href="#" role="doc-biblioref" data-xml-rid="bib16 bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-4" aria-controls="sref17-4">Chicas et&nbsp;al., 2010; Chien et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref17-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Chicas, A. ∙ Wang, X. ∙ Zhang, C. ...</div><div><strong>Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:376-387</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77950486542" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20385362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.01.023&amp;pmid=20385362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chien, Y. ∙ Scuoppo, C. ∙ Wang, X. ...</div><div><strong>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</strong></div><div><em>Genes Dev.</em> 2011; <strong>25</strong>:2125-2136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.17276711" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80054789761" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21979375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.17276711&amp;pmid=21979375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Retroviruses were packaged by co-transfection of Gag-Pol expressing 293 T&nbsp;cells with expression constructs and envelope vectors (VSV-G) using the calcium phosphate method, and virus containing media applied to target <i>KPC</i><sup><i>mut</i></sup> cells. Infected cells were selected with 1&nbsp;μg/ml puromycin for 5&nbsp;days. Knockdown was confirmed by qRT-PCR and immunohistochemistry (following transplantation into C57BL/6 mice).</div><div id="p0285" role="paragraph">For p65 knockdown studies in <i>KPC</i><sup><i>mut</i></sup> organoids, virus containing media was collected in AdDMEM supplemented with 1X P/S and 2mM glutamine and mixed 1:1 with full organoid media. Organoids were treated with virus overnight twice and subsequently selected for 1&nbsp;week with 1μg/ml puromycin. Knockdown was confirmed by immuhistochemistry following transplantation into C57BL/6 mice.</div></section><section id="sec-4-4-3"><h4>Preclinical drug studies</h4><div id="p0290" role="paragraph">Mice were treated with vehicle, trametinib (1&nbsp;mg/kg or 0.3&nbsp;mg/kg body weight), and/or palbociclib (100&nbsp;mg/kg body weight) <i>per os</i> for 4 consecutive days followed by 3&nbsp;days off treatment. Gemcitabine (100&nbsp;mg/kg body weight) was administered twice per week, or an α-PD-1 antibody (200&nbsp;μg; RMP1-14, BioXcell) was given 3 times per week by intraperitoneal (IP) injection alone or in combination with trametinib and palbociclib treatment concurrently. Gemcitabine was also given on an alternating treatment schedule with T/P, where T/P was given on 4 consecutive days followed by 3&nbsp;days off treatment for 1&nbsp;week, followed by gemcitabine administration twice a week for 1&nbsp;week. For PDX models propogated in NSG mice, gemcitabine was administered once per week. No obvious toxicities were observed in the vehicle- or drug-treated animals as assessed by changes in body weight (taking tumor size into account).</div></section><section id="sec-4-4-4"><h4>Neutralizing antibody studies</h4><div id="p0295" role="paragraph">High doses of an α-VEGFR-2 blocking antibody (800&nbsp;μg; DC101, BioXcell) were administered twice per week by IP injection to block neo-vascularization. For NK cell depletion, mice were injected IP with an α-NK1.1 antibody (250&nbsp;μg; PK136, BioXcell) twice per week. For T&nbsp;cell depletion, mice were injected IP with either an α-CD4 (200&nbsp;μg; GK1.5, BioXcell) or α-CD8 antibody (200&nbsp;μg; 2.43, BioXcell) twice per week. Depletion of NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T&nbsp;cells was confirmed by flow cytometric and immunohistochemical analysis of pancreas tumor tissue. For neutralization of cell surface molecules that mediate immune-endothelial interactions, mice were injected IP with either an α-VCAM-1 (200&nbsp;μg; M/K-2.7, BioXcell), α-PSGL-1 (50&nbsp;μg; 4RA10, BioXcell), or α-ICAM-1 antibody (200&nbsp;μg; YN1/1.7.4, BioXcell) twice per week. For neutralization of SASP factors, mice were injected IP with either an α-VEGFR2 (800&nbsp;μg; DC101, BioXcell), α-IL-6 (200&nbsp;μg; MP5-20F3, BioXcell), α-TGF-β (300&nbsp;μg; 1D11.16.8, BioXcell), α-IL-1β (200&nbsp;μg; B122, BioXcell), CCL-5 (50&nbsp;μg; 53405, R&amp;D systems), or CXCL-1 antibody (25&nbsp;μg, 48415, R&amp;D systems) twice per week.</div></section><section id="sec-4-4-5"><h4>Ultrasound Imaging</h4><div id="p0300" role="paragraph">High-contrast ultrasound imaging was performed on a Vevo 2100 System with a MS250 13- to 24-MHz scanhead (VisualSonics) to stage and quantify pancreas tumor burden. Tumor volume was analyzed using Vevo LAB software.</div></section><section id="sec-4-4-6"><h4>Bioluminescence imaging</h4><div id="p0305" role="paragraph">Bioluminescence imaging (BLI) was used to track luciferase expression in orthotopically transplanted <i>KPC</i><sup><i>mut</i></sup> PDAC tumor cells expressing a LUC-GFP reporter. Mice were injected IP with luciferin (5&nbsp;mg/mouse; Gold Technologies) and then imaged on a Xenogen IVIS Spectrum imager (PerkinElmer) 10-15&nbsp;minutes later for 60 s. Quantification of luciferase signaling was analyzed using Living Image software (Caliper Life Sciences).</div></section><section id="sec-4-4-7"><h4>Tumor perfusion, permeability, and drug uptake assays</h4><div id="p0310" role="paragraph">PDAC-bearing <i>KPC</i><sup><i>mut</i></sup> organoid transplant and <i>KPC</i><sup><i>flox</i></sup> GEMM mice were pretreated for 2&nbsp;weeks with vehicle or combined trametinib (1&nbsp;mg/kg body weight) and palbociclib (100&nbsp;mg/kg body weight) <i>per os</i> for 4 consecutive days followed by 3&nbsp;days off treatment. To assess vascular permeability following treatment, 1&nbsp;mg of FITC–dextran (MW 2,000,000; Sigma-Aldrich) was administered intravenously in the lateral tail vein 30&nbsp;minutes before sacrifice. Similarly, to measure vascular perfusion/patency, 100&nbsp;μg of biotinylated tomato lectin (B1175; Vector Laboratories) was injected intravenously 1 hour before sacrifice. To assess hypoxia in PDAC tissue, 60&nbsp;mg/kg hydoxyprobe (Hypoxyprobe; HP1-100 kit) was administered by IP injection 30&nbsp;minutes prior to euthanasia.</div><div id="p0315" role="paragraph">To assess gemcitabine uptake into pancreas tumors, <sup>14</sup>C-gemcitabine (specific activity 58.8 mCi/mmol; Moravek Biochemicals) was administered in sterile saline by IP injection at 2 μCi/animal. Animals were euthanized 2 hours after <sup>14</sup>C-gemcitabine administration, and tumor tissue, as well as tissue from normal pancreas and other organs were collected for downstream analysis. Tumors were divided for scintillation counting and autoradiography. Fragments of tumor (approximately 100&nbsp;mg) were weighed and dissolved in Solvable™ (Perkin Elmer, Waltham MA), followed by 100&nbsp;mL hydrogen peroxide, and counted in 7&nbsp;mL Ultima Gold™ (Perkin Elmer). Activity was expressed as disintegrations per minute (dpm)/milligram. Autoradiographs were obtained from flash-frozen tumor cryosections, exposed to GE storage phosphor screens for 7&nbsp;days and read with the Typhoon FLA 7000 laser scanner (GE Healthcare Life Sciences, Pittsburgh, PA). Before exposure, slides were marked with nail polish containing a blue dye and <sup>14</sup>C to permit registration of autoradiographic and microscopic images.</div></section><section id="sec-4-4-8"><h4>Flow cytometry</h4><div id="p0320" role="paragraph">For <i>in&nbsp;vivo</i> sample preparation, tumors were isolated following removal of the spleen and normal pancreas tissue, and allocated for 10% formalin fixation, OCT frozen blocks, snap frozen tissue, and flow cytometry analysis following 2-week treatment. To prepare single cell suspensions for flow cytometry analysis, tumors were minced with scissors into small pieces and placed in 5ml of collagenase buffer (1x HBSS w/ calcium and magnesium (GIBCO), 1&nbsp;mg/ml Collagenase V (C9263; Sigma), and 0.1&nbsp;mg/ml DNase I (DN25; Sigma)). Samples were then transferred to C tubes and processed using program 37C_m_TDK1_1 on a gentleMACS Octo dissociator with heaters (Miltenyi Biotec). Dissociated tissue was passaged through a 70&nbsp;μm cell strainer and centrifuged at 1500&nbsp;rpm x 5&nbsp;minutes. Red blood cells were lysed with ACK lysis buffer (Quality Biological) for 5&nbsp;minutes, and samples were centrifuged and resuspended in PBS supplemented with 2% FBS. Samples were blocked with anti-CD16/32 (FC block, BD Pharmigen) for 20&nbsp;minutes and then incubated with the following antibodies for 30&nbsp;minutes on ice: CD45 (30-F11), NK1.1 (PK136), CD3 (17A2), CD8 (53-6.7), CD4 (GK1.5), Gr-1 (RB6-8C5), PD-L1 (CD274;10F.9G2), CD31 (390), VCAM-1 (CD106;MVCAM.A), P-selectin (CD62P; RMP-1), CD69 (H1.2F3), CTLA-4 (CD152; UC10-4B9), 2B4 (CD244.2; m2B4 (B6)458.1), VLA-4 (CD49d; R1-2), F4/80 (BM8), PD-1 (CD279; RMP1-30), CD44 (IM7), CD86 (GL-1), CD206 (MMR), Ly6G (1A8) (Biolegend); CD11b (M1/70) (BD Biosciences); MHC-I (H-2k<sup>b</sup>; AF6-88.5.5.3), LAG-3 (eBioC9B7W) (eBioscience); and ICAM-1 (AB796) (R&amp;D Systems). DAPI was used to distinguish live/dead cells, and tumor cells were gated as GFP<sup>+</sup> in the <i>KPC</i><sup><i>mut</i></sup> PDAC cell line transplant model where tumor cells harbor a LUC-GFP construct. Flow cytometry was performed on an LSRFortessa, and data were analyzed using FlowJo (TreeStar).</div></section><section id="sec-4-4-9"><h4><i>In&nbsp;vivo</i> degranulation assay</h4><div id="p0325" role="paragraph">Mice were injected intravenously with 250&nbsp;μL of a solution containing 25&nbsp;μg anti-CD107a PE (ID4B, Biolegend) in 1X PBS 3 hours before mice were euthanized. Pancreas tumor tissue was then isolated, dissociated, stained with cell surface antibodies, and analyzed by flow cytometry as described above.</div></section><section id="sec-4-4-10"><h4>Immunohistochemistry and immunofluorescence</h4><div id="p0330" role="paragraph">Tissues were fixed overnight in 10% formalin, embedded in paraffin, and cut into 5&nbsp;μm sections. Haematoxylin and eosin (H&amp;E) and Masson’s trichrome staining were performed using standard protocols. For frozen sections, pancreata were directly embedded in OCT (VWR Chemicals, 361603E) and frozen on dry ice. For immunohistochemical and immunofluorescence analysis, sections were de-paraffinized, rehydrated, and boiled in a microwave for 15&nbsp;minutes in 10&nbsp;mM citrate buffer (pH 6.0) for antigen retrieval. Antibodies were incubated overnight at 4°C.</div><div id="p0335" role="paragraph">The following primary antibodies were used: pERK<sup>T202/Y204</sup> (4370), cleaved caspase-3 (CC3) (9664), PDGFRβ (3169), NF-κB (p65;8242) (Cell Signaling); Ki67 (AB16667), CD31 (AB28364), α-smooth muscle actin (αSMA;AB5694), CD3 (AB5690), granzyme B (AB4059), LYVE1 (AB14917) (Abcam); pRB<sup>S807/S811</sup> (Sc-16670) (Santa Cruz); NKp46 (AF2225), VCAM-1 (AF643), ICAM-1 (AF796) (R&amp;D Systems); FOXP3 (14-5773-82), CD8 (14-0808-82) (eBioscience); mouse pan-endothelial cell antigen (MECA-32) (University of Iowa); P-selectin (LS-B3578) (LSBio); FAP (ABT11) (Millipore); CD31 (DIA-310) (Dianova); biotinylated hyaluronic acid binding protein (HABP) (AMS.HKD-BC41; AMSBIO); and cytokeratin 19 (CK19; TROMA-III) (DSHB).</div><div id="p0340" role="paragraph">HRP-conjugated secondary antibodies (Vectastain Elite ABC HRP Kits) were applied for 30&nbsp;minutes and visualized with DAB (Vector Laboratories; SK-4100), or secondary Alexa Fluor 488 or 594 dye-conjugated antibodies (Life Technologies) applied for 1 hour at room temperature. Fluorescence antibody-labeled slides were mounted with Prolong Gold Antifade mountant (Prolong Molecular Probes; P36934) after counterstaining with DAPI.</div><div id="p0345" role="paragraph">Analysis of protein adducts of reductively activated pimonidazole were identified through immunohistochemistry in fixed tissues with a monoclonal antibody against hypoxyprobe-1 according to the manufacturer’s protocol (Hypoxyprobe; HP1-100 kit). To assess lectin perfusion, PDAC tissue sections isolated from mice injected with biotinylated tomato lectin (B1175; Vector Laboratories) were stained with a fluorescein-conjugated streptavidin (SA-5001: Vector Laboratories) for 30&nbsp;minutes and processed as described above.</div></section><section id="sec-4-4-11"><h4>SA-β-gal staining</h4><div id="p0350" role="paragraph">SA-β-gal staining was performed at pH 6.0 for human cells and 5.5 for mouse cells and tissue. Fresh frozen sections of pancreas tumor tissue, or adherent cells plated in 6-well plates and treated for 8&nbsp;days in culture with vehicle (DMSO), trametinib (25nM), and/or palbociclib (500nM), were fixed with 0.5% Gluteraldehyde in PBS for 15&nbsp;min, washed with PBS supplemented with 1mM MgCl<sub>2</sub>, and stained for 5–8 hours in PBS containing 1&nbsp;mM MgCl<sub>2</sub>, 1mg/ml X-Gal, and 5&nbsp;mM each of Potassium ferricyanide and Potassium ferrocyanide. Tissue sections were counterstained with eosin. 5 high power fields per well/section were counted and averaged.</div></section><section id="sec-4-4-12"><h4>Conditioned Media collection</h4><div id="p0355" role="paragraph">PDAC cells were plated in 6-well plates and treated for 6&nbsp;days in the presence or absence of trametinib (25nM) and/or palbociclib (500nM). On day 6, 2&nbsp;mL of serum-free or complete DMEM was added to each well and cells were incubated an additional 48 hours in the presence or absence of drugs. Conditioned media was then collected and the cells were trypsinized and counted using a cellometer (Nexcelom Biosciences). After normalizing the concentration of the conditioned media by the cell count, conditioned media from vehicle- or T/P-pretreated <i>KPC</i><sup><i>mut</i></sup> PDAC tumor cells was then applied to endothelial cells, fibroblasts, and bone marrow-derived macrophages to assess changes in growth, or used for downstream cytokine array analysis.</div></section><section id="sec-4-4-13"><h4>Cytokine array</h4><div id="p0360" role="paragraph">Conditioned media samples (collected in complete DMEM) from treated PDAC cell lines or primary pancreatic murine fibroblasts (plated in triplicate) were normalized based on cell number by diluting with complete DMEM. Aliquots (50&nbsp;μl) of the conditioned media were analyzed using multiplex immunoassays designed for human (Human Cytokine/Chemokine Array 42-Plex Discovery Assay) or mouse (Mouse Cytokine/Chemokine Array 31-Plex or MMP Discovery Array 5-Plex Discovery Assay) from Eve Technologies. Biological replicates were averaged to determine cytokine levels. Heatmaps display relative cytokine expression values normalized to vehicle-treated samples.</div></section><section id="sec-4-4-14"><h4><i>In&nbsp;vitro</i> cell growth assays</h4><div id="p0365" role="paragraph"><i>KPC</i><sup><i>mut</i></sup> tumor cells were treated with vehicle or combined trametinib (25nM) and palbociclib (500nM) for 6&nbsp;days, and conditioned serum-free DMEM was collected as described above. Filtered conditioned media (CM) or basal serum-free media was then applied to various primary and established cell lines. To measure endothelial cell and fibroblast growth, 5,000 3B11 murine endothelial cells and 10,000 primary murine pancreatic fibroblasts were plated in 24-well dishes. Cells were counted daily in quadruplicate using a Guava Easycyte (Millipore) and media changed every 3&nbsp;days. To analyze the impact on macrophage growth, 10,000 bone marrow-derived macrophages (BMDMs) were plated in 96 well dishes and, one day thereafter, were exposed to CM or basal&nbsp;serum-free media diluted 1:2 in DMEM containing 10% FBS and 10&nbsp;ng/mL Csf1. Cell viability was assessed using the CellTiter-Glo Viability Assay (Promega) according to the manufacturer’s protocol.</div></section><section id="sec-4-4-15"><h4><i>In&nbsp;vitro</i> endothelial tube formation assay</h4><div id="p0370" role="paragraph">3B11 endothelial cells were plated in 48 well dishes coated with a 150&nbsp;μL layer of Cultrex reduced growth factor basement membrane extract (3533-005-02; R&amp;D Systems) and cultured in basal or serum-free conditioned DMEM media for 8 hours. Images of tube structures were captured on a INCell 6000 high-content imager (GE Healthcare Life Sciences) at 10x magnification.</div></section><section id="sec-4-4-16"><h4>T cell functionality assays</h4><div id="p0375" role="paragraph">Spleens were harvested from female OT-1 mice (Jackson laboratory), mechanically disrupted by passing them through a 70&nbsp;μm cell strainer, and centrifuged at 1500&nbsp;rpm x 5&nbsp;minutes. Red blood cells were lysed with ACK lysis buffer (Quality Biological) for 5&nbsp;minutes. Total splenocytes or CD8<sup>+</sup> T&nbsp;cells FACS sorted on a Sony MA900 were then activated with CD3/CD28 Dynabeads (one bead/T cell, Thermo Fisher) and cultured in presence of IL-2 (2&nbsp;ng/ml; Biolegend), IL-7 (2.5&nbsp;ng/ml; Peprotech) and IL-15 (50&nbsp;ng/ml; Peprotech) in complete RPMI media supplemented with 10% FBS and 100 IU/ml penicillin/streptomycin for four to six days prior to co-culture assays with PDAC cells.</div><div id="p0380" role="paragraph">To generate <i>KPC</i><sup><i>mut</i></sup> PDAC cells expressing chicken ovalbumin (<i>KPC</i><sup><i>mut</i></sup>-OVA), <i>KPC</i><sup><i>mut</i></sup> PDAC cells were transduced with a pCDH-derived lentiviral vector expressing amino acids 48-386 of the chicken ovalbumin protein under the control of a minimal CMV promoter and a blasticidin resistance cassette under the control of an EF1-α promoter. Lentiviruses were packaged by co-transfection of 293 T&nbsp;cells with the expression construct, envelope vector (VSV-G), and lenti Gag-Pol vector using the calcium phosphate method. Selection of OVA-expressing tumor cells was performed with blasticidin (10&nbsp;μg/ml; Thermo Fisher) over 3&nbsp;days.</div><div id="p0385" role="paragraph">For analysis of expression of cytokines and activation markers on CD8<sup>+</sup> T&nbsp;cells, total splenocytes were co-cultured for 4 hours with <i>KPC</i><sup><i>mut</i></sup> or <i>KPC</i><sup><i>mut</i></sup>-OVA PDAC tumor cells (pretreated with vehicle or combined trametinib (25nM) and palbociclib (500nM) (T/P) for 8&nbsp;days) at a 1:1 effector to target (E:T) ratio in complete RPMI. To functionally block MHC-I activity, T&nbsp;cells were also co-cultured with tumor cells in the presence of a H-2k<sup>b</sup> blocking antibody (40&nbsp;μg/ml; Y-3, BioXcell). As a positive control for T&nbsp;cell activation, cells were treated for 4 hours with PMA (20&nbsp;ng/ml, sigma aldrich) and Ionomycin (1&nbsp;μg/ml, stem cell technologies). Co-culture experiments were performed either in the absence (surface staining) or in the presence (intracellular cytokine staining) of GolgiStop (BD Biosciences). Cell surface staining was performed with CD8 (53-6.7), CD44 (IM7) and CD69 (H1.2F3) antibodies (Biolegend) for those cells that were not pretreated with GolgiStop. GolgiStop-pretreated cells were first stained with CD8 (53-6.7) antibody, then intracellular staining was performed using the Foxp3/transcription factor staining buffer set (eBioscience), where cells were fixed, permeabilized, and then stained with IFN-γ (XMG1.2; TONBO Biosciences) and TNF-α (MP6-XT22; eBiosciences) antibodies. Expression of cytokines and activation markers was evaluated by gating on CD8<sup>+</sup> T&nbsp;cells. Flow cytometry was performed on an LSRFortessa, and data were analyzed using FlowJo (TreeStar).</div><div id="p0390" role="paragraph">To assess the functionality of PDAC-infiltrating lymphocytes <i>ex&nbsp;vivo</i>, PDAC tumors isolated from <i>KPC</i><sup><i>mut</i></sup> organoid transplant mice treated for two weeks with vehicle, combined trametinib (1&nbsp;mg/kg body weight) and palbociclib (100&nbsp;mg/kg), and/or an α-PD-1 antibody (200&nbsp;μg; RMP1-14, BioXcell) were dissociated into single cell suspensions, incubated for 4 hours with PMA (20&nbsp;ng/ml, sigma aldrich) and Ionomycin (1&nbsp;μg/ml, stem cell technologies), and stained with CD8, IFN-γ, and TNF-α antibodies for flow cytometry analysis as above.</div></section><section id="sec-4-4-17"><h4>qRT-PCR</h4><div id="p0395" role="paragraph">For analysis of macrophage polarization following T/P treatment, total RNA was extracted from CD45<sup>+</sup>CD11b<sup>+</sup>Gr-1<sup>-</sup>F4/80<sup>+</sup> macrophages (sorted on a FACSAria (BD Biosciences)) isolated from <i>KPC</i><sup><i>mut</i></sup> transplant PDAC tumors treated for 2 weeks with vehicle or combined trametinib (1&nbsp;mg/kg body weight) and palbociclib (100&nbsp;mg/kg) using TRIzol RNA Isolation Reagents (Invitrogen). Total RNA was also extracted from indicated <i>KPC</i><sup><i>mut</i></sup> PDAC cell lines following 8&nbsp;day treatment with vehicle or trametinib (25nM) and palbociclib (500nM) in culture using the RNeasy Mini Kit (QIAGEN). Complementary DNA (cDNA) was obtained using the TaqMan reverse transcription reagents (Applied Biosystems). Real-time PCR was performed in duplicate or triplicate using SYBR Green&nbsp;PCR Master Mix (Applied Biosystems) on the ViiA 7 Real-Time PCR System (Invitrogen). 36B4 served as an endogenous normalization control.</div></section><section id="sec-4-4-18"><h4>High throughput RNA-sequencing (RNA-seq) analysis</h4><div id="p0400" role="paragraph">For RNA-seq analysis of the transcriptional profiles of tumor cells from <i>KPC</i><sup><i>mut</i></sup> transplant PDAC tumors in mice treated for 2 weeks with vehicle or combined trametinib (1&nbsp;mg/kg body weight) and palbociclib (100&nbsp;mg/kg), total RNA was extracted from GFP<sup>+</sup> tumor cells (sorted on a FACSAria (BD Biosciences)) using the RNeasy Mini Kit (QIAGEN). Purified polyA mRNA was subsequently fragmented, and first and second strand cDNA synthesis performed using standard Illumina mRNA TruSeq library preparation protocols. Double stranded cDNA was subsequently processed for TruSeq dual-index Illumina library generation. For sequencing, pooled multiplexed libraries were run on a HiSeq 2500 machine on RAPID mode. Approximately 10 million 76bp single-end reads were retrieved per replicate condition. Resulting RNA-Seq data was analyzed by removing adaptor sequences using Trimmomatic (<span class="dropBlock reference-citations"><a id="body-ref-sref8-2" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-2" aria-controls="sref8-2">Bolger et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref8-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bolger, A.M. ∙ Lohse, M. ∙ Usadel, B.</div><div><strong>Trimmomatic: a flexible trimmer for Illumina sequence data</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:2114-2120</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu170" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84905049901" target="_blank" aria-label="Open Scopus in new tab">Scopus (13125)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24695404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu170&amp;pmid=24695404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), aligning sequencing data to GRCh37.75(hg19) with STAR (<span class="dropBlock reference-citations"><a id="body-ref-sref28-2" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-2" aria-controls="sref28-2">Dobin et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref28-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ...</div><div><strong>STAR: ultrafast universal RNA-seq aligner</strong></div><div><em>Bioinformatics.</em> 2013; <strong>29</strong>:15-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/bts635" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84871809302" target="_blank" aria-label="Open Scopus in new tab">Scopus (8544)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23104886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbts635&amp;pmid=23104886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and genome wide transcript counting using HTSeq (<span class="dropBlock reference-citations"><a id="body-ref-sref3-2" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-2" aria-controls="sref3-2">Anders et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref3-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Anders, S. ∙ Pyl, P.T. ∙ Huber, W.</div><div><strong>HTSeq--a Python framework to work with high-throughput sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:166-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu638" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84928987900" target="_blank" aria-label="Open Scopus in new tab">Scopus (6221)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25260700/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu638&amp;pmid=25260700" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to generate a RPKM matrix of transcript counts. Genes were identified as differentially expressed using R package DESeq2 with a cutoff of absolute log<sub>2</sub>FoldChange ≥ 1 and adjusted p value&nbsp;&lt; 0.05 between experimental conditions (<span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Love et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Love, M.I. ∙ Huber, W. ∙ Anders, S.</div><div><strong>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</strong></div><div><em>Genome Biol.</em> 2014; <strong>15</strong>:550</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13059-014-0550-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84924629414" target="_blank" aria-label="Open Scopus in new tab">Scopus (12911)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25516281/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13059-014-0550-8&amp;pmid=25516281" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Functional enrichments of these differential expressed genes were performed with enrichment analysis tool Enrichr (<span class="dropBlock reference-citations"><a id="body-ref-sref49-2" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-2" aria-controls="sref49-2">Kuleshov et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref49-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Kuleshov, M.V. ∙ Jones, M.R. ∙ Rouillard, A.D. ...</div><div><strong>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:W90-7</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkw377" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987663170" target="_blank" aria-label="Open Scopus in new tab">Scopus (1516)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27141961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkw377&amp;pmid=27141961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and the retrieved combined score (log(p value) <sup>∗</sup> <i>z</i>-score) was displayed.</div><div id="p0405" role="paragraph">To assess expression of antigen presentation and processing genes in human PDAC cell lines treated with vehicle (DMSO), trametinib (25nM), and/or palbociclib (500nM) for 8&nbsp;days in culture, we interrogated a previously published RNA-seq dataset from <span class="dropBlock reference-citations"><a id="body-ref-sref84-9" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-9" aria-controls="sref84-9">Ruscetti et&nbsp;al. (2018)</a><div class="dropBlock__holder" data-db-target-of="sref84-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span> (GEO: <a id="intref0085" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110397" target="_blank">GSE110397</a>). Heatmaps display the fold change in RPKM expression values normalized to vehicle-treated samples.</div></section><section id="sec-4-4-19"><h4>Clustering and Gene Set Enrichment Analysis (GSEA)</h4><div id="p0410" role="paragraph">Principal component analysis was performed using the DESeq2 package in R. Gene expressions of RNA-Seq data were clustered using hierarchical clustering based on one minus pearson correlation test. For pathway enrichment analysis, the weighted GSEA Preranked mode was used on a set of curated signatures in the molecular signatures database (MSigDB v6.2) (<a id="intref0090" href="https://www.broadinstitute.org/gsea/msigdb/index.jsp" target="_blank">https://www.broadinstitute.org/gsea/msigdb/index.jsp</a>). From 17,810 signatures, signatures with 15-500 genes were only considered for the further analyses. From the results, enriched signatures with an adjusted <i>p</i> value less than 0.05 were considered as statistically significant.</div></section><section id="sec-4-4-20"><h4>Whole exome sequencing (WES)</h4><div id="p0415" role="paragraph">WES was conducted on genomic DNA (gDNA) isolated from PDAC tumors harvested at survival endpoint from <i>KPC</i><sup><i>mut</i></sup> organoid transplant and <i>KPC</i><sup><i>flox</i></sup> GEMM mice. gDNA was also isolated from peripheral blood of a non-tumor bearing C57/BL6 mouse to generate a baseline reference sequence. gDNA was isolated using the DNeasy Blood &amp; Tissue Kit (QIAGEN) and WES was conducted and sequenced by BGI. The data was then processed through the Illumina (HiSeq) Exome Variant Detection Pipeline for detecting variants by the Bioinformatics Core at MSKCC. First, the FASTQ files were processed to remove any adaptor sequences at the end of the reads using cutadapt (v1.6). The files were then mapped using the BWA mapper (bwa mem v0.7.12). After mapping the SAM files were sorted and read group tags added using the PICARD tools. After sorting in coordinate order the BAMs were processed with PICARD MarkDuplicates. The marked BAM files were then processed using the GATK toolkit (v 3.2) according to the best practices for tumor normal pairs. They were first realigned using ABRA (v 0.92) and then the base quality values recalibrated with the BaseQRecalibrator. Somatic variants were then called in the processed BAMs using muTect (v1.1.7) for SNV and the Haplotype caller from GATK with a custom post-processing script to call somatic indels. Mutations that occurred more than once among all <i>in vivo</i> mouse PDAC tumor samples, but did not appear <i>in vitro</i> prior to transplantation, were removed. Based on the information provided by Agilent SureSelect XT Mouse All Exon Kit, the total exome coverage was about 49.6MB. This coverage length was used to calculate mutations per MB and compared with publicly available mutational data downloaded from (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Alexandrov et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alexandrov, L.B. ∙ Nik-Zainal, S. ∙ Wedge, D.C. ..., Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, ICGC PedBrain</div><div><strong>Signatures of mutational processes in human cancer</strong></div><div><em>Nature.</em> 2013; <strong>500</strong>:415-421</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84882837534" target="_blank" aria-label="Open Scopus in new tab">Scopus (4094)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23945592/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12477&amp;pmid=23945592" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section></section><section id="sec-4-5"><h3>Quantification and Statistical Analysis</h3><section id="sec-4-5-1"><h4>Histological and Image Analysis</h4><div id="p0420" role="paragraph">To measure endothelial tube formation <i>in&nbsp;vitro</i>, four fields per well were analyzed and grouped by well using Cell Profiler. In order to outline the whole cell/tube profile, the image was first processed using the EnhanceEdges function, followed by Smooth filters. The subsequent image was then thresholded to produce an outline object for the tube formation within each field. This object mask was then transformed with the skeletonize mask function and measurements on this skeleton used to determine tube length.</div><div id="p0425" role="paragraph">Quantification of the number of CD31<sup>+</sup> blood vessels (mean vessel density), SA-β-gal<sup>+</sup> senescent cells, Ki67<sup>+</sup> proliferating cells, CC3<sup>+</sup> dead/dying cells, CD3<sup>+</sup> and CD8<sup>+</sup> T&nbsp;cells, and other immune and stromal cell types was performed on 5 high power 20x fields per section that were counted and averaged. The distance between blood vessels and tumor cells was determined for 20 randomly chosen blood vessels, and the distance to the four nearest tumors cells was measured and averaged using ImageJ software. Assessment of stromal reactivity was performed by scoring the number and intensity of the pixels by color deconvolution using Aperio software (IHC score) on trichrome, αSMA, and HA-stained sections.</div><div id="p0430" role="paragraph">Metastatic burden in the lungs and liver, as well as necrotic areas in primary PDAC lesions, were quantified from low magnification (1x) H&amp;E-stained whole tissue sections. Tumor necrosis was assessed by the percentage of total tumor area covered in necrotic tissue on H&amp;E-stained sections using ImageJ software.</div><div id="p0435" role="paragraph">To quantify colocalization of various markers with blood vessels, slides were first scanned with Pannoramic 250 Flash scanner (3DHistech, Hungary) using 20x/0.8NA objective lens. Regions of interest around the tissues were then drawn and exported as .tif files from these scans using Caseviewer (3DHistech, Hungary.) These images were then analyzed using ImageJ/FIJI (NIH, USA) where a median filter, thresholding, and watershedding were used to segment the nuclei in the DAPI channel. These segmented nuclei were then used to determine percent overlap between the different combinations of markers with their respective thresholds in order to quantify colocalization.</div><div id="p0440" role="paragraph">To assess lectin perfusion, PDAC tissue sections were co-stained with CD31, and the percentage of lectin<sup>+</sup> blood vessels was quantified. Hypoxia was assessed as the percentage of tumor tissue containing activated pimonidazole using ImageJ software. Vascular permeability was assessed by percentage of total tumor area that was FITC-dextran positive on fresh frozen sections.</div></section><section id="sec-4-5-2"><h4>Statistical analysis</h4><div id="p0445" role="paragraph">Statistical significance between groups was calculated by two-tailed Student’s t test unless specified otherwise in the figure legend. Data are expressed as mean ± SEM. Group size was determined on the basis of the results of preliminary experiments and no statistical method was used to predetermine sample size. The indicated sample size (<i>n</i>) represents biological replicates. Group allocation and outcome assessment were not performed in a blinded manner. All samples that met proper experimental conditions were included in the analysis. Survival was measured using the Kaplan–Meier method. Statistical significance was determined by one- and two-way ANOVA, Student’s t test, and log-rank test using Prism 6 software (GraphPad Software) as indicated. Significance was set at p&nbsp;&lt; 0.05.</div></section></section><section id="sec-4-6"><h3>Data and Code Availability</h3><div id="p0450" role="paragraph">The accession number for the RNA-seq data reported in this paper is GEO: <a id="intref0095" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141684" target="_blank">GSE141684</a>. The access number for the whole exome sequencing data reported in this paper is NCBI BioProject: PRJNA607826.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0455" role="paragraph">We thank K.L. Pitter, O. Grbovic-Huezo, and T. Tammela for sharing antibodies; the Molecular Cytology Core at MSKCC for immunofluorescence analysis and quantification; N. Socci and the Bioinformatics Core at MSKCC for assistance with whole-exome sequencing analysis; L. Zamechek, S. Tian, K. Rybczyk, A. Tehuitzil, A. Wuest, and M. Chalarca for technical assistance; A. Schietinger and T. Tammela for helpful suggestions and comments on the manuscript; and other members of the Lowe laboratory for insightful discussions. We thank Mr. William H. Goodwin, Mrs. Alice Goodwin, and the Commonwealth Foundation for Cancer Research for research support. We acknowledge support from the American Cancer Society (ACS) (PF-16-115-01-TBG to M.R., PF-14-066-01-TBE to J.P.M., and GC230452 to D.A.H.), NWO (Rubicon Fellowship 452182318 to R.M.), the German Research Foundation (to J. Leibold), the Alan and Sandra Gerry Metastasis and Ecosystem Center (to J. Leibold), the Blavatnik Family Foundation (to J. Li), the NSF (1752506 to D.A.H.), the Pershing Square Sohn Cancer Research Alliance (to D.A.H.), the Experimental Therapeutics Center at MSKCC (to D.A.H.), the V Foundation (to B.Z.S.), the Abramson Family Cancer Research Institute (to B.Z.S.), the Herrick Foundation endowed chair (to C.J.S.), and the American Lebanese Syrian-Associated Charities of St. Jude Children’s Research Hospital (to C.J.S.). This work was also supported by a Research Investigator award from the Lustgarten Foundation (to S.W.L.), the NCI (CA013106 to S.W.L., K99 CA241110 to M.R., T32 CA062948 and F31 CA 232665 to R.S., and R01 CA215719 to D.A.H.), the NIH (U54 OD020355 to S.W.L. and E.d.S., R01 CA194321 to J.R., K12 CA184746 to P.B.R., and CA229803 to B.Z.S.), a pilot grant from the MSKCC-Parker Institute for Cancer Immunotherapy (to S.W.L.), and a MSKCC support grant (P30 CA008748 to S.W.L.). S.W.L. is the Geoffrey Beene Chair for Cancer Biology and an investigator in the Howard Hughes Medical Institute.</div><section id="sec-5"><h3>Author Contributions</h3><div id="p0460" role="paragraph">M.R., J.P.M., and R.M. conceived the project, performed and analyzed experiments, and wrote the paper with assistance from all authors. M.F., D.A.-C., R.S., and D.A.H. performed and analyzed experiments. J.R., J. Leibold, P.B.R., J.S. A.K., J. Li, R.J.N., E.d.S., and B.Z.S. provided animal models and performed and analyzed <i>in&nbsp;vivo</i> experiments. Y.-j.H. analyzed genomic and transcriptomic datasets. J.E.W. provided histopathological analysis of tissue specimens. C.J.S. and S.W.L. conceived the project, supervised experiments, and wrote the paper.</div></section><section id="sec-6"><h3>Declaration of Interests</h3><div id="p0465" role="paragraph">P.B.R. is a consultant for EMD Serono. D.A.H. is a cofounder of LipidSense, Inc., a cofounder and officer with equity interest in Goldilocks Therapeutics Inc., and a member of the scientific advisory board of Concarlo Holdings, LLC. B.Z.S. is an advisor to iTeos Therapeutics and receives research funding from Boehringer Ingelheim. S.W.L. is a founder and scientific advisory board member of Blueprint Medicines, ORIC Pharmaceuticals, and Geras Bio and received an award and honorarium from Eli Lilly and Company. M.R., J.P.M., R.M., J. Leibold, C.J.S., and S.W.L. have filed a U.S. patent application (Ser. No. 62/694,519) related to this work.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental Information (2)</h2><div id="p0475" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.03.008/attachment/1401f32f-3ea2-4dc0-ac7d-f0243eea6127/mmc1.xlsx" download="mmc1.xlsx" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">Spreadsheet (13.64 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. Antibodies, Related to STAR Methods</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.03.008/attachment/82fe9a6b-5027-4551-869f-ee07ad730786/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (9.36 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. qPCR Primers, Related to STAR Methods</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#figs7" title="View in article">1.</a></div><div>Alexandrov, L.B. ∙ Nik-Zainal, S. ∙ Wedge, D.C. ..., Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, ICGC PedBrain</div><div><strong>Signatures of mutational processes in human cancer</strong></div><div><em>Nature.</em> 2013; <strong>500</strong>:415-421</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84882837534" target="_blank" aria-label="Open Scopus in new tab">Scopus (4094)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23945592/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12477&amp;pmid=23945592" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">2.</a></div><div>Ancrile, B. ∙ Lim, K.H. ∙ Counter, C.M.</div><div><strong>Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis</strong></div><div><em>Genes Dev.</em> 2007; <strong>21</strong>:1714-1719</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1549407" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-34447506658" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17639077/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1549407&amp;pmid=17639077" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3-1" title="View in article">3.</a></div><div>Anders, S. ∙ Pyl, P.T. ∙ Huber, W.</div><div><strong>HTSeq--a Python framework to work with high-throughput sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:166-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu638" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84928987900" target="_blank" aria-label="Open Scopus in new tab">Scopus (6221)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25260700/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu638&amp;pmid=25260700" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88" title="View in article">4.</a></div><div>Baker, D.J. ∙ Childs, B.G. ∙ Durik, M. ...</div><div><strong>Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan</strong></div><div><em>Nature.</em> 2016; <strong>530</strong>:184-189</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature16932" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84958093401" target="_blank" aria-label="Open Scopus in new tab">Scopus (895)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26840489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature16932&amp;pmid=26840489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">5.</a></div><div>Bardeesy, N. ∙ Aguirre, A.J. ∙ Chu, G.C. ...</div><div><strong>Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2006; <strong>103</strong>:5947-5952</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0601273103" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33645824724" target="_blank" aria-label="Open Scopus in new tab">Scopus (387)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16585505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0601273103&amp;pmid=16585505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99" title="View in article">6.</a></div><div>Blando, J. ∙ Sharma, A. ∙ Higa, M.G. ...</div><div><strong>Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2019; <strong>116</strong>:1692-1697</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1811067116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85060784961" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30635425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1811067116&amp;pmid=30635425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">7.</a></div><div>Boj, S.F. ∙ Hwang, C.I. ∙ Baker, L.A. ...</div><div><strong>Organoid models of human and mouse ductal pancreatic cancer</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:324-338</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.12.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.12.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84920983131" target="_blank" aria-label="Open Scopus in new tab">Scopus (662)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25557080/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.12.021&amp;pmid=25557080" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8-1" title="View in article">8.</a></div><div>Bolger, A.M. ∙ Lohse, M. ∙ Usadel, B.</div><div><strong>Trimmomatic: a flexible trimmer for Illumina sequence data</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:2114-2120</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu170" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84905049901" target="_blank" aria-label="Open Scopus in new tab">Scopus (13125)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24695404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu170&amp;pmid=24695404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83-2" title="View in article">9.</a></div><div>Brahmer, J.R. ∙ Tykodi, S.S. ∙ Chow, L.Q. ...</div><div><strong>Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2455-2465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1200694" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84862903106" target="_blank" aria-label="Open Scopus in new tab">Scopus (4530)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22658128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1200694&amp;pmid=22658128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">10.</a></div><div>Brea, E.J. ∙ Oh, C.Y. ∙ Manchado, E. ...</div><div><strong>Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells</strong></div><div><em>Cancer Immunol. Res.</em> 2016; <strong>4</strong>:936-947</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2326-6066.CIR-16-0177" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85016108628" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27680026/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2326-6066.CIR-16-0177&amp;pmid=27680026" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">11.</a></div><div>Buckanovich, R.J. ∙ Facciabene, A. ∙ Kim, S. ...</div><div><strong>Endothelin B receptor mediates the endothelial barrier to T&nbsp;cell homing to tumors and disables immune therapy</strong></div><div><em>Nat. Med.</em> 2008; <strong>14</strong>:28-36</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm1699" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-38049000452" target="_blank" aria-label="Open Scopus in new tab">Scopus (322)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18157142/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm1699&amp;pmid=18157142" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">12.</a></div><div>Caldwell, M.E. ∙ DeNicola, G.M. ∙ Martins, C.P. ...</div><div><strong>Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer</strong></div><div><em>Oncogene.</em> 2012; <strong>31</strong>:1599-1608</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/onc.2011.350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84860389717" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21860420/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fonc.2011.350&amp;pmid=21860420" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13-1" title="View in article">13.</a></div><div>Carmichael, J. ∙ Fink, U. ∙ Russell, R.C. ...</div><div><strong>Phase II study of gemcitabine in patients with advanced pancreatic cancer</strong></div><div><em>Br. J. Cancer.</em> 1996; <strong>73</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/bjc.1996.18" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8554969/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fbjc.1996.18&amp;pmid=8554969" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">14.</a></div><div>Carrière, C. ∙ Gore, A.J. ∙ Norris, A.M. ...</div><div><strong>Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions</strong></div><div><em>Gastroenterology.</em> 2011; <strong>141</strong>:1091-1101</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1053%2Fj.gastro.2011.05.041&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1053%2Fj.gastro.2011.05.041&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80052127297" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21699781/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2011.05.041&amp;pmid=21699781" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78-2" title="View in article">15.</a></div><div>Chauhan, V.P. ∙ Martin, J.D. ∙ Liu, H. ...</div><div><strong>Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels</strong></div><div><em>Nat. Commun.</em> 2013; <strong>4</strong>:2516</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms3516" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84885129359" target="_blank" aria-label="Open Scopus in new tab">Scopus (381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24084631/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms3516&amp;pmid=24084631" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">16.</a></div><div>Chicas, A. ∙ Wang, X. ∙ Zhang, C. ...</div><div><strong>Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:376-387</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2010.01.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77950486542" target="_blank" aria-label="Open Scopus in new tab">Scopus (214)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20385362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.01.023&amp;pmid=20385362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98-1" title="View in article">17.</a></div><div>Chien, Y. ∙ Scuoppo, C. ∙ Wang, X. ...</div><div><strong>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</strong></div><div><em>Genes Dev.</em> 2011; <strong>25</strong>:2125-2136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.17276711" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-80054789761" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21979375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.17276711&amp;pmid=21979375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">18.</a></div><div>Cibulskis, K. ∙ Lawrence, M.S. ∙ Carter, S.L. ...</div><div><strong>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</strong></div><div><em>Nat. Biotechnol.</em> 2013; <strong>31</strong>:213-219</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.2514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84874025843" target="_blank" aria-label="Open Scopus in new tab">Scopus (1950)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23396013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.2514&amp;pmid=23396013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99" title="View in article">19.</a></div><div>Clark, C.E. ∙ Hingorani, S.R. ∙ Mick, R. ...</div><div><strong>Dynamics of the immune reaction to pancreatic cancer from inception to invasion</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:9518-9527</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-07-0175" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-35148814410" target="_blank" aria-label="Open Scopus in new tab">Scopus (518)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17909062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-07-0175&amp;pmid=17909062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">20.</a></div><div>Collins, M.A. ∙ Bednar, F. ∙ Zhang, Y. ...</div><div><strong>Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2012; <strong>122</strong>:639-653</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI59227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84863012865" target="_blank" aria-label="Open Scopus in new tab">Scopus (360)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22232209/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI59227&amp;pmid=22232209" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">21.</a></div><div>Collins, M.A. ∙ Brisset, J.C. ∙ Zhang, Y. ...</div><div><strong>Metastatic pancreatic cancer is dependent on oncogenic Kras in mice</strong></div><div><em>PLoS ONE.</em> 2012; <strong>7</strong>:e49707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0049707" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84870709449" target="_blank" aria-label="Open Scopus in new tab">Scopus (95)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23226501/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0049707&amp;pmid=23226501" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">22.</a></div><div>Coppé, J.P. ∙ Kauser, K. ∙ Campisi, J. ...</div><div><strong>Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2006; <strong>281</strong>:29568-29574</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M603307200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33749549246" target="_blank" aria-label="Open Scopus in new tab">Scopus (292)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16880208/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M603307200&amp;pmid=16880208" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">23.</a></div><div>Coppé, J.P. ∙ Patil, C.K. ∙ Rodier, F. ...</div><div><strong>Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor</strong></div><div><em>PLoS Biol.</em> 2008; <strong>6</strong>:2853-2868</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pbio.0060301" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-58149163445" target="_blank" aria-label="Open Scopus in new tab">Scopus (1689)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19053174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pbio.0060301&amp;pmid=19053174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">24.</a></div><div>Coppé, J.P. ∙ Desprez, P.Y. ∙ Krtolica, A. ...</div><div><strong>The senescence-associated secretory phenotype: the dark side of tumor suppression</strong></div><div><em>Annu. Rev. Pathol.</em> 2010; <strong>5</strong>:99-118</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-pathol-121808-102144" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77949881221" target="_blank" aria-label="Open Scopus in new tab">Scopus (1551)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20078217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-pathol-121808-102144&amp;pmid=20078217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">25.</a></div><div>Demaria, M. ∙ Ohtani, N. ∙ Youssef, S.A. ...</div><div><strong>An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA</strong></div><div><em>Dev. Cell.</em> 2014; <strong>31</strong>:722-733</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84919480323" target="_blank" aria-label="Open Scopus in new tab">Scopus (528)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25499914/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2014.11.012&amp;pmid=25499914" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88" title="View in article">26.</a></div><div>Demaria, M. ∙ O’Leary, M.N. ∙ Chang, J. ...</div><div><strong>Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse</strong></div><div><em>Cancer Discov.</em> 2017; <strong>7</strong>:165-176</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-0241" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85011802318" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27979832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-0241&amp;pmid=27979832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">27.</a></div><div>Deng, J. ∙ Wang, E.S. ∙ Jenkins, R.W. ...</div><div><strong>CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:216-233</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0915" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85041378182" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29101163/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-0915&amp;pmid=29101163" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28-1" title="View in article">28.</a></div><div>Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ...</div><div><strong>STAR: ultrafast universal RNA-seq aligner</strong></div><div><em>Bioinformatics.</em> 2013; <strong>29</strong>:15-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/bts635" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84871809302" target="_blank" aria-label="Open Scopus in new tab">Scopus (8544)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23104886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbts635&amp;pmid=23104886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">29.</a></div><div>Ebert, P.J.R. ∙ Cheung, J. ∙ Yang, Y. ...</div><div><strong>MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:609-621</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2016.01.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84960450202" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26944201/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.01.024&amp;pmid=26944201" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93" title="View in article">30.</a></div><div>Ewald, J.A. ∙ Desotelle, J.A. ∙ Wilding, G. ...</div><div><strong>Therapy-induced senescence in cancer</strong></div><div><em>J.&nbsp;Natl. Cancer Inst.</em> 2010; <strong>102</strong>:1536-1546</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jnci/djq364" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77958590185" target="_blank" aria-label="Open Scopus in new tab">Scopus (351)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20858887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fjnci%2Fdjq364&amp;pmid=20858887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">31.</a></div><div>Faget, D.V. ∙ Ren, Q. ∙ Stewart, S.A.</div><div><strong>Unmasking senescence: context-dependent effects of SASP in cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:439-453</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0156-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85068065547" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31235879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0156-2&amp;pmid=31235879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">32.</a></div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (623)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">33.</a></div><div>Goel, S. ∙ DeCristo, M.J. ∙ Watt, A.C. ...</div><div><strong>CDK4/6 inhibition triggers anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>548</strong>:471-475</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23465" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85028340229" target="_blank" aria-label="Open Scopus in new tab">Scopus (296)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813415/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23465&amp;pmid=28813415" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">34.</a></div><div>Hamzah, J. ∙ Jugold, M. ∙ Kiessling, F. ...</div><div><strong>Vascular normalization in Rgs5-deficient tumours promotes immune destruction</strong></div><div><em>Nature.</em> 2008; <strong>453</strong>:410-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature06868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-43749112760" target="_blank" aria-label="Open Scopus in new tab">Scopus (360)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18418378/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature06868&amp;pmid=18418378" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103" title="View in article">35.</a></div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>The hallmarks of cancer</strong></div><div><em>Cell.</em> 2000; <strong>100</strong>:57-70</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981683-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981683-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0034614637" target="_blank" aria-label="Open Scopus in new tab">Scopus (19600)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10647931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2800%2981683-9&amp;pmid=10647931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">36.</a></div><div>Herreros-Villanueva, M. ∙ Hijona, E. ∙ Cosme, A. ...</div><div><strong>Mouse models of pancreatic cancer</strong></div><div><em>World J. Gastroenterol.</em> 2012; <strong>18</strong>:1286-1294</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3748/wjg.v18.i12.1286" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84859081186" target="_blank" aria-label="Open Scopus in new tab">Scopus (94)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22493542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3748%2Fwjg.v18.i12.1286&amp;pmid=22493542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">37.</a></div><div>Hingorani, S.R. ∙ Petricoin, E.F. ∙ Maitra, A. ...</div><div><strong>Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse</strong></div><div><em>Cancer Cell.</em> 2003; <strong>4</strong>:437-450</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1535-6108%2803%2900309-X&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1535-6108%2803%2900309-X&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-9144266295" target="_blank" aria-label="Open Scopus in new tab">Scopus (1501)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14706336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1535-6108%2803%2900309-X&amp;pmid=14706336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">38.</a></div><div>Huang, Y. ∙ Yuan, J. ∙ Righi, E. ...</div><div><strong>Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:17561-17566</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1215397109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84867902940" target="_blank" aria-label="Open Scopus in new tab">Scopus (412)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23045683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1215397109&amp;pmid=23045683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">39.</a></div><div>Huang, Y. ∙ Kim, B.Y.S. ∙ Chan, C.K. ...</div><div><strong>Improving immune-vascular crosstalk for cancer immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:195-203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.145" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85042584062" target="_blank" aria-label="Open Scopus in new tab">Scopus (72)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29332937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.145&amp;pmid=29332937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-1" title="View in article">40.</a></div><div>Hunt, B.J. ∙ Jurd, K.M.</div><div><strong>Endothelial cell activation. A central pathophysiological process</strong></div><div><em>BMJ.</em> 1998; <strong>316</strong>:1328-1329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.316.7141.1328" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9563977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fbmj.316.7141.1328&amp;pmid=9563977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103" title="View in article">41.</a></div><div>Jain, R.K. ∙ Duda, D.G. ∙ Clark, J.W. ...</div><div><strong>Lessons from phase III clinical trials on anti-VEGF therapy for cancer</strong></div><div><em>Nat. Clin. Pract. Oncol.</em> 2006; <strong>3</strong>:24-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncponc0403" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-30944446883" target="_blank" aria-label="Open Scopus in new tab">Scopus (855)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16407877/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncponc0403&amp;pmid=16407877" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">42.</a></div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">43.</a></div><div>Kang, T.W. ∙ Yevsa, T. ∙ Woller, N. ...</div><div><strong>Senescence surveillance of pre-malignant hepatocytes limits liver cancer development</strong></div><div><em>Nature.</em> 2011; <strong>479</strong>:547-551</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10599" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-81855169964" target="_blank" aria-label="Open Scopus in new tab">Scopus (661)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22080947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10599&amp;pmid=22080947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">44.</a></div><div>Kapoor, A. ∙ Yao, W. ∙ Ying, H. ...</div><div><strong>Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer</strong></div><div><em>Cell.</em> 2014; <strong>158</strong>:185-197</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.06.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2014.06.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84903984143" target="_blank" aria-label="Open Scopus in new tab">Scopus (324)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24954535/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.06.003&amp;pmid=24954535" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100" title="View in article">45.</a></div><div>Kotsantis, P. ∙ Petermann, E. ∙ Boulton, S.J.</div><div><strong>Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place</strong></div><div><em>Cancer Discov.</em> 2018; <strong>8</strong>:537-555</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-17-1461" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85047864974" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29653955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-17-1461&amp;pmid=29653955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Kraman, M. ∙ Bambrough, P.J. ∙ Arnold, J.N. ...</div><div><strong>Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha</strong></div><div><em>Science.</em> 2010; <strong>330</strong>:827-830</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1195300" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-78149298209" target="_blank" aria-label="Open Scopus in new tab">Scopus (559)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21051638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1195300&amp;pmid=21051638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">47.</a></div><div>Krizhanovsky, V. ∙ Yon, M. ∙ Dickins, R.A. ...</div><div><strong>Senescence of activated stellate cells limits liver fibrosis</strong></div><div><em>Cell.</em> 2008; <strong>134</strong>:657-667</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2008.06.049&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-49749145668" target="_blank" aria-label="Open Scopus in new tab">Scopus (955)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18724938/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2008.06.049&amp;pmid=18724938" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">48.</a></div><div>Kuilman, T. ∙ Peeper, D.S.</div><div><strong>Senescence-messaging secretome: SMS-ing cellular stress</strong></div><div><em>Nat. Rev. Cancer.</em> 2009; <strong>9</strong>:81-94</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2560" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-58849154235" target="_blank" aria-label="Open Scopus in new tab">Scopus (510)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19132009/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2560&amp;pmid=19132009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-1" title="View in article">49.</a></div><div>Kuleshov, M.V. ∙ Jones, M.R. ∙ Rouillard, A.D. ...</div><div><strong>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:W90-7</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkw377" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987663170" target="_blank" aria-label="Open Scopus in new tab">Scopus (1516)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27141961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkw377&amp;pmid=27141961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib104" class="citations"><div id="sref104" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref104" title="View in article">50.</a></div><div>Lee, J.J. ∙ Perera, R.M. ∙ Wang, H. ...</div><div><strong>Stromal response to Hedgehog signaling restrains pancreatic cancer progression.</strong></div><div><em>Proc Natl Acad Sci U S A.</em> 2014; E3091-E3100</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1411679111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84904994417" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25024225/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1411679111&amp;pmid=25024225" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98-1" title="View in article">51.</a></div><div>Lesina, M. ∙ Wörmann, S.M. ∙ Morton, J. ...</div><div><strong>RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2016; <strong>126</strong>:2919-2932</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI86477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84987806939" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27454298/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI86477&amp;pmid=27454298" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">52.</a></div><div>Li, H. ∙ Durbin, R.</div><div><strong>Fast and accurate short read alignment with Burrows-Wheeler transform</strong></div><div><em>Bioinformatics.</em> 2009; <strong>25</strong>:1754-1760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67649884743" target="_blank" aria-label="Open Scopus in new tab">Scopus (17629)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtp324&amp;pmid=19451168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">53.</a></div><div>Liao, Y. ∙ Smyth, G.K. ∙ Shi, W.</div><div><strong>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:923-930</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btt656" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84897397058" target="_blank" aria-label="Open Scopus in new tab">Scopus (3491)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24227677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtt656&amp;pmid=24227677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">54.</a></div><div>Ligorio, M. ∙ Sil, S. ∙ Malagon-Lopez, J. ...</div><div><strong>Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:160-175 e127</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2019.05.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2019.05.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85067683716" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31155233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.05.012&amp;pmid=31155233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-1" title="View in article">55.</a></div><div>Lorenzon, P. ∙ Vecile, E. ∙ Nardon, E. ...</div><div><strong>Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1998; <strong>142</strong>:1381-1391</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.142.5.1381" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0032494169" target="_blank" aria-label="Open Scopus in new tab">Scopus (194)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9732297/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.142.5.1381&amp;pmid=9732297" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">56.</a></div><div>Love, M.I. ∙ Huber, W. ∙ Anders, S.</div><div><strong>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</strong></div><div><em>Genome Biol.</em> 2014; <strong>15</strong>:550</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13059-014-0550-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84924629414" target="_blank" aria-label="Open Scopus in new tab">Scopus (12911)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25516281/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs13059-014-0550-8&amp;pmid=25516281" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">57.</a></div><div>Lujambio, A. ∙ Akkari, L. ∙ Simon, J. ...</div><div><strong>Non-cell-autonomous tumor suppression by p53</strong></div><div><em>Cell.</em> 2013; <strong>153</strong>:449-460</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2013.03.020&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.cell.2013.03.020&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84876291823" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23562644/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2013.03.020&amp;pmid=23562644" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">58.</a></div><div>Manchado, E. ∙ Weissmueller, S. ∙ Morris, 4th, J.P. ...</div><div><strong>A combinatorial strategy for treating KRAS-mutant lung cancer</strong></div><div><em>Nature.</em> 2016; <strong>534</strong>:647-651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18600" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338794/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18600&amp;pmid=27338794" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">59.</a></div><div>Martin, M.</div><div><strong>Cutadapt removes adapter sequences from high-throughput sequencing reads</strong></div><div><em>EMBnet.journal.</em> 2011; <strong>17</strong>:10-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.14806/ej.17.1.200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.14806%2Fej.17.1.200" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59" title="View in article">60.</a></div><div>McKenna, A. ∙ Hanna, M. ∙ Banks, E. ...</div><div><strong>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</strong></div><div><em>Genome Res.</em> 2010; <strong>20</strong>:1297-1303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gr.107524.110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77956295988" target="_blank" aria-label="Open Scopus in new tab">Scopus (9757)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgr.107524.110&amp;pmid=20644199" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">61.</a></div><div>Meylan, E. ∙ Dooley, A.L. ∙ Feldser, D.M. ...</div><div><strong>Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma</strong></div><div><em>Nature.</em> 2009; <strong>462</strong>:104-107</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature08462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-70449109147" target="_blank" aria-label="Open Scopus in new tab">Scopus (383)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19847165/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature08462&amp;pmid=19847165" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">62.</a></div><div>Mikuła-Pietrasik, J. ∙ Sosińska, P. ∙ Naumowicz, E. ...</div><div><strong>Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in&nbsp;vitro and in a mouse xenograft model in&nbsp;vivo</strong></div><div><em>Clin. Exp. Metastasis.</em> 2016; <strong>33</strong>:15-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10585-015-9753-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84957438754" target="_blank" aria-label="Open Scopus in new tab">Scopus (11)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26433963/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10585-015-9753-y&amp;pmid=26433963" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62" title="View in article">63.</a></div><div>Morris, 4th, J.P. ∙ Wang, S.C. ∙ Hebrok, M.</div><div><strong>KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:683-695</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2899" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77957150824" target="_blank" aria-label="Open Scopus in new tab">Scopus (376)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20814421/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2899&amp;pmid=20814421" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63-1" title="View in article">64.</a></div><div>Morris, 4th, J.P. ∙ Yashinskie, J.J. ∙ Koche, R. ...</div><div><strong>α-Ketoglutarate links p53 to cell fate during tumour suppression</strong></div><div><em>Nature.</em> 2019; <strong>573</strong>:595-599</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1577-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85072686860" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31534224/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1577-5&amp;pmid=31534224" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">65.</a></div><div>Morton, J.P. ∙ Timpson, P. ∙ Karim, S.A. ...</div><div><strong>Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:246-251</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0908428107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-76249108357" target="_blank" aria-label="Open Scopus in new tab">Scopus (344)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20018721/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0908428107&amp;pmid=20018721" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">66.</a></div><div>Mose, L.E. ∙ Wilkerson, M.D. ∙ Hayes, D.N. ...</div><div><strong>ABRA: improved coding indel detection via assembly-based realignment</strong></div><div><em>Bioinformatics.</em> 2014; <strong>30</strong>:2813-2815</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84911383104" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24907369/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu376&amp;pmid=24907369" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">67.</a></div><div>Mosteiro, L. ∙ Pantoja, C. ∙ Alcazar, N. ...</div><div><strong>Tissue damage and senescence provide critical signals for cellular reprogramming in&nbsp;vivo</strong></div><div><em>Science.</em> 2016; <strong>354</strong>:aaf4445</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf4445" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27884981/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf4445&amp;pmid=27884981" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">68.</a></div><div>Muller, W.A.</div><div><strong>Mechanisms of transendothelial migration of leukocytes</strong></div><div><em>Circ. Res.</em> 2009; <strong>105</strong>:223-230</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/CIRCRESAHA.109.200717" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-69249238022" target="_blank" aria-label="Open Scopus in new tab">Scopus (194)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19644057/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FCIRCRESAHA.109.200717&amp;pmid=19644057" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">69.</a></div><div>Nandi, A. ∙ Estess, P. ∙ Siegelman, M.</div><div><strong>Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T&nbsp;cell extravasation</strong></div><div><em>Immunity.</em> 2004; <strong>20</strong>:455-465</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1074-7613%2804%2900077-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS1074-7613%2804%2900077-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-1842633889" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15084274/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2804%2900077-9&amp;pmid=15084274" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">70.</a></div><div>Narita, M. ∙ Nũnez, S. ∙ Heard, E. ...</div><div><strong>Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence</strong></div><div><em>Cell.</em> 2003; <strong>113</strong>:703-716</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2803%2900401-X&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2803%2900401-X&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0037667702" target="_blank" aria-label="Open Scopus in new tab">Scopus (1447)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12809602/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2803%2900401-X&amp;pmid=12809602" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">71.</a></div><div>Neves, J. ∙ Demaria, M. ∙ Campisi, J. ...</div><div><strong>Of flies, mice, and men: evolutionarily conserved tissue damage responses and aging</strong></div><div><em>Dev. Cell.</em> 2015; <strong>32</strong>:9-18</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.028&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.devcel.2014.11.028&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84922350817" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25584795/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2014.11.028&amp;pmid=25584795" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">72.</a></div><div>Öhlund, D. ∙ Handly-Santana, A. ∙ Biffi, G. ...</div><div><strong>Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2017; <strong>214</strong>:579-596</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20162024" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85018017663" target="_blank" aria-label="Open Scopus in new tab">Scopus (381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28232471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20162024&amp;pmid=28232471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">73.</a></div><div>Okumura, S. ∙ Jänne, P.A.</div><div><strong>Molecular pathways: the basis for rational combination using MEK inhibitors in KRAS-mutant cancers</strong></div><div><em>Clin. Cancer Res.</em> 2014; <strong>20</strong>:4193-4199</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-13-2365" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84905985518" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24907112/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-13-2365&amp;pmid=24907112" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78-1" title="View in article">74.</a></div><div>Olive, K.P. ∙ Jacobetz, M.A. ∙ Davidson, C.J. ...</div><div><strong>Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</strong></div><div><em>Science.</em> 2009; <strong>324</strong>:1457-1461</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1171362" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-67149143399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1982)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19460966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1171362&amp;pmid=19460966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">75.</a></div><div>Oubaha, M. ∙ Miloudi, K. ∙ Dejda, A. ...</div><div><strong>Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:362ra144</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aaf9440" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84993927167" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aaf9440&amp;pmid=27797960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">76.</a></div><div>Panni, R.Z. ∙ Herndon, J.M. ∙ Zuo, C. ...</div><div><strong>Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies</strong></div><div><em>Sci. Transl. Med.</em> 2019; <strong>11</strong>:eaau9240</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aau9240" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85069269407" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31270275/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aau9240&amp;pmid=31270275" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">77.</a></div><div>Plunkett, W. ∙ Huang, P. ∙ Xu, Y.Z. ...</div><div><strong>Gemcitabine: metabolism, mechanisms of action, and self-potentiation</strong></div><div><em>Semin. Oncol.</em> 1995; <strong>22</strong>:3-10</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7481842/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=7481842" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">78.</a></div><div>Poirier, J.T. ∙ Gardner, E.E. ∙ Connis, N. ...</div><div><strong>DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2</strong></div><div><em>Oncogene.</em> 2015; <strong>34</strong>:5869-5878</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/onc.2015.38" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84948570001" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25746006/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fonc.2015.38&amp;pmid=25746006" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78-1" title="View in article">79.</a></div><div>Provenzano, P.P. ∙ Cuevas, C. ∙ Chang, A.E. ...</div><div><strong>Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:418-429</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2012.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84858602107" target="_blank" aria-label="Open Scopus in new tab">Scopus (1020)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22439937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.01.007&amp;pmid=22439937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79-1" title="View in article">80.</a></div><div>Rhim, A.D. ∙ Oberstein, P.E. ∙ Thomas, D.H. ...</div><div><strong>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:735-747</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84902435628" target="_blank" aria-label="Open Scopus in new tab">Scopus (857)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.021&amp;pmid=24856585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83-1" title="View in article">81.</a></div><div>Ribas, A. ∙ Wolchok, J.D.</div><div><strong>Cancer immunotherapy using checkpoint blockade</strong></div><div><em>Science.</em> 2018; <strong>359</strong>:1350-1355</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aar4060" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85045378539" target="_blank" aria-label="Open Scopus in new tab">Scopus (1070)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29567705/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aar4060&amp;pmid=29567705" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81" title="View in article">82.</a></div><div>Ribas, A. ∙ Lawrence, D. ∙ Atkinson, V. ...</div><div><strong>Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:936-940</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0476-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85067192938" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31171879/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0476-5&amp;pmid=31171879" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82" title="View in article">83.</a></div><div>Rosow, D.E. ∙ Liss, A.S. ∙ Strobel, O. ...</div><div><strong>Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench</strong></div><div><em>Surgery.</em> 2012; <strong>152</strong>:S19-S32</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.surg.2012.05.030&amp;cf=fulltext&amp;site=ymsy-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.surg.2012.05.030&amp;cf=pdf&amp;site=ymsy-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84865266369" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770959/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.surg.2012.05.030&amp;pmid=22770959" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83-1" title="View in article">84.</a></div><div>Royal, R.E. ∙ Levy, C. ∙ Turner, K. ...</div><div><strong>Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma</strong></div><div><em>J.&nbsp;Immunother.</em> 2010; <strong>33</strong>:828-833</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/CJI.0b013e3181eec14c" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77958050577" target="_blank" aria-label="Open Scopus in new tab">Scopus (506)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20842054/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCJI.0b013e3181eec14c&amp;pmid=20842054" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84-1" title="View in article">85.</a></div><div>Ruscetti, M. ∙ Leibold, J. ∙ Bott, M.J. ...</div><div><strong>NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination</strong></div><div><em>Science.</em> 2018; <strong>362</strong>:1416-1422</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aas9090" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85058822733" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30573629/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aas9090&amp;pmid=30573629" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">86.</a></div><div>Salmon, H. ∙ Remark, R. ∙ Gnjatic, S. ...</div><div><strong>Host tissue determinants of tumour immunity</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:215-227</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0125-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85063013311" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30867580/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0125-9&amp;pmid=30867580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">87.</a></div><div>Samstein, R.M. ∙ Lee, C.H. ∙ Shoushtari, A.N. ...</div><div><strong>Tumor mutational load predicts survival after immunotherapy across multiple cancer types</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:202-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41588-018-0312-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85059965982" target="_blank" aria-label="Open Scopus in new tab">Scopus (423)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41588-018-0312-8&amp;pmid=30643254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">88.</a></div><div>Schaer, D.A. ∙ Beckmann, R.P. ∙ Dempsey, J.A. ...</div><div><strong>The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade</strong></div><div><em>Cell Rep.</em> 2018; <strong>22</strong>:2978-2994</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2018.02.053&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85043587035" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29539425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.02.053&amp;pmid=29539425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88" title="View in article">89.</a></div><div>Schafer, M.J. ∙ White, T.A. ∙ Iijima, K. ...</div><div><strong>Cellular senescence mediates fibrotic pulmonary disease</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:14532</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms14532" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85013807598" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28230051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms14532&amp;pmid=28230051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib89" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">90.</a></div><div>Schumacher, T.N. ∙ Schreiber, R.D.</div><div><strong>Neoantigens in cancer immunotherapy</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:69-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa4971" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84928770388" target="_blank" aria-label="Open Scopus in new tab">Scopus (1840)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25838375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa4971&amp;pmid=25838375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib90" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">91.</a></div><div>Serrano, M. ∙ Lin, A.W. ∙ McCurrach, M.E. ...</div><div><strong>Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</strong></div><div><em>Cell.</em> 1997; <strong>88</strong>:593-602</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981902-9&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2FS0092-8674%2800%2981902-9&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-0030944985" target="_blank" aria-label="Open Scopus in new tab">Scopus (3547)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9054499/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2800%2981902-9&amp;pmid=9054499" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib91" class="citations"><div id="sref91" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97" title="View in article">92.</a></div><div>Sharpe, A.H. ∙ Pauken, K.E.</div><div><strong>The diverse functions of the PD1 inhibitory pathway</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:153-167</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.108" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85041484537" target="_blank" aria-label="Open Scopus in new tab">Scopus (266)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28990585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.108&amp;pmid=28990585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib92" class="citations"><div id="sref92" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">93.</a></div><div>Shrimali, R.K. ∙ Yu, Z. ∙ Theoret, M.R. ...</div><div><strong>Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer</strong></div><div><em>Cancer Res.</em> 2010; <strong>70</strong>:6171-6180</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-0153" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-77955406159" target="_blank" aria-label="Open Scopus in new tab">Scopus (353)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20631075/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-0153&amp;pmid=20631075" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib93" class="citations"><div id="sref93" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93" title="View in article">94.</a></div><div>Sieben, C.J. ∙ Sturmlechner, I. ∙ van de Sluis, B. ...</div><div><strong>Two-Step Senescence-Focused Cancer Therapies</strong></div><div><em>Trends Cell Biol.</em> 2018; <strong>28</strong>:723-737</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.tcb.2018.04.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.tcb.2018.04.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85047207382" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29776716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tcb.2018.04.006&amp;pmid=29776716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib94" class="citations"><div id="sref94" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94" title="View in article">95.</a></div><div>Siegel, R.L. ∙ Miller, K.D. ∙ Jemal, A.</div><div><strong>Cancer statistics, 2019</strong></div><div><em>CA Cancer J. Clin.</em> 2019; <strong>69</strong>:7-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3322/caac.21551" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85059687888" target="_blank" aria-label="Open Scopus in new tab">Scopus (5520)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30620402/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3322%2Fcaac.21551&amp;pmid=30620402" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib95" class="citations"><div id="sref95" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref95" title="View in article">96.</a></div><div>Steele, C.W. ∙ Karim, S.A. ∙ Leach, J.D.G. ...</div><div><strong>CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2016; <strong>29</strong>:832-845</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccell.2016.04.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.ccell.2016.04.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84976515614" target="_blank" aria-label="Open Scopus in new tab">Scopus (247)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27265504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.04.014&amp;pmid=27265504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib96" class="citations"><div id="sref96" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">97.</a></div><div>Sun, C. ∙ Hobor, S. ∙ Bertotti, A. ...</div><div><strong>Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3</strong></div><div><em>Cell Rep.</em> 2014; <strong>7</strong>:86-93</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2014.02.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.celrep.2014.02.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84898023140" target="_blank" aria-label="Open Scopus in new tab">Scopus (171)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24685132/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.02.045&amp;pmid=24685132" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib97" class="citations"><div id="sref97" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97" title="View in article">98.</a></div><div>Sun, C. ∙ Mezzadra, R. ∙ Schumacher, T.N.</div><div><strong>Regulation and Function of the PD-L1 Checkpoint</strong></div><div><em>Immunity.</em> 2018; <strong>48</strong>:434-452</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2018.03.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=10.1016%2Fj.immuni.2018.03.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85043754064" target="_blank" aria-label="Open Scopus in new tab">Scopus (945)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29562194/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.03.014&amp;pmid=29562194" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib98" class="citations"><div id="sref98" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98-1" title="View in article">99.</a></div><div>Tasdemir, N. ∙ Banito, A. ∙ Roe, J.S. ...</div><div><strong>BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:612-629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-16-0217" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27099234/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-16-0217&amp;pmid=27099234" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib99" class="citations"><div id="sref99" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99" title="View in article">100.</a></div><div>Vonderheide, R.H. ∙ Bayne, L.J.</div><div><strong>Inflammatory networks and immune surveillance of pancreatic carcinoma</strong></div><div><em>Curr. Opin. Immunol.</em> 2013; <strong>25</strong>:200-205</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2013.01.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-84877052290" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23422836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2013.01.006&amp;pmid=23422836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib100" class="citations"><div id="sref100" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100" title="View in article">101.</a></div><div>Woo, R.A. ∙ Poon, R.Y.</div><div><strong>Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation</strong></div><div><em>Genes Dev.</em> 2004; <strong>18</strong>:1317-1330</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1165204" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-2642527955" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15175263/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1165204&amp;pmid=15175263" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib101" class="citations"><div id="sref101" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">102.</a></div><div>Wu, N.Z. ∙ Klitzman, B. ∙ Dodge, R. ...</div><div><strong>Diminished leukocyte-endothelium interaction in tumor microvessels</strong></div><div><em>Cancer Res.</em> 1992; <strong>52</strong>:4265-4268</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1638539/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=1638539" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib102" class="citations"><div id="sref102" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref102" title="View in article">103.</a></div><div>Xue, W. ∙ Zender, L. ∙ Miething, C. ...</div><div><strong>Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas</strong></div><div><em>Nature.</em> 2007; <strong>445</strong>:656-660</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature05529" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-33846937033" target="_blank" aria-label="Open Scopus in new tab">Scopus (1502)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17251933/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature05529&amp;pmid=17251933" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib103" class="citations"><div id="sref103" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103" title="View in article">104.</a></div><div>Zirlik, K. ∙ Duyster, J.</div><div><strong>Anti-Angiogenics: Current Situation and Future Perspectives</strong></div><div><em>Oncol. Res. Treat.</em> 2018; <strong>41</strong>:166-171</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1159/000488087" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.03.008&amp;key=2-s2.0-85044394391" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29562226/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1159%2F000488087&amp;pmid=29562226" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/bc125d76-9d1d-43c1-98af-1775c2a7d20d/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/f6ea2f17-fe06-46c4-b219-e45b0f8e2fcd/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/b336d3c0-3025-4666-9bca-626889fe2b59/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/5cdece2b-6299-4872-bf78-ae386cc84e33/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/63b1ddea-97ae-4ba1-95ef-f75925f7a5a6/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/74ea3da0-c903-4286-81e3-fed3f15df195/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/f2eb2959-6c57-4f37-80bc-05bbb69fc476/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/a0dfc3bc-8d0b-41cc-bcc4-54f1feb70233/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/21dbc32c-28a9-4c5c-b193-f26f548142da/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/b9f8c110-e985-4688-b253-f3b0e5930fd7/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/498a237c-641a-43ea-ac39-541dc85da308/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/0d56817e-9b04-4dca-9c83-d200589e95ff/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/c1be2b73-90b0-4e29-8f0f-3edc174d46e6/main.assets/figs7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/asset/81d8b5bc-f40f-42bc-a96c-d3a80315a538/main.assets/gr7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Barticle%3Aarticle%3Apii%5C%3AS0092867420302701%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3Apii%5C%3AS0092867419X00094" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">271</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">368</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-mention">
                        <div class="plum-x__item-num">1</div>
                        <div class="plum-x__item-title">Mentions</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">17</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2020.03.008&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (2)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/attachment/1401f32f-3ea2-4dc0-ac7d-f0243eea6127/mmc1.xlsx" download="mmc1.xlsx"><span id="mmc1-link">Spreadsheet (13.64 KB)</span></a><div class="core-description">Table S1. Antibodies, Related to STAR Methods</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.03.008/attachment/82fe9a6b-5027-4551-869f-ee07ad730786/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (9.36 KB)</span></a><div class="core-description">Table S2. qPCR Primers, Related to STAR Methods</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867420302701" class="ux3DeferredOnScrollWidget axel-related-articles__body" data-show-more="true"></div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2020.03.008","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.03.008/asset/bc125d76-9d1d-43c1-98af-1775c2a7d20d/main.assets/gr1.jpg" height="698" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/0c1016e4-8971-48ba-a998-8a26797c70c2/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.03.008/asset/f6ea2f17-fe06-46c4-b219-e45b0f8e2fcd/main.assets/figs1.jpg" height="950" width="738" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6e51877a-02e5-404e-96d0-a7c057c84b36/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.03.008/asset/b336d3c0-3025-4666-9bca-626889fe2b59/main.assets/gr2.jpg" height="865" width="762" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/06d3b520-2fdc-4369-9b86-4e86dec74055/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.03.008/asset/5cdece2b-6299-4872-bf78-ae386cc84e33/main.assets/figs2.jpg" height="941" width="812" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/e03d9525-93b8-4d16-be1a-ef8fbbce7425/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.03.008/asset/63b1ddea-97ae-4ba1-95ef-f75925f7a5a6/main.assets/figs3.jpg" height="573" width="762" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/f9557230-afbb-4256-b274-2b4f43dbcc62/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.03.008/asset/74ea3da0-c903-4286-81e3-fed3f15df195/main.assets/gr3.jpg" height="951" width="754" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/887a5c76-69f5-48fb-af02-cded82efc560/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.03.008/asset/f2eb2959-6c57-4f37-80bc-05bbb69fc476/main.assets/figs4.jpg" height="950" width="742" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/35f5a4ee-0de0-4fe9-bb7d-ca377baade99/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.03.008/asset/a0dfc3bc-8d0b-41cc-bcc4-54f1feb70233/main.assets/gr4.jpg" height="951" width="741" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6a978171-43e4-4e7b-a6ab-2a5acf373a93/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.03.008/asset/21dbc32c-28a9-4c5c-b193-f26f548142da/main.assets/figs5.jpg" height="361" width="762" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/5a12f040-eb55-44f0-80f9-3633e07311d8/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.03.008/asset/b9f8c110-e985-4688-b253-f3b0e5930fd7/main.assets/gr5.jpg" height="636" width="762" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/89261136-185e-46cb-be63-893ba8579cf4/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.03.008/asset/498a237c-641a-43ea-ac39-541dc85da308/main.assets/figs6.jpg" height="806" width="762" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/fa1cd72c-b600-4d21-b764-b57fee0a8610/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.03.008/asset/0d56817e-9b04-4dca-9c83-d200589e95ff/main.assets/gr6.jpg" height="753" width="678" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/99f48614-18d7-48b0-94c7-95bab5edfaa2/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.03.008/asset/c1be2b73-90b0-4e29-8f0f-3edc174d46e6/main.assets/figs7.jpg" height="950" width="763" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/d1cbc36e-743d-4b32-8d02-876c989efc6e/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.03.008/asset/81d8b5bc-f40f-42bc-a96c-d3a80315a538/main.assets/gr7.jpg" height="956" width="786" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/4c4db4a0-924b-4a5f-925e-5213893373a9/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.03.008/asset/bc125d76-9d1d-43c1-98af-1775c2a7d20d/main.assets/gr1.jpg" height="698" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/0c1016e4-8971-48ba-a998-8a26797c70c2/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.03.008/asset/f6ea2f17-fe06-46c4-b219-e45b0f8e2fcd/main.assets/figs1.jpg" height="950" width="738" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6e51877a-02e5-404e-96d0-a7c057c84b36/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.03.008/asset/b336d3c0-3025-4666-9bca-626889fe2b59/main.assets/gr2.jpg" height="865" width="762" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/06d3b520-2fdc-4369-9b86-4e86dec74055/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.03.008/asset/5cdece2b-6299-4872-bf78-ae386cc84e33/main.assets/figs2.jpg" height="941" width="812" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/e03d9525-93b8-4d16-be1a-ef8fbbce7425/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.03.008/asset/63b1ddea-97ae-4ba1-95ef-f75925f7a5a6/main.assets/figs3.jpg" height="573" width="762" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/f9557230-afbb-4256-b274-2b4f43dbcc62/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.03.008/asset/74ea3da0-c903-4286-81e3-fed3f15df195/main.assets/gr3.jpg" height="951" width="754" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/887a5c76-69f5-48fb-af02-cded82efc560/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.03.008/asset/f2eb2959-6c57-4f37-80bc-05bbb69fc476/main.assets/figs4.jpg" height="950" width="742" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/35f5a4ee-0de0-4fe9-bb7d-ca377baade99/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.03.008/asset/a0dfc3bc-8d0b-41cc-bcc4-54f1feb70233/main.assets/gr4.jpg" height="951" width="741" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/6a978171-43e4-4e7b-a6ab-2a5acf373a93/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.03.008/asset/21dbc32c-28a9-4c5c-b193-f26f548142da/main.assets/figs5.jpg" height="361" width="762" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/5a12f040-eb55-44f0-80f9-3633e07311d8/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.03.008/asset/b9f8c110-e985-4688-b253-f3b0e5930fd7/main.assets/gr5.jpg" height="636" width="762" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/89261136-185e-46cb-be63-893ba8579cf4/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.03.008/asset/498a237c-641a-43ea-ac39-541dc85da308/main.assets/figs6.jpg" height="806" width="762" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/fa1cd72c-b600-4d21-b764-b57fee0a8610/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.03.008/asset/0d56817e-9b04-4dca-9c83-d200589e95ff/main.assets/gr6.jpg" height="753" width="678" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/99f48614-18d7-48b0-94c7-95bab5edfaa2/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.03.008/asset/c1be2b73-90b0-4e29-8f0f-3edc174d46e6/main.assets/figs7.jpg" height="950" width="763" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/d1cbc36e-743d-4b32-8d02-876c989efc6e/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.03.008/asset/81d8b5bc-f40f-42bc-a96c-d3a80315a538/main.assets/gr7.jpg" height="956" width="786" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.03.008/asset/4c4db4a0-924b-4a5f-925e-5213893373a9/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30270-1';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30270-1';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749586099736","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"181","issueNumber":"2","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867420302701","coverDate":"202004","type":"XOCS-JOURNAL:SCOPE-FULL","title":"SenescenceInduced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94db7ffa5a85428c',t:'MTc0OTU4NjA5OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94db7ffa5a85428c&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2020.03.008&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>